{
    "__type__": "Deck", 
    "children": [], 
    "crowdanki_uuid": "91b6beb0-576b-11e8-9d0c-5ce0c5bacc04", 
    "deck_config_uuid": "edd25bf0-1693-11e8-9adc-0050b6c6d7f0", 
    "deck_configurations": [
        {
            "__type__": "DeckConfig", 
            "autoplay": true, 
            "crowdanki_uuid": "edd25bf0-1693-11e8-9adc-0050b6c6d7f0", 
            "dyn": false, 
            "lapse": {
                "delays": [
                    10
                ], 
                "leechAction": 0, 
                "leechFails": 8, 
                "minInt": 1, 
                "mult": 0.0
            }, 
            "maxTaken": 60, 
            "name": "Default", 
            "new": {
                "bury": true, 
                "delays": [
                    1, 
                    10
                ], 
                "initialFactor": 2500, 
                "ints": [
                    1, 
                    4, 
                    7
                ], 
                "order": 1, 
                "perDay": 40, 
                "separate": true
            }, 
            "replayq": true, 
            "rev": {
                "bury": true, 
                "ease4": 1.3, 
                "fuzz": 0.05, 
                "ivlFct": 1.0, 
                "maxIvl": 36500, 
                "minSpace": 1, 
                "perDay": 100
            }, 
            "timer": 0
        }
    ], 
    "desc": "", 
    "dyn": 0, 
    "extendNew": 10, 
    "extendRev": 50, 
    "media_files": [
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-7-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-O.svg", 
        "31da79e1352d420083df88127db7706c-oa-14-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-7-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-6-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-O.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-1-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-9-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-2-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-16-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-8-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-4-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-2-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-7-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-3-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-11-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-8-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-4-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-2-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-1-Q.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-3-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-4-A.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-1-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-17-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-2-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-O.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-4-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-10-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-7-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-6-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-3-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-14-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-5-A.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-6-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-6-A.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-1-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-3-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-5-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-7-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-12-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-5-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-5-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-1-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-6-Q.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-3-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-9-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-O.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-6-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-10-A.svg", 
        "tmp0TYXXg.png", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-1-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-7-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-2-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-1-A.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-6-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-13-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-2-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-1-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-3-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-10-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-4-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-6-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-6-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-5-Q.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-4-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-7-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-5-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-2-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-10-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-3-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-3-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-11-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-7-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-5-Q.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-3-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-4-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-3-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-3-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-O.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-12-Q.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-O.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-9-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-8-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-3-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-1-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-11-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-12-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-2-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-3-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-12-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-3-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-8-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-3-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-3-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-16-A.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-6-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-3-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-2-Q.svg", 
        "tmpZHmUBT.png", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-2-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-12-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-2-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-6-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-2-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-11-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-4-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-8-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-6-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-5-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-2-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-1-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-17-A.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-1-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-9-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-4-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-2-Q.svg", 
        "paste-43383464657282.jpg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-5-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-10-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-2-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-6-Q.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-1-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-15-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-7-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-5-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-1-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-6-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-8-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-4-A.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-5-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-7-A.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-5-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-4-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-5-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-11-A.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-1-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-7-Q.svg", 
        "e4e3e8a5d2c54cbe844eabed65e6d984-ao-O.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-3-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-5-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-7-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-10-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-8-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-5-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-5-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-12-A.svg", 
        "tmp2ytuxP.png", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-7-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-15-A.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-2-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-2-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-1-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-7-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-3-A.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-2-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-7-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-10-A.svg", 
        "tmpk6Dfx1.png", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-4-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-1-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-9-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-7-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-5-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-8-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-1-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-9-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-1-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-6-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-7-Q.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png", 
        "97e3949ec6864d339848a7028ed74ead-oa-1-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-2-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-6-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-7-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-1-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-12-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-9-A.svg", 
        "tmpiorSOQ.png", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-12-A.svg", 
        "e4e3e8a5d2c54cbe844eabed65e6d984_tmpkgpmq8.png", 
        "52ff00f3d70e41368901ccf194969601-oa-6-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-1-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-12-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-10-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-14-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-13-A.svg", 
        "tmpYAdUX8.png", 
        "9bb412689a134f32933ea71a789c39cf-oa-5-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-11-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-2-A.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-2-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-3-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-4-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-3-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-4-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-1-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-18-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-1-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-2-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-1-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-6-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-12-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-2-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-5-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-6-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-4-A.svg", 
        "tmpnDFoAn.png", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-13-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-4-A.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-8-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-5-A.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-1-Q.svg", 
        "stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-O.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-10-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-3-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-1-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-1-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-11-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-8-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-3-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-6-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-16-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-2-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-7-Q.svg", 
        "e4e3e8a5d2c54cbe844eabed65e6d984-ao-1-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-3-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-4-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-O.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-4-A.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-3-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-9-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-3-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-2-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-9-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-11-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-6-Q.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-3-A.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-2-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-7-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-5-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-3-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-7-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-2-A.svg", 
        "tmpLS5C_u.png", 
        "169747a37db545b38cd40d8c86d4b008-oa-3-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-10-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-8-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png", 
        "085981af72b143f5922ad8a3ad0ba694-ao-O.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-6-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-7-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-12-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-2-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-8-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-4-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-5-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-3-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-6-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-6-A.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-4-Q.svg", 
        "tmpUY78F4.png", 
        "0cdbd102581e4338bd9a115361607b07-oa-8-A.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-1-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-10-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-11-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-9-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-3-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-7-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-11-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-2-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-5-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-2-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-2-A.svg", 
        "tmpVxw4g8.png", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-12-A.svg", 
        "tmpqQN7cL.png", 
        "068a0307b9104679a8ae92ced0f693bb-oa-5-A.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-1-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-1-A.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-4-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-10-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-5-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-12-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-O.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-1-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-3-A.svg", 
        "tmpkwNqOz.png", 
        "067223f9a9e6452491d86b393eac9300-oa-12-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-2-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-4-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-2-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-10-Q.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-2-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-5-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-11-Q.svg", 
        "paste-43349104918912.jpg", 
        "31da79e1352d420083df88127db7706c-oa-14-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-8-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-1-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-3-Q.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-5-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-13-A.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-3-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-9-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-4-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-11-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-10-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-8-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-1-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-1-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-7-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-5-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-7-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-1-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-4-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-8-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-9-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-2-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-1-A.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-2-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-8-A.svg", 
        "tmpvvPiYo.png", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-5-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-12-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-9-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-1-A.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-O.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-2-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-1-A.svg", 
        "tmpcv6CXV.png", 
        "0cdbd102581e4338bd9a115361607b07-oa-7-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-14-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-16-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-4-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-O.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-5-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-4-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-3-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-7-A.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-2-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-9-A.svg", 
        "tmplgxGdZ.png", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-2-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-11-A.svg", 
        "tmprblswa.png", 
        "31da79e1352d420083df88127db7706c-oa-12-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-5-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-15-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-2-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-2-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-6-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-4-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-3-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-8-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-2-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-11-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-8-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-1-Q.svg", 
        "4740d913cfa140c3a4207d3c151f2a7b-oa-4-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-3-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-3-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-6-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-2-Q.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-9-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-4-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-4-A.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-O.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-7-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-15-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-18-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-1-Q.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-6-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-9-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-3-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-2-Q.svg", 
        "tmpHeEwuG.png", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-11-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-7-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-4-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-7-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-4-A.svg", 
        "tmpj0M47r.png", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-7-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-12-A.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-6-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-10-Q.svg", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-4-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-5-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-2-A.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-11-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-8-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-8-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-5-A.svg", 
        "paste-3539053051907.jpg", 
        "e4e3e8a5d2c54cbe844eabed65e6d984-ao-1-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-11-A.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-4-A.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-6-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-6-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-3-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-4-Q.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-6-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-5-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-10-Q.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-4-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-7-Q.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-6-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-2-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-4-A.svg", 
        "c83fc304c11f412abfb7a595aa3f498e-oa-5-Q.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-7-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-13-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-11-A.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-4-A.svg", 
        "tmpkQmGQQ.png", 
        "02ec0421dd3c4d5c963b8f320b19967a-oa-1-Q.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-3-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-1-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-6-A.svg", 
        "ad09d0d34d2d464dbf64527c53e0058b-oa-1-Q.svg", 
        "169747a37db545b38cd40d8c86d4b008-oa-5-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-14-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-12-A.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-5-A.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-13-Q.svg", 
        "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-1-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-8-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-8-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-9-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-O.svg", 
        "4ca0f2879c1741d4907301a746fdcaa6-oa-1-Q.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-4-Q.svg", 
        "0cdbd102581e4338bd9a115361607b07-oa-6-A.svg", 
        "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-5-A.svg", 
        "067223f9a9e6452491d86b393eac9300-oa-4-Q.svg", 
        "068a0307b9104679a8ae92ced0f693bb-oa-3-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-6-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-8-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-6-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-1-A.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg", 
        "97e3949ec6864d339848a7028ed74ead-oa-3-A.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-10-Q.svg", 
        "627e5df105064a4aa4c3db7b1f6c3fb2-ao-3-A.svg", 
        "0ba9d2e615d54bcda9057ef9b71fa453-oa-6-Q.svg", 
        "56d415d9bb6d4c20b337b2e3b0b16959-oa-8-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-13-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-7-Q.svg", 
        "tmpsDyI_A.png", 
        "067223f9a9e6452491d86b393eac9300-oa-13-Q.svg", 
        "31da79e1352d420083df88127db7706c-oa-9-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-4-A.svg", 
        "7a5c00eb50a54ed5b6538d3ad2f97923-oa-3-A.svg", 
        "085981af72b143f5922ad8a3ad0ba694-ao-8-A.svg", 
        "9bb412689a134f32933ea71a789c39cf-oa-5-A.svg", 
        "31da79e1352d420083df88127db7706c-oa-10-Q.svg", 
        "7845c17daf0a499db1d8d21ca0f099ef-oa-8-Q.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-6-Q.svg", 
        "52ff00f3d70e41368901ccf194969601-oa-3-A.svg", 
        "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-8-Q.svg", 
        "a98e7f6f69d546e88ea027530f7358c1-ao-5-A.svg"
    ], 
    "mid": "1526461900154", 
    "name": "PastQns", 
    "note_models": [
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE DEVICES */\n\n.mobile .card, .mobile #content {\n  font-size: 120%;\n  margin: 0;\n}\n\n.mobile #io-extra-wrapper {\n  width: 95%;\n}\n\n.mobile #io-revl-btn {\n  font-size: 0.8em;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "ID (hidden)", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Header", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Image", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question Mask", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Footer", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 1", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 2", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer Mask", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original Mask", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Image Occlusion Enhanced", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        2
                    ]
                ]
            ], 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<script>\n  // Toggle answer mask on clicking the image\n  var toggle = function() {\n    var amask = document.getElementById('io-overlay');\n    if (amask.style.display === 'block' || amask.style.display === '')\n      amask.style.display = 'none';\n    else\n      amask.style.display = 'block'\n  }\n</script>\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n{{/Image}}\n", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "IO Card", 
                    "ord": 0, 
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n{{/Image}}\n"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE */\n\n.card .mobile, #content .mobile {\n  font-size: 100%;\n  margin: 0;\n}\n\n#io-extra-wrapper .mobile {\n  width: 95%;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "ID (hidden)", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Header", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Image", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Footer", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 1", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 2", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question Mask", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer Mask", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original Mask", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Image Occlusion Enhanced-fa23d", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        2
                    ]
                ]
            ], 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<script>\n  // Toggle answer mask on clicking the image\n  var toggle = function() {\n    var amask = document.getElementById('io-overlay');\n    if (amask.style.display === 'block' || amask.style.display === '')\n      amask.style.display = 'none';\n    else\n      amask.style.display = 'block'\n  }\n</script>\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n{{/Image}}\n", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "IO Card", 
                    "ord": 0, 
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n{{/Image}}\n"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "css": ".card {\n font-family: arial;\n font-size: 20px;\n text-align: center;\n color: black;\n background-color: white;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Front", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Back", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Basic", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Card 1", 
                    "ord": 0, 
                    "qfmt": "{{Front}}"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE DEVICES */\n\n.mobile .card, .mobile #content {\n  font-size: 120%;\n  margin: 0;\n}\n\n.mobile #io-extra-wrapper {\n  width: 95%;\n}\n\n.mobile #io-revl-btn {\n  font-size: 0.8em;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "ID (hidden)", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Header", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Image", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question Mask", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Footer", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 1", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 2", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer Mask", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original Mask", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Image Occlusion Enhanced-6dfaa", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        2
                    ]
                ]
            ], 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<script>\n  // Toggle answer mask on clicking the image\n  var toggle = function() {\n    var amask = document.getElementById('io-overlay');\n    if (amask.style.display === 'block' || amask.style.display === '')\n      amask.style.display = 'none';\n    else\n      amask.style.display = 'block'\n  }\n</script>\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n{{/Image}}\n", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "IO Card", 
                    "ord": 0, 
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n{{/Image}}\n"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "css": "/* general card style */\n\nhtml {\n  /* scrollbar always visible in order to prevent shift when revealing answer*/\n  overflow-y: scroll;\n}\n\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* general layout */\n\n.text {\n  /* center left-aligned text on card */\n  display: inline-block;\n  align: center;\n  text-align: left;\n  margin: auto;\n  max-width: 40em;\n}\n\n.hidden {\n  /* guarantees a consistent width across front and back */\n  font-weight: bold;\n  display: block;\n  line-height:0;\n  height: 0;\n  overflow: hidden;\n  visibility: hidden;\n}\n\n.title {\n  font-weight: bold;\n  font-size: 1.1em;\n  margin-bottom: 1em;\n  text-align: center;\n}\n\n/* clozes */\n\n.cloze {\n  /* regular cloze deletion */\n  font-weight: bold;\n  color: #0048FF;\n}\n\n/* original text reveal hint */\n\n.fullhint a {\n  color: #0048FF;\n}\n\n.card21 .fullhint{\n  /* no need to display hint on last card */\n  display:none;\n}\n\n/* additional fields */\n\n.extra{\n  margin-top: 0.5em;\n  margin: auto;\n  max-width: 40em;\n}\n\n.extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.extra-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Title", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Settings", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": true
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text1", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text2", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text3", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text4", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text5", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text6", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text7", 
                    "ord": 11, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text8", 
                    "ord": 12, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text9", 
                    "ord": 13, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text10", 
                    "ord": 14, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text11", 
                    "ord": 15, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text12", 
                    "ord": 16, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text13", 
                    "ord": 17, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text14", 
                    "ord": 18, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text15", 
                    "ord": 19, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text16", 
                    "ord": 20, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text17", 
                    "ord": 21, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text18", 
                    "ord": 22, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text19", 
                    "ord": 23, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text20", 
                    "ord": 24, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Full", 
                    "ord": 25, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Cloze (overlapping)-bd6fc", 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "<div class=\"back\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">{{Original}}</div>\n  </div>\n  <div class=\"extra\"><hr></div>\n  <div class=\"text\"><div class=\"fullhint\">{{hint:Original}}</div></div>\n  <div class=\"extra\">\n    {{#Remarks}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Remarks</div><div>{{Remarks}}</div>\n    </div>\n    {{/Remarks}}\n    {{#Sources}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Sources</div><div>{{Sources}}</div>\n    </div>\n    {{/Sources}}\n  </div>\n</div>\n<script>\n  // remove cloze syntax from revealed hint\n  var hint = document.querySelector('.fullhint>[id^=\"hint\"]')\n  var html = hint.innerHTML.replace(/\\[\\[oc(\\d+)::(.*?)(::(.*?))?\\]\\]/mg, \"$2\")\n  hint.innerHTML = html\n  // scroll to cloze\n  document.addEventListener('DOMContentLoaded', function() {\n    setTimeout(function(){\n      const cloze1 = document.getElementsByClassName(\"cloze\")[0];\n      const rect = cloze1.getBoundingClientRect();\n      const absTop = rect.top + window.pageYOffset;\n      const absBot = rect.bottom + window.pageYOffset;\n      if (absBot >= window.innerHeight) {\n        const height = rect.top - rect.bottom\n        const middle = absTop - (window.innerHeight/2) - (height/2);\n        window.scrollTo(0, middle);};\n    }, 1);\n  }, false);\n</script>", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "cloze-ol", 
                    "ord": 0, 
                    "qfmt": "<div class=\"front\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">\n       <div>{{Original}}</div>\n    </div>\n  </div>\n</div>"
                }
            ], 
            "type": 1, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "5f874e54-5d06-11e8-8b3a-30e37ab3e4ac", 
            "css": "/* general card style */\n\nhtml {\n  /* scrollbar always visible in order to prevent shift when revealing answer*/\n  overflow-y: scroll;\n}\n\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* general layout */\n\n.text {\n  /* center left-aligned text on card */\n  display: inline-block;\n  align: center;\n  text-align: left;\n  margin: auto;\n  max-width: 40em;\n}\n\n.hidden {\n  /* guarantees a consistent width across front and back */\n  font-weight: bold;\n  display: block;\n  line-height:0;\n  height: 0;\n  overflow: hidden;\n  visibility: hidden;\n}\n\n.title {\n  font-weight: bold;\n  font-size: 1.1em;\n  margin-bottom: 1em;\n  text-align: center;\n}\n\n/* clozes */\n\n.cloze {\n  /* regular cloze deletion */\n  font-weight: bold;\n  color: #0048FF;\n}\n\n/* original text reveal hint */\n\n.fullhint a {\n  color: #0048FF;\n}\n\n.card21 .fullhint{\n  /* no need to display hint on last card */\n  display:none;\n}\n\n/* additional fields */\n\n.extra{\n  margin-top: 0.5em;\n  margin: auto;\n  max-width: 40em;\n}\n\n.extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.extra-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Title", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Settings", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": true
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text1", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text2", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text3", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text4", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text5", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text6", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text7", 
                    "ord": 11, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text8", 
                    "ord": 12, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text9", 
                    "ord": 13, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text10", 
                    "ord": 14, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text11", 
                    "ord": 15, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text12", 
                    "ord": 16, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text13", 
                    "ord": 17, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text14", 
                    "ord": 18, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text15", 
                    "ord": 19, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text16", 
                    "ord": 20, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text17", 
                    "ord": 21, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text18", 
                    "ord": 22, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text19", 
                    "ord": 23, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text20", 
                    "ord": 24, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Full", 
                    "ord": 25, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Cloze (overlapping)-c3c0f", 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "<div class=\"back\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">{{Original}}</div>\n  </div>\n  <div class=\"extra\"><hr></div>\n  <div class=\"text\"><div class=\"fullhint\">{{hint:Original}}</div></div>\n  <div class=\"extra\">\n    {{#Remarks}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Remarks</div><div>{{Remarks}}</div>\n    </div>\n    {{/Remarks}}\n    {{#Sources}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Sources</div><div>{{Sources}}</div>\n    </div>\n    {{/Sources}}\n  </div>\n</div>\n<script>\n  // remove cloze syntax from revealed hint\n  var hint = document.querySelector('.fullhint>[id^=\"hint\"]')\n  var html = hint.innerHTML.replace(/\\[\\[oc(\\d+)::(.*?)(::(.*?))?\\]\\]/mg, \"$2\")\n  hint.innerHTML = html\n  // scroll to cloze\n  document.addEventListener('DOMContentLoaded', function() {\n    setTimeout(function(){\n      const cloze1 = document.getElementsByClassName(\"cloze\")[0];\n      const rect = cloze1.getBoundingClientRect();\n      const absTop = rect.top + window.pageYOffset;\n      const absBot = rect.bottom + window.pageYOffset;\n      if (absBot >= window.innerHeight) {\n        const height = rect.top - rect.bottom\n        const middle = absTop - (window.innerHeight/2) - (height/2);\n        window.scrollTo(0, middle);};\n    }, 1);\n  }, false);\n</script>", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "cloze-ol", 
                    "ord": 0, 
                    "qfmt": "<div class=\"front\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">\n       <div>{{Original}}</div>\n    </div>\n  </div>\n</div>"
                }
            ], 
            "type": 1, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "css": "/* general card style */\n\nhtml {\n  /* scrollbar always visible in order to prevent shift when revealing answer*/\n  overflow-y: scroll;\n}\n\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* general layout */\n\n.text {\n  /* center left-aligned text on card */\n  display: inline-block;\n  align: center;\n  text-align: left;\n  margin: auto;\n  max-width: 40em;\n}\n\n.hidden {\n  /* guarantees a consistent width across front and back */\n  font-weight: bold;\n  display: block;\n  line-height:0;\n  height: 0;\n  overflow: hidden;\n  visibility: hidden;\n}\n\n.title {\n  font-weight: bold;\n  font-size: 1.1em;\n  margin-bottom: 1em;\n  text-align: center;\n}\n\n/* clozes */\n\n.cloze {\n  /* regular cloze deletion */\n  font-weight: bold;\n  color: #0048FF;\n}\n\n/* original text reveal hint */\n\n.fullhint a {\n  color: #0048FF;\n}\n\n.card21 .fullhint{\n  /* no need to display hint on last card */\n  display:none;\n}\n\n/* additional fields */\n\n.extra{\n  margin-top: 0.5em;\n  margin: auto;\n  max-width: 40em;\n}\n\n.extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.extra-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Title", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Settings", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": true
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text1", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text2", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text3", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text4", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text5", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text6", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text7", 
                    "ord": 11, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text8", 
                    "ord": 12, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text9", 
                    "ord": 13, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text10", 
                    "ord": 14, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text11", 
                    "ord": 15, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text12", 
                    "ord": 16, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text13", 
                    "ord": 17, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text14", 
                    "ord": 18, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text15", 
                    "ord": 19, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text16", 
                    "ord": 20, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text17", 
                    "ord": 21, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text18", 
                    "ord": 22, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text19", 
                    "ord": 23, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Text20", 
                    "ord": 24, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Full", 
                    "ord": 25, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Cloze (overlapping)-fa23d", 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "<div class=\"back\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">{{Original}}</div>\n  </div>\n  <div class=\"extra\"><hr></div>\n  <div class=\"text\"><div class=\"fullhint\">{{hint:Original}}</div></div>\n  <div class=\"extra\">\n    {{#Remarks}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Remarks</div><div>{{Remarks}}</div>\n    </div>\n    {{/Remarks}}\n    {{#Sources}}\n    <div class=\"extra-entry\">\n      <div class=\"extra-descr\">Sources</div><div>{{Sources}}</div>\n    </div>\n    {{/Sources}}\n  </div>\n</div>\n<script>\n  // remove cloze syntax from revealed hint\n  var hint = document.querySelector('.fullhint>[id^=\"hint\"]')\n  var html = hint.innerHTML.replace(/\\[\\[oc(\\d+)::(.*?)(::(.*?))?\\]\\]/mg, \"$2\")\n  hint.innerHTML = html\n  // scroll to cloze\n  document.addEventListener('DOMContentLoaded', function() {\n    setTimeout(function(){\n      const cloze1 = document.getElementsByClassName(\"cloze\")[0];\n      const rect = cloze1.getBoundingClientRect();\n      const absTop = rect.top + window.pageYOffset;\n      const absBot = rect.bottom + window.pageYOffset;\n      if (absBot >= window.innerHeight) {\n        const height = rect.top - rect.bottom\n        const middle = absTop - (window.innerHeight/2) - (height/2);\n        window.scrollTo(0, middle);};\n    }, 1);\n  }, false);\n</script>", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "cloze-ol", 
                    "ord": 0, 
                    "qfmt": "<div class=\"front\">\n  {{#Title}}<div class=\"title\">{{Title}}</div>{{/Title}}\n  <div class=\"text\">\n    {{cloze:Text1}}\n    {{cloze:Text2}}\n    {{cloze:Text3}}\n    {{cloze:Text4}}\n    {{cloze:Text5}}\n    {{cloze:Text6}}\n    {{cloze:Text7}}\n    {{cloze:Text8}}\n    {{cloze:Text9}}\n    {{cloze:Text10}}\n    {{cloze:Text11}}\n    {{cloze:Text12}}\n    {{cloze:Text13}}\n    {{cloze:Text14}}\n    {{cloze:Text15}}\n    {{cloze:Text16}}\n    {{cloze:Text17}}\n    {{cloze:Text18}}\n    {{cloze:Text19}}\n    {{cloze:Text20}}\n    {{cloze:Full}}\n    <div class=\"hidden\">\n       <div>{{Original}}</div>\n    </div>\n  </div>\n</div>"
                }
            ], 
            "type": 1, 
            "vers": []
        }
    ], 
    "notes": [
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A 65 year old female who had a 10 year history of hypertension and a myocardial infarction three years previously, presented to the Emergency Department with sudden onset of weakness in &nbsp;the left arm and leg.</div><div>&nbsp;</div><div>On examination, her pulse was rapid and irregularly irregular. She had a left VII cranial nerve palsy of the upper motor neuron type and left spastic hemiparesis, with an ipsilateral upgoing plantar response</div><div><br /></div><div>What is the <b>lesion</b> that caused this neurological deficit and <i>what areas</i> are likely to be affected?</div>", 
                "1.&nbsp;R sided CVA caused by <i>lenticulostriate artery</i> <b>occlusion</b> or&nbsp;<div>2. <b>Haemorrhage</b>&nbsp;(likely Charcot Bouchard aneurysm rupture) affecting <i>internal capsule, basal ganglia and thalamus</i><div><br /></div></div>"
            ], 
            "flags": 0, 
            "guid": "e6`U7;0=CS", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A 65 year old female who had a 10 year history of hypertension and a myocardial infarction three years previously, presented to the Emergency Department with sudden onset of weakness in &nbsp;the left arm and leg.&nbsp;</div><div><br /></div><div>On examination, her pulse was rapid and irregularly irregular. She had a left VII cranial nerve palsy of the upper motor neuron type and left spastic hemiparesis, with an ipsilateral upgoing plantar response</div><div><br /></div><div>What are your differentials?</div>", 
                "<ol type=\"1\" start=\"1\"><li>R sided MCA stroke (less likely in this case bc you would see contralateral sensory loss, cortical symptoms and a lower limb sparing)</li><li>Brain tumour&nbsp;</li><li>Seizure with post-ictal deficit&nbsp;</li></ol><div><br /></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "E&Hnz(}+B[", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- [[oc1::cardiogenic]] embolus (Mural thrombus can be due to AF/MI)<br />- [[oc2::carotid]] embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; [[oc3::tunica media thinning]] --&gt; [[oc4::aneurysm]] --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>", 
                "Path", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- {{c1::cardiogenic}} embolus (Mural thrombus can be due to AF/MI)<br />- ... embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; ... --&gt; ... --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>", 
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- cardiogenic embolus (Mural thrombus can be due to AF/MI)<br />- {{c2::carotid}} embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; ... --&gt; ... --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>", 
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- ... embolus (Mural thrombus can be due to AF/MI)<br />- carotid embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; {{c3::tunica media thinning}} --&gt; ... --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>", 
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- ... embolus (Mural thrombus can be due to AF/MI)<br />- ... embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; tunica media thinning --&gt; {{c4::aneurysm}} --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "How might this pathological process have occurred?<div><br /></div><div><ol type=\"1\" start=\"1\"><li>Ischaemic stroke<br />- {{c21::cardiogenic}} embolus (Mural thrombus can be due to AF/MI)<br />- {{c21::carotid}} embolus (from atherosclerosis)<br /><br /></li><li>Haemorrhagic stroke<br />HTN --&gt; accelerated atherosclerosis --&gt; {{c21::tunica media thinning}} --&gt; {{c21::aneurysm}} --&gt; ruptures under HTN --&gt; pressure oedema --&gt; disrupts motor pathways&nbsp;</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "ytaddq{l+.", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-1", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-1-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-1-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q=h.j2Zc`F", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-2", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-2-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-2-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GWI2Ii&eJ_", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-3", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-3-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-3-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OlkwN2eXaj", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-4", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-4-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-4-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qE~E;l=4Ij", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-5", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-5-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-5-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q`s~Cw0!Qq", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-6", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-6-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-6-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OxUDn$kD:3", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-7", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-7-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-7-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JC$kRJVP1>", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-8", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-8-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-8-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vHT3sXVG]%", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-9", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-9-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-9-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MVTMvNm-c", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-10", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-10-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-10-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "LeTOm>aYnG", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-11", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-11-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-11-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "whG&#p]st0", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-12", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-12-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-12-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D@h^[lb[w;", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-13", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-13-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-13-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N|?6zbg&sP", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-14", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-14-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-14-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z])>H>Zga3", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-15", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-15-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-15-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "prs#A];0SU", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-16", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-16-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-16-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d~FHM6[[Bz", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-17", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-17-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-17-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OT.@jP8,)z", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "067223f9a9e6452491d86b393eac9300-oa-18", 
                "", 
                "<img src=\"tmplgxGdZ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-18-Q.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-18-A.svg\" />", 
                "<img src=\"067223f9a9e6452491d86b393eac9300-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nCVOH[J{Gq", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-1", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-1-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-1-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DsPczzA)y^", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-2", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-2-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-2-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l8i_+F38Tt", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-3", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-3-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-3-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JNCB&XP_P]", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-4", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-4-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-4-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P]g%K(fnWg", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-5", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-5-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-5-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "C?m8Jy}:B~", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-6", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-6-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-6-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g6~Xc5dYKE", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-7", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-7-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-7-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e+K8w^|63U", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-8", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-8-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-8-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lO(%ec[v&X", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-9", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-9-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-9-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sw^qi.hLc-", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-10", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-10-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-10-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d3r1B25M1@", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-11", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-11-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-11-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n{zwVJbb[5", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-12", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-12-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-12-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "6pS{P@t42", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-13", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-13-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-13-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "faNMJ`{&=k", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "31da79e1352d420083df88127db7706c-oa-14", 
                "", 
                "<img src=\"tmpj0M47r.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-14-Q.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-14-A.svg\" />", 
                "<img src=\"31da79e1352d420083df88127db7706c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G[0fdia|W!", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-1", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-1-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-1-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ke+9_2~I^Z", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-2", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-2-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-2-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eN>2H>3Y.n", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-3", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-3-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-3-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p_8dd^M,Jr", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-4", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-4-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-4-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Hd>L4Nb`w^", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-5", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-5-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-5-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cAIkYa&],$", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-6", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-6-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-6-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jAbWT*)w@D", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-7", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-7-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-7-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z!ma;P%!a(", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-8", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-8-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-8-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AQJ(2AoT1a", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-9", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-9-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-9-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b;_0D}`ABy", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-10", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-10-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-10-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OX^k5bQ<Ky", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-11", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-11-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-11-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Fhd5QQqkO:", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-12", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-12-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-12-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I+CJB4%Jos", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-13", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-13-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-13-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mYdWVXP!?.", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-14", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-14-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-14-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "TcA@C3a4b", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-15", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-15-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-15-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pQuwrXqrNW", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0cdbd102581e4338bd9a115361607b07-oa-16", 
                "", 
                "<img src=\"tmpVxw4g8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-16-Q.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-16-A.svg\" />", 
                "<img src=\"0cdbd102581e4338bd9a115361607b07-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "CVyQzGhRl0", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a [[oc1::white matter]] structure. White matter consists of myelinated and unmyelinated axons and glial cells such as [[oc2::astrocytes]], [[oc3::oligodendrocytes]], and [[oc4::microglial]] cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the [[oc6::caudate nucleus]] and the [[oc7::thalamus]] from the [[oc8::putamen]] and the [[oc9::globus pallidus]].&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a [[oc10::transverse]] plane and the bend called the genu &nbsp;containing [[oc11::corticobulbar]] fibres, run between the [[oc12::cortex]] and the [[oc13::brainstem]].</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the [[oc14::head of the caudate nucleus]] and the [[oc15::lenticular nucleus]]<br /></li><li>The posterior limb is between the [[oc18::thalamus]] and [[oc19::lenticular nucleus]]<br />- Contains [[oc20::corticospinal]] fibers, sensory fibers (including the [[oc21::medial lemniscus]] and the [[oc22::anterolateral system]]) from the body and a few [[oc23::corticobulbar]] fibers.</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,1,0,1,1,1 | n,n,n,n,n,n,n", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a {{c1::white matter}} structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a white matter structure. White matter consists of myelinated and unmyelinated axons and glial cells such as {{c2::astrocytes}}, ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as astrocytes, {{c3::oligodendrocytes}}, and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., oligodendrocytes, and {{c4::microglial}} cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and microglial cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the {{c5::caudate nucleus}} and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the caudate nucleus and the {{c6::thalamus}} from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the thalamus from the {{c7::putamen}} and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the putamen and the {{c8::globus pallidus}}.&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the globus pallidus.&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a {{c9::transverse}} plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a transverse plane and the bend called the genu &nbsp;containing {{c10::corticobulbar}} fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing corticobulbar fibres, run between the {{c11::cortex}} and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the cortex and the {{c12::brainstem}}.</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the brainstem.</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the {{c13::head of the caudate nucleus}} and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the head of the caudate nucleus and the {{c14::lenticular nucleus}}<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the lenticular nucleus<br /></li><li>The posterior limb is between the {{c15::thalamus}} and ...<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the thalamus and {{c16::lenticular nucleus}}<br />- Contains ... fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and lenticular nucleus<br />- Contains {{c17::corticospinal}} fibers, sensory fibers (including the ... and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains corticospinal fibers, sensory fibers (including the {{c18::medial lemniscus}} and the ...) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the medial lemniscus and the {{c19::anterolateral system}}) from the body and a few ... fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a ... structure. White matter consists of myelinated and unmyelinated axons and glial cells such as ..., ..., and ... cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the ... and the ... from the ... and the ....&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a ... plane and the bend called the genu &nbsp;containing ... fibres, run between the ... and the ....</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the ... and the ...<br /></li><li>The posterior limb is between the ... and ...<br />- Contains ... fibers, sensory fibers (including the ... and the anterolateral system) from the body and a few {{c20::corticobulbar}} fibers.</li></ul></div></div>", 
                "What is the anatomy and function of internal capsule?<div><br /></div><div><div>The internal capsule is a {{c21::white matter}} structure. White matter consists of myelinated and unmyelinated axons and glial cells such as {{c21::astrocytes}}, {{c21::oligodendrocytes}}, and {{c21::microglial}} cells.</div><div><br /></div><div>The internal capsule contains both ascending and descending axons --&gt; carries info past the basal ganglia, separating the {{c21::caudate nucleus}} and the {{c21::thalamus}} from the {{c21::putamen}} and the {{c21::globus pallidus}}.&nbsp;</div><div><br /></div><div>The internal capsule is V-shaped when cut in a {{c21::transverse}} plane and the bend called the genu &nbsp;containing {{c21::corticobulbar}} fibres, run between the {{c21::cortex}} and the {{c21::brainstem}}.</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>The anterior limb is between the {{c21::head of the caudate nucleus}} and the {{c21::lenticular nucleus}}<br /></li><li>The posterior limb is between the {{c21::thalamus}} and {{c21::lenticular nucleus}}<br />- Contains {{c21::corticospinal}} fibers, sensory fibers (including the {{c21::medial lemniscus}} and the {{c21::anterolateral system}}) from the body and a few {{c21::corticobulbar}} fibers.</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "gaMNe;#,}M", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the [[oc1::putamen]] makes up the [[oc2::dorsal striatum]] part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- [[oc3::Goal-directed movements]]:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- [[oc4::Spatial mnemonic processing]]:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- [[oc5::Memory]], [[oc6::Learning]], [[oc7::Sleep]]</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the {{c1::putamen}} makes up the ... part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- ...:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- ...:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- ..., ..., ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the putamen makes up the {{c2::dorsal striatum}} part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- ...:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- ...:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- ..., ..., ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the ... makes up the dorsal striatum part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- {{c3::Goal-directed movements}}:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- ...:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- ..., ..., ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the ... makes up the ... part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- Goal-directed movements:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- {{c4::Spatial mnemonic processing}}:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- ..., ..., ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the ... makes up the ... part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- ...:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- Spatial mnemonic processing:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- {{c5::Memory}}, ..., ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the ... makes up the ... part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- ...:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- ...:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- Memory, {{c6::Learning}}, ...</li></ul></div></div>", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the ... makes up the ... part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- ...:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- ...:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- ..., Learning, {{c7::Sleep}}</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What is the function of the head of caudate nucleus?<div><br /></div><div><div>The caudate nucleus together with the {{c21::putamen}} makes up the {{c21::dorsal striatum}} part of the basal ganglia</div><div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Motor Functions</li></ul></div><div>- {{c21::Goal-directed movements}}:&nbsp;Translates idea to move into actual movement,&nbsp;contributes to body &amp; limb posture and speed &amp; accuracy of directed movements</div><div>- {{c21::Spatial mnemonic processing}}:&nbsp;integrates spatial information with motor behaviour formulation</div><div><ul style=\"margin-left: 20px; \"><li>Cognitive Functions<br />- {{c21::Memory}}, {{c21::Learning}}, {{c21::Sleep}}</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "mmcS@lSlRx", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>[[oc1::Higher/executive]] function such as [[oc2::decision making]], [[oc3::consideration of culture, society and religion]].</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates [[oc4::emotions]], [[oc5::behaviour]], [[oc6::motivation]], [[oc7::long-term memory]], and [[oc8::olfaction]].</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for [[oc9::memory formation]]&nbsp;</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>{{c1::Higher/executive}} function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., ..., ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>Higher/executive function such as {{c2::decision making}}, ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., ..., ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as decision making, {{c3::consideration of culture, society and religion}}.</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., ..., ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., consideration of culture, society and religion.</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates {{c4::emotions}}, ..., ..., ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates emotions, {{c5::behaviour}}, ..., ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., behaviour, {{c6::motivation}}, ..., and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., motivation, {{c7::long-term memory}}, and ....</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., ..., long-term memory, and {{c8::olfaction}}.</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for ...&nbsp;</div></div><div><br /></div>", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>... function such as ..., ....</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates ..., ..., ..., ..., and olfaction.</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for {{c9::memory formation}}&nbsp;</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Where are the centres for personality?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Frontal lobes</li></ol></div><div>{{c21::Higher/executive}} function such as {{c21::decision making}}, {{c21::consideration of culture, society and religion}}.</div><div><ol type=\"1\" start=\"2\"><li>Limbic system&nbsp;</li></ol></div><div>Regulates {{c21::emotions}}, {{c21::behaviour}}, {{c21::motivation}}, {{c21::long-term memory}}, and {{c21::olfaction}}.</div><div><ol type=\"1\" start=\"3\"><li>Hippocampus&nbsp;</li></ol></div><div>Important for {{c21::memory formation}}&nbsp;</div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "y[F(a2J~=5", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-1", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-1-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-1-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hfV=QAkm#t", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-2", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-2-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-2-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vJb5O!WCz>", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-3", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-3-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-3-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DeW?c+T;0t", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-4", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-4-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-4-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H;Y=0/=ONe", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-5", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-5-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-5-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J69yKU}7u-", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-6", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-6-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-6-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "E>xP|EVM*K", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-7", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-7-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-7-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g3,df`IfhH", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-8", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-8-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-8-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Neh4A;^#R_", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-9", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-9-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-9-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "iSkiQ?+J;7", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-10", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-10-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-10-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "C]]:{f=vp0", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-11", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-11-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-11-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J)m71;ZSFi", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "56d415d9bb6d4c20b337b2e3b0b16959-oa-12", 
                "", 
                "<img src=\"tmpcv6CXV.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-12-Q.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-12-A.svg\" />", 
                "<img src=\"56d415d9bb6d4c20b337b2e3b0b16959-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s*A0u.owU", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-1", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-1-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-1-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P,+?`ihi#3", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-2", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-2-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-2-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s-9|zQ2|/5", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-3", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-3-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-3-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P`p]ZGB1B(", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-4", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-4-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-4-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Qn!nn-3/fa", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-5", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-5-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-5-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r__6`rw,H", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-6", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-6-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-6-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e9/9%D;YNV", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-7", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-7-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-7-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k=7[*,H`y{", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "068a0307b9104679a8ae92ced0f693bb-oa-8", 
                "", 
                "<img src=\"tmp0TYXXg.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-8-Q.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-8-A.svg\" />", 
                "<img src=\"068a0307b9104679a8ae92ced0f693bb-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "gN,w,van.(", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-1", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-1-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-1-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yv#j#EUt!P", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-2", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-2-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-2-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F0X!){iF#N", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-3", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-3-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-3-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pF.7O*rs,f", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-4", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-4-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-4-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M;hCMH%Xcc", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-5", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-5-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-5-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dk0gnDqqL2", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-6", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-6-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-6-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BXXZ9U5F*&", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-7", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-7-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-7-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FxEMC9uUeb", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7845c17daf0a499db1d8d21ca0f099ef-oa-8", 
                "", 
                "<img src=\"tmpHeEwuG.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-8-Q.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-8-A.svg\" />", 
                "<img src=\"7845c17daf0a499db1d8d21ca0f099ef-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yy@[{8)mCs", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-1", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-1-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-1-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b1)RMS&J<", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-2", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-2-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-2-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PZ2R5&J%n", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-3", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-3-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-3-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qD%A_@~Edv", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-4", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-4-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-4-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pUe`,fUN=7", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-5", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-5-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-5-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v,a};Ofpz8", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-6", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-6-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-6-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K$us2}<fy<", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-7", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-7-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-7-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N+sh6_lxVx", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4174ebb3d68f40d1be6a8e44f94fbf3c-oa-8", 
                "", 
                "<img src=\"tmpUY78F4.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-8-Q.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-8-A.svg\" />", 
                "<img src=\"4174ebb3d68f40d1be6a8e44f94fbf3c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "L6!D=i?lfe", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-1", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-1-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-1-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Oe12:bvBK|", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-2", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-2-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-2-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Fu-o5-wS9*", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-3", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-3-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-3-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "x^wu&1qm*P", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-4", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-4-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-4-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BFRs*Tk>uA", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-5", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-5-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-5-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q`]vK$r,/X", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-6", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-6-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-6-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "wy0)*!{}r>", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ba9d2e615d54bcda9057ef9b71fa453-oa-7", 
                "", 
                "<img src=\"tmpkQmGQQ.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-7-Q.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-7-A.svg\" />", 
                "<img src=\"0ba9d2e615d54bcda9057ef9b71fa453-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K<TWDOqobf", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. [[oc1::Primary motor cortex]] (precentral gyrus): head shoulders, arms</div><div>2. [[oc2::Primary Somatosensory cortex]] &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. [[oc3::Association cortex]] (parietal lobe – abstract thinking/language/perception)</div><div>4. [[oc4::Broca’s area]] (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. [[oc5::Optic radiation&nbsp;]]</div><div>2. [[oc6::Wernicke’s area]] (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. [[oc7::Putamen and GP via lenticulostriate aa]]&nbsp;</div></div><div><br /></div>", 
                "MCA functional supplies", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. {{c1::Primary motor cortex}} (precentral gyrus): head shoulders, arms</div><div>2. ... &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. ... (parietal lobe – abstract thinking/language/perception)</div><div>4. ... (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. ...</div><div>2. ... (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. Primary motor cortex (precentral gyrus): head shoulders, arms</div><div>2. {{c2::Primary Somatosensory cortex}} &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. ... (parietal lobe – abstract thinking/language/perception)</div><div>4. ... (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. ...</div><div>2. ... (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. ... (precentral gyrus): head shoulders, arms</div><div>2. Primary Somatosensory cortex &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. {{c3::Association cortex}} (parietal lobe – abstract thinking/language/perception)</div><div>4. ... (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. ...</div><div>2. ... (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. ... (precentral gyrus): head shoulders, arms</div><div>2. ... &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. Association cortex (parietal lobe – abstract thinking/language/perception)</div><div>4. {{c4::Broca’s area}} (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. ...</div><div>2. ... (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. ... (precentral gyrus): head shoulders, arms</div><div>2. ... &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. ... (parietal lobe – abstract thinking/language/perception)</div><div>4. Broca’s area (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. {{c5::Optic radiation&nbsp;}}</div><div>2. ... (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. ... (precentral gyrus): head shoulders, arms</div><div>2. ... &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. ... (parietal lobe – abstract thinking/language/perception)</div><div>4. ... (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. Optic radiation&nbsp;</div><div>2. {{c6::Wernicke’s area}} (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. ...&nbsp;</div></div><div><br /></div>", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. ... (precentral gyrus): head shoulders, arms</div><div>2. ... &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. ... (parietal lobe – abstract thinking/language/perception)</div><div>4. ... (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. ...</div><div>2. Wernicke’s area (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. {{c7::Putamen and GP via lenticulostriate aa}}&nbsp;</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What functional areas does the MCA supply?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Superior division</li></ul><div>1. {{c21::Primary motor cortex}} (precentral gyrus): head shoulders, arms</div><div>2. {{c21::Primary Somatosensory cortex}} &nbsp;(postcentral gyrus): head, shoulders, arms</div><div>3. {{c21::Association cortex}} (parietal lobe – abstract thinking/language/perception)</div><div>4. {{c21::Broca’s area}} (inferior frontal gyrus of L &nbsp;frontal lobe)&nbsp;</div><div><br /></div><ul style=\"margin-left: 20px; \"><li>Inferior division</li></ul><div>1. {{c21::Optic radiation&nbsp;}}</div><div>2. {{c21::Wernicke’s area}} (Sup. temporal gyrus L temp lobe)&nbsp;</div><div>3. {{c21::Putamen and GP via lenticulostriate aa}}&nbsp;</div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "gYGgDLsb,B", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does occlusion of MCA cause?", 
                "<ol type=\"1\" start=\"1\"><li>contralateral hemiplegia</li><li>hemisensory loss of face &amp; arm</li><li>contralateral homonymouse hemianopia (disruption to optic radiation)</li><li>dysphasia (dominant)</li><li>visuospatial disturbance- cannot dress, gets lost (non dominant)</li></ol>"
            ], 
            "flags": 0, 
            "guid": "pLz&Q!!jJt", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What types of deficits can unilateral cerebral strokes cause?", 
                "<ol type=\"1\" start=\"1\"><li>Motor control</li><li>Somatic sensation</li><li>Vision</li><li>Not hearing, bc auditory information goes to both hemispheres</li></ol>"
            ], 
            "flags": 0, 
            "guid": "GcC5iax+ex", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What effects do you see in occlusion of PCA?", 
                "<ul style=\"margin-left: 20px; \"><li>Supplies occipital lobe</li><li>Contralateral homonymous hemianopia with macula sparing. If bilateral --&gt; cortical blindness</li><li>Possible visual agnosia (lack of recognition&nbsp;or understanding of visual objects or constructs)</li><li>Possible alexia &nbsp;(disorders of reading)</li></ul>"
            ], 
            "flags": 0, 
            "guid": "P0U=smG!9q", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What can lesions to lenticulostriate aa (of MCA) and Heubner aa (of ACA) cause?", 
                "<ul style=\"margin-left: 20px; \"><li>Pure motor loss: paralyis of face, arm &amp; leg on one side OR</li><li>Pure sensory loss: mild hemi-numbness OR</li><li>Mixed sensori-motor<br /></li><li>Ataxic hemiparesis</li></ul>"
            ], 
            "flags": 0, 
            "guid": "c?bYLgJUq.", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What can a lesion to PICA cause?", 
                "<ol type=\"1\" start=\"1\"><li>Vertigo</li><li>Emesis</li><li>Dysphagia</li><li>Nystagmus</li><li>Ipsilateral ataxia</li></ol>"
            ], 
            "flags": 0, 
            "guid": "QK/CKo(2-9", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-1", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-1-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-1-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MrNMEmLWdc", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-2", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-2-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-2-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g0{?4)Ef*/", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-3", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-3-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-3-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q(_/OP6.AC", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-4", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-4-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-4-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q4-arp$)^|", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-5", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-5-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-5-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GjMIcRgrDr", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-6", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-6-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-6-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "gmVaTR2oEk", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-7", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-7-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-7-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Pu/uSiU$)F", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0c7aeee1db3d46c2baf11e1e21f68b8c-oa-8", 
                "", 
                "<img src=\"tmpsDyI_A.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-8-Q.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-8-A.svg\" />", 
                "<img src=\"0c7aeee1db3d46c2baf11e1e21f68b8c-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q]rBx*&(52", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>[[oc1::Central retinal artery]]: retina</li><li>[[oc2::Ophthalmic artery]]: optic nerve ([[oc3::prox. 2/3rd]]), muscles, lacrimal duct</li><li>[[oc4::ACA]]: optic chiasm and intracranial optic nerve</li><li>[[oc5::Anterior choroidal artery]] (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>[[oc6::Inferior branches of MCA]]: optic radiation</li><li>[[oc7::Calcarine artery branch of PCA + MCA contributions]]: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c1::Central retinal artery}}: retina</li><li>...: optic nerve (...), muscles, lacrimal duct</li><li>...: optic chiasm and intracranial optic nerve</li><li>... (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>...: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Central retinal artery: retina</li><li>{{c2::Ophthalmic artery}}: optic nerve (...), muscles, lacrimal duct</li><li>...: optic chiasm and intracranial optic nerve</li><li>... (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>...: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...: retina</li><li>Ophthalmic artery: optic nerve ({{c3::prox. 2/3rd}}), muscles, lacrimal duct</li><li>...: optic chiasm and intracranial optic nerve</li><li>... (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>...: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...: retina</li><li>...: optic nerve (prox. 2/3rd), muscles, lacrimal duct</li><li>{{c4::ACA}}: optic chiasm and intracranial optic nerve</li><li>... (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>...: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...: retina</li><li>...: optic nerve (...), muscles, lacrimal duct</li><li>ACA: optic chiasm and intracranial optic nerve</li><li>{{c5::Anterior choroidal artery}} (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>...: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...: retina</li><li>...: optic nerve (...), muscles, lacrimal duct</li><li>...: optic chiasm and intracranial optic nerve</li><li>Anterior choroidal artery (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>{{c6::Inferior branches of MCA}}: optic radiation</li><li>...: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...: retina</li><li>...: optic nerve (...), muscles, lacrimal duct</li><li>...: optic chiasm and intracranial optic nerve</li><li>... (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>Inferior branches of MCA: optic radiation</li><li>{{c7::Calcarine artery branch of PCA + MCA contributions}}: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What is the blood supply to the visual system?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c21::Central retinal artery}}: retina</li><li>{{c21::Ophthalmic artery}}: optic nerve ({{c21::prox. 2/3rd}}), muscles, lacrimal duct</li><li>{{c21::ACA}}: optic chiasm and intracranial optic nerve</li><li>{{c21::Anterior choroidal artery}} (branches off the internal carotid artery):&nbsp;Optic tract, lateral geniculate nucleus&nbsp;</li><li>{{c21::Inferior branches of MCA}}: optic radiation</li><li>{{c21::Calcarine artery branch of PCA + MCA contributions}}: primary visual cortex (posterior pole of the occipital cortex)</li></ol></div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "kf1nJ<qkQy", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is the primary visual cortex located?", 
                "On either side of the calcarine fissure of the occipital lobe, which is supplied by the posterior cerebral artery"
            ], 
            "flags": 0, 
            "guid": "r${FLp;{C)", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the significacne of aneurysm of internal carotic to the visual system?", 
                "<div>Internal carotid &nbsp;is immediately lateral to the chiasm. Aneurysm can cause pressure on the chiasm and cause a partial, nasal hemianopia.</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "j5#U*i81_}", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the [[oc1::internal carotid artery]] and goes along the [[oc2::optic nerve]]. It gives off a branch, the [[oc3::central retinal artery]], that penetrates the optic nerve head to spread out over [[oc4::the inner surface of the retina]].</div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the {{c1::internal carotid artery}} and goes along the .... It gives off a branch, the ..., that penetrates the optic nerve head to spread out over ....</div></div>", 
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the internal carotid artery and goes along the {{c2::optic nerve}}. It gives off a branch, the ..., that penetrates the optic nerve head to spread out over ....</div></div>", 
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the ... and goes along the optic nerve. It gives off a branch, the {{c3::central retinal artery}}, that penetrates the optic nerve head to spread out over ....</div></div>", 
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the ... and goes along the .... It gives off a branch, the central retinal artery, that penetrates the optic nerve head to spread out over {{c4::the inner surface of the retina}}.</div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Describe the course and function of ophthalmic artery.<div><br /></div><div><div>The ophthalmic artery is the first branch of the {{c21::internal carotid artery}} and goes along the {{c21::optic nerve}}. It gives off a branch, the {{c21::central retinal artery}}, that penetrates the optic nerve head to spread out over {{c21::the inner surface of the retina}}.</div></div>"
            ], 
            "flags": 0, 
            "guid": "xMi6]7&k~T", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>[[oc1::Increased ICP]]<br />- [[oc2::Vasogenic and cytotoxic oedema]] --&gt; raised ICP --&gt; tonsillar herniation --&gt; [[oc3::cardiorespiratory failure]]<br />- [[oc4::Superimposed haemorrhage]] --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- [[oc5::Basilar artery]] --&gt; [[oc6::cardiorespiratory centre hypoperfusion]] --&gt; death</li><li>[[oc7::Hospital related causes of death]]<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; [[oc8::UTI]] (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; [[oc9::Staph sepsis]] (cannula)<br />&nbsp; &nbsp; &nbsp; [[oc10::Pressure sores]] (immobility)</li></ol></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c1::Increased ICP}}<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Increased ICP<br />- {{c2::Vasogenic and cytotoxic oedema}} --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- Vasogenic and cytotoxic oedema --&gt; raised ICP --&gt; tonsillar herniation --&gt; {{c3::cardiorespiratory failure}}<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; cardiorespiratory failure<br />- {{c4::Superimposed haemorrhage}} --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- Superimposed haemorrhage --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- {{c5::Basilar artery}} --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- Basilar artery --&gt; {{c6::cardiorespiratory centre hypoperfusion}} --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; cardiorespiratory centre hypoperfusion --&gt; death</li><li>{{c7::Hospital related causes of death}}<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>Hospital related causes of death<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; {{c8::UTI}} (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; UTI (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; {{c9::Staph sepsis}} (cannula)<br />&nbsp; &nbsp; &nbsp; ... (immobility)</li></ol></div></div><div><br /></div>", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...<br />- ... --&gt; raised ICP --&gt; tonsillar herniation --&gt; ...<br />- ... --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- ... --&gt; ... --&gt; death</li><li>...<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; ... (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; Staph sepsis (cannula)<br />&nbsp; &nbsp; &nbsp; {{c10::Pressure sores}} (immobility)</li></ol></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What are the most likely causes of death in the first two weeks following lesion to the internal capsule?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c21::Increased ICP}}<br />- {{c21::Vasogenic and cytotoxic oedema}} --&gt; raised ICP --&gt; tonsillar herniation --&gt; {{c21::cardiorespiratory failure}}<br />- {{c21::Superimposed haemorrhage}} --&gt; raised ICP --&gt; herniation --&gt; cardiorespiratory failure</li><li>Secondary stroke<br />- {{c21::Basilar artery}} --&gt; {{c21::cardiorespiratory centre hypoperfusion}} --&gt; death</li><li>{{c21::Hospital related causes of death}}<br />- PE from immobility and hypercoagulable state&nbsp;<br />- Aspiration pneumonia (impaired cough reflex, hypoventilation)<br />- Hospital acquired infection --&gt; Overwhelming sepsis&nbsp;<br />&nbsp; &nbsp; &nbsp; {{c21::UTI}} (catheter)&nbsp;<br />&nbsp; &nbsp; &nbsp; {{c21::Staph sepsis}} (cannula)<br />&nbsp; &nbsp; &nbsp; {{c21::Pressure sores}} (immobility)</li></ol></div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "Mn*XQ$z]&{", 
            "note_model_uuid": "3e08bea1-29b5-11e8-92e6-5ce0c5bacc04", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Warfarin MOA&nbsp;", 
                "Inhibition of Vit K epoxide reductase, affecting Factors (2,7,9,10) and Protein C&amp;S&nbsp;"
            ], 
            "flags": 0, 
            "guid": "oG~r|_N{WN", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-1", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-1-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g9InwhiIx@", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-2", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-2-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "O|pk6(<,4>", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-3", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-3-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b./cc1L~=y", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-4", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-4-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n+8R]8PEIO", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-5", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-5-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z=2)hK4DsQ", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-6", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-6-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J>rkRgr1yT", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-7", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-7-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nt({Bf=fkn", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-8", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-8-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zE?WpNE:%b", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-9", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-9-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K1Kuqj>cR:", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-10", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-10-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w+n*p$cq3Q", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-11", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-11-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kHzKfAqUDM", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "085981af72b143f5922ad8a3ad0ba694-ao-12", 
                "", 
                "<img src=\"stomach-blood-supply-anatomy-detail-anatomy-of-the-abdomen-blood-supply-nerve-supply-to-the.jpg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-12-A.svg\" />", 
                "<img src=\"085981af72b143f5922ad8a3ad0ba694-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zYfK%Rx0?K", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><div><b>All risk factors</b></div><div><b>Modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>Medical&nbsp;</li><ul><li>[[oc1::Hypertension]]&nbsp;</li><li>[[oc1::Diabetes&nbsp;]]</li><li>[[oc1::CKD&nbsp;]]</li><li>[[oc1::Dyslipidaemia&nbsp;]]</li></ul><li>Lifestyle</li><ul><li>[[oc2::Smoking]]&nbsp;</li><li>[[oc2::Sedentary Lifestyle&nbsp;]]</li><li>[[oc2::Dietary Choices]]</li><li>[[oc2::Obesity&nbsp;]]</li><li>[[oc2::Stress]]</li></ul></ul></div><div><b>Non-modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>[[oc3::Male]]</li><li>[[oc3::Post-menopausal woman]]</li><li>[[oc3::Age]]</li><li>[[oc3::Family History]]</li><li>[[oc3::Ethinicity]]</li><li>[[oc3::PMH]]</li></ul></div></div><div><br /></div><div><br /></div>", 
                "&nbsp;55M, 2hr hx of central, retrosternal, crushing chest pain on exertion.<div><hr />What are his cardiac risk factors?&nbsp;</div><div><br /></div>", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<div><div><b>All risk factors</b></div><div><b>Modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>Medical&nbsp;</li><ul><li>{{c1::Hypertension}}&nbsp;</li><li>{{c1::Diabetes&nbsp;}}</li><li>{{c1::CKD&nbsp;}}</li><li>{{c1::Dyslipidaemia&nbsp;}}</li></ul><li>Lifestyle</li><ul><li>...&nbsp;</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div><b>Non-modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div></div><div><br /></div><div><br /></div>", 
                "<div><div><b>All risk factors</b></div><div><b>Modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>Medical&nbsp;</li><ul><li>...&nbsp;</li><li>...</li><li>...</li><li>...</li></ul><li>Lifestyle</li><ul><li>{{c2::Smoking}}&nbsp;</li><li>{{c2::Sedentary Lifestyle&nbsp;}}</li><li>{{c2::Dietary Choices}}</li><li>{{c2::Obesity&nbsp;}}</li><li>{{c2::Stress}}</li></ul></ul></div><div><b>Non-modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div></div><div><br /></div><div><br /></div>", 
                "<div><div><b>All risk factors</b></div><div><b>Modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>Medical&nbsp;</li><ul><li>...&nbsp;</li><li>...</li><li>...</li><li>...</li></ul><li>Lifestyle</li><ul><li>...&nbsp;</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div><b>Non-modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>{{c3::Male}}</li><li>{{c3::Post-menopausal woman}}</li><li>{{c3::Age}}</li><li>{{c3::Family History}}</li><li>{{c3::Ethinicity}}</li><li>{{c3::PMH}}</li></ul></div></div><div><br /></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><div><b>All risk factors</b></div><div><b>Modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>Medical&nbsp;</li><ul><li>{{c21::Hypertension}}&nbsp;</li><li>{{c21::Diabetes&nbsp;}}</li><li>{{c21::CKD&nbsp;}}</li><li>{{c21::Dyslipidaemia&nbsp;}}</li></ul><li>Lifestyle</li><ul><li>{{c21::Smoking}}&nbsp;</li><li>{{c21::Sedentary Lifestyle&nbsp;}}</li><li>{{c21::Dietary Choices}}</li><li>{{c21::Obesity&nbsp;}}</li><li>{{c21::Stress}}</li></ul></ul></div><div><b>Non-modifiable</b></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Male}}</li><li>{{c21::Post-menopausal woman}}</li><li>{{c21::Age}}</li><li>{{c21::Family History}}</li><li>{{c21::Ethinicity}}</li><li>{{c21::PMH}}</li></ul></div></div><div><br /></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "Q&x}RZ*i8g", 
            "note_model_uuid": "5f874e54-5d06-11e8-8b3a-30e37ab3e4ac", 
            "tags": [
                "Anatomy.", 
                "Cardiac", 
                "STEM,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><b>PDx:</b>[[oc1::&nbsp;IBD, most probably Ulcerative Colitis]]<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- [[oc2::Crohn's disease]]</li><li><b>Infectious</b>&nbsp;- [[oc3::Gastroenteritis (Camp., Shigella, C. Diff)]]</li><li><b>Malabsorptive</b>&nbsp;- [[oc4::Coeliac disease]]</li><li><b>Medications</b>&nbsp;- [[oc5::Pseudomembranous colitis, laxatives]]</li><li><b>Others, especially when older</b>&nbsp;- [[oc6::Ischaemic colitis, malignancy, diverticulitis, bleeding disorder]]</li></ul></div></div>", 
                "<div style=\"font-weight: bold; \">State your PDx and DDx<br /><hr /></div><div>43yo F, presents with 2wk Hx of bloody diarrhoea, 12x in last 10hrs. Pain in L and R upper quadrants, previous episode 2yrs ago that resolved.</div>", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<div><b>PDx:</b>{{c1::&nbsp;IBD, most probably Ulcerative Colitis}}<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- ...</li><li><b>Infectious</b>&nbsp;- ...</li><li><b>Malabsorptive</b>&nbsp;- ...</li><li><b>Medications</b>&nbsp;- ...</li><li><b>Others, especially when older</b>&nbsp;- ...</li></ul></div></div>", 
                "<div><b>PDx:</b>...<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- {{c2::Crohn's disease}}</li><li><b>Infectious</b>&nbsp;- ...</li><li><b>Malabsorptive</b>&nbsp;- ...</li><li><b>Medications</b>&nbsp;- ...</li><li><b>Others, especially when older</b>&nbsp;- ...</li></ul></div></div>", 
                "<div><b>PDx:</b>...<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- ...</li><li><b>Infectious</b>&nbsp;- {{c3::Gastroenteritis (Camp., Shigella, C. Diff)}}</li><li><b>Malabsorptive</b>&nbsp;- ...</li><li><b>Medications</b>&nbsp;- ...</li><li><b>Others, especially when older</b>&nbsp;- ...</li></ul></div></div>", 
                "<div><b>PDx:</b>...<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- ...</li><li><b>Infectious</b>&nbsp;- ...</li><li><b>Malabsorptive</b>&nbsp;- {{c4::Coeliac disease}}</li><li><b>Medications</b>&nbsp;- ...</li><li><b>Others, especially when older</b>&nbsp;- ...</li></ul></div></div>", 
                "<div><b>PDx:</b>...<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- ...</li><li><b>Infectious</b>&nbsp;- ...</li><li><b>Malabsorptive</b>&nbsp;- ...</li><li><b>Medications</b>&nbsp;- {{c5::Pseudomembranous colitis, laxatives}}</li><li><b>Others, especially when older</b>&nbsp;- ...</li></ul></div></div>", 
                "<div><b>PDx:</b>...<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- ...</li><li><b>Infectious</b>&nbsp;- ...</li><li><b>Malabsorptive</b>&nbsp;- ...</li><li><b>Medications</b>&nbsp;- ...</li><li><b>Others, especially when older</b>&nbsp;- {{c6::Ischaemic colitis, malignancy, diverticulitis, bleeding disorder}}</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><b>PDx:</b>{{c21::&nbsp;IBD, most probably Ulcerative Colitis}}<div><br /></div><div><b>DDx:</b></div><div><ul style=\"margin-left: 20px; \"><li><b>Other IBD</b>&nbsp;- {{c21::Crohn's disease}}</li><li><b>Infectious</b>&nbsp;- {{c21::Gastroenteritis (Camp., Shigella, C. Diff)}}</li><li><b>Malabsorptive</b>&nbsp;- {{c21::Coeliac disease}}</li><li><b>Medications</b>&nbsp;- {{c21::Pseudomembranous colitis, laxatives}}</li><li><b>Others, especially when older</b>&nbsp;- {{c21::Ischaemic colitis, malignancy, diverticulitis, bleeding disorder}}</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "dT-[>=:0~C", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DDx", 
                "STEM"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>[[oc1::Characterise pain and diarrhoea.&nbsp;</li><li>Ask about extraintestinal IBD Sx (joints, eyes, skin)</li><li>Constitutional and infective Sx</li><li>PMHx, Meds, FHx, travel Hx</li><li>Smoking/drugs/ETOH</li>]]</ul><b>Examination:</b></div><div><ul style=\"margin-left: 20px; \"><li></li><li>[[oc5::</li><li>Clubbing</li><li>Anaemia (pallor, stomatitis, sinus tachy)</li><li>Abdominal palpation (tenderness, masses)</li><li>DRE – peri-anal disease (UC), mass, fissure, haemorrhoid, frank blood</li><li>Extra-intestinal examination (eyes – uveitis, joints – sacroillitis, skin – pyoderma gangrenosum, erythema nodosum</li>]]</ul></div><div><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc2::Stool MCS, OPS (ova, parasites, spores)</li><li>C. Diff toxin test (TcdA/TcdB)</li>]]</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc3::FBC (Fe anaemia), ESR/CRP</li><li>LFT (liver issues, pri sclerosing cholangitis)</li><li>EUC/CMP (electrolyte disturbances, dehydration)</li><li>ANCA/ASCA (p-ANCA +ve in&nbsp;70%&nbsp;of&nbsp;UC)</li><li>Blood cultures (sepsis)</li>]]</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc4::Colonoscopy + biopsy (contraindicated with toxic megacolon)</li><li>AXR or CT Abdo (if suspect perforation or toxic megacolon - &gt;6cm diameter)</li><ul><li>UC - loss of haustra, granular mucosa, shortened colon</li><li>Crohn's - cobblestoning, \"rose thorn\" ulcers, colon strictures w/ rectal sparing</li></ul>]]</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>", 
                "<div>What investigations would you perform?<br /><hr /></div><div>43yo F, presents with 2wk Hx of bloody diarrhoea, 12x in last 10hrs. Pain in L and R upper quadrants, previous episode 2yrs ago that resolved.</div>", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>{{c1::Characterise pain and diarrhoea.&nbsp;</li><li>Ask about extraintestinal IBD Sx (joints, eyes, skin)</li><li>Constitutional and infective Sx</li><li>PMHx, Meds, FHx, Smoking/drugs/ETOH</li><li>Examination</li>}}</ul><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>", 
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c2::Stool MCS</li><li>C. Diff toxin (TcdA/TcdB)</li>}}</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>", 
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c3::FBC (Fe anaemia), ESR/CRP</li><li>LFT (liver issues, pri sclerosing cholangitis)</li><li>EUC/CMP (electrolyte disturbances, dehydration)</li><li>ANCA/ASCA (p-ANCA +ve in UC)</li><li>Blood cultures (sepsis)</li>}}</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>", 
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c4::Colonoscopy + biopsy (contraindicated with toxic megacolon)</li><li>AXR or CT Abdo (if suspect perforation or toxic megacolon - &gt;6cm diameter)</li>}}</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<b>History:&nbsp;</b><div><ul style=\"margin-left: 20px; \"><li>{{c21::Characterise pain and diarrhoea.&nbsp;</li><li>Ask about extraintestinal IBD Sx (joints, eyes, skin)</li><li>Constitutional and infective Sx</li><li>PMHx, Meds, FHx, Smoking/drugs/ETOH</li><li>Examination</li>}}</ul><div><b>Bedside:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Stool MCS</li><li>C. Diff toxin (TcdA/TcdB)</li>}}</ul><div><b>Bloods:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::FBC (Fe anaemia), ESR/CRP</li><li>LFT (liver issues, pri sclerosing cholangitis)</li><li>EUC/CMP (electrolyte disturbances, dehydration)</li><li>ANCA/ASCA (p-ANCA +ve in UC)</li><li>Blood cultures (sepsis)</li>}}</ul><div><b>Imaging:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Colonoscopy + biopsy (contraindicated with toxic megacolon)</li><li>AXR or CT Abdo (if suspect perforation or toxic megacolon - &gt;6cm diameter)</li>}}</ul><div><b>Other:</b></div></div><div><ul style=\"margin-left: 20px; \"><li>TFT (hyperthyroid = non-bloody diarrhoea)</li><li>Transglutaminase Ab test + Anti-endomysial Ab (IgA type) = Coeliac disease</li><li>FOBT&nbsp;</li><li>PCR (?virus)</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "K/)3?(U#%G", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Ix", 
                "STEM"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-1", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-1-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-1-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IQQS]k3(t5", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-2", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-2-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-2-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nFp*6?Pr{]", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-3", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-3-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-3-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QL#z75H9Cp", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-4", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-4-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-4-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "le.^S]+9G8", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-5", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-5-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-5-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v*j&P~=~l#", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-6", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-6-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-6-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lo@3IDBn*u", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-7", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-7-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-7-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dMvYVPdclY", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-8", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-8-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-8-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mvg*_!]Z7w", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-9", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-9-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-9-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l65]h*cFQ7", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-10", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-10-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-10-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HLC|spce}x", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-11", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-11-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-11-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hsnM%km&(>", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "627e5df105064a4aa4c3db7b1f6c3fb2-ao-12", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-12-Q.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-12-A.svg\" />", 
                "<img src=\"627e5df105064a4aa4c3db7b1f6c3fb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eQ`++gXnrf", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e4e3e8a5d2c54cbe844eabed65e6d984-ao-1", 
                "Crohn's disease VS Ulcerative Colitis", 
                "<img src=\"e4e3e8a5d2c54cbe844eabed65e6d984_tmpkgpmq8.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e4e3e8a5d2c54cbe844eabed65e6d984-ao-1-Q.svg\" />", 
                "<img src=\"e4e3e8a5d2c54cbe844eabed65e6d984-ao-1-A.svg\" />", 
                "<img src=\"e4e3e8a5d2c54cbe844eabed65e6d984-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I[dA-vGo|?", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the categories of complications of UC?", 
                "Intestinal (acute,&nbsp;chronic)<div><br /><div><div>Extra-intestinal (eyes, skin, joints, haem, hepatobill, bones, dehydration, nails)</div></div></div>"
            ], 
            "flags": 0, 
            "guid": "y$jC]e|N4M", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the acute complications of UC?", 
                "<ul style=\"margin-left: 20px; \"><li style=\"text-align: left;\">Perforation +/- peritonitis</li><li style=\"text-align: left;\">Bleeding (from erosion of an artery, rare, but life threatening)</li><li style=\"text-align: left;\">Toxic megacolon +/- rupture</li></ul>"
            ], 
            "flags": 0, 
            "guid": "O2mE=Zi<OS", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the chronic complications of UC?", 
                "<ul style=\"margin-left: 20px; \"><li>Colonic adenocarcinoma (CRC)</li><li>Perianal abscess</li><li>Fistula (more likely with Crohn's due to transmural inflammation)</li><li>Strictures</li><li>amyloidosis</li></ul>"
            ], 
            "flags": 0, 
            "guid": "kirx*2cT$?", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Symptomatic relief:&nbsp;</div><div><div><ul style=\"margin-left: 20px; \"><li>[[oc1::Antidiarrheal agents: loperamide</li><li>Anticholinergic medication: propantheline, dicyclomine</li>]]</ul><div>Acute:&nbsp;[[oc2::using 5-aminosalicylic acid derivatives (5-ASAs)&nbsp;</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>rectal → +oral → +oral corticosteroids → alternatives and biologicals</div></div></blockquote></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>]]&nbsp;</div></div></blockquote><br /><div>Maintainence: [[oc3::Oral/rectal 5-ASA&nbsp;→ both&nbsp;→ alternatives]]</div></div>", 
                "General features of treatment of Ulcerative Colitis", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div>Symptomatic relief:&nbsp;</div><div><div><ul style=\"margin-left: 20px; \"><li>{{c1::Antidiarrheal agents: loperamide</li><li>Anticholinergic medication: propantheline, dicyclomine</li>}}</ul><div>Acute:&nbsp;...&nbsp;</div></div></blockquote><br /><div>Maintainence: ...</div></div>", 
                "<div>Symptomatic relief:&nbsp;</div><div><div><ul style=\"margin-left: 20px; \"><li>Antidiarrheal agents: loperamide</li><li>Anticholinergic medication: propantheline, dicyclomine</li></ul><div>Acute:&nbsp;{{c2::using 5-aminosalicylic acid derivatives (5-ASAs)&nbsp;</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>rectal → +oral → +oral corticosteroids → alternatives and biologicals</div></div></blockquote></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>}}&nbsp;</div></div></blockquote><br /><div>Maintainence: ...</div></div>", 
                "<div>Symptomatic relief:&nbsp;</div><div><div><ul style=\"margin-left: 20px; \"><li>...</ul><div>Acute:&nbsp;using 5-aminosalicylic acid derivatives (5-ASAs)&nbsp;</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>rectal → +oral → +oral corticosteroids → alternatives and biologicals</div></div></blockquote></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>&nbsp;</div></div></blockquote><br /><div>Maintainence: {{c3::Oral/rectal 5-ASA&nbsp;→ both&nbsp;→ alternatives}}</div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div>Symptomatic relief:&nbsp;</div><div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Antidiarrheal agents: loperamide</li><li>Anticholinergic medication: propantheline, dicyclomine</li>}}</ul><div>Acute:&nbsp;{{c21::using 5-aminosalicylic acid derivatives (5-ASAs)&nbsp;</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>rectal → +oral → +oral corticosteroids → alternatives and biologicals</div></div></blockquote></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 40px; border-top-style: none; border-right-style: none; border-bottom-style: none; border-left-style: none; border-width: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; \"><div><div>}}&nbsp;</div></div></blockquote><br /><div>Maintainence: {{c21::Oral/rectal 5-ASA&nbsp;→ both&nbsp;→ alternatives}}</div></div>"
            ], 
            "flags": 0, 
            "guid": "n?83m1ZGk`", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "5-ASAs ([[oc1::5-Animosalicylic acid derivatives]]):<div><ul style=\"margin-left: 20px; \"><li>[[oc2::Mesalamine]]</li><li>[[oc2::Sulfasalazine]]</li><li>[[oc2::Olsalazine]]</li></ul><b>Mild:</b> [[oc3::5-ASA as suppository or enema, topical steroid (budesonide) if not tolerated]]</div><div><br /></div><div><b>Moderate:</b> [[oc4::Oral + topical 5-ASAs, can use in combination with topical budesonide]]</div><div><br /></div><div><b>Severe:</b>&nbsp;[[oc5::High dose oral + topical 5-ASA and Oral corticosteroids.</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>if insufficient: IV corticosteroids]]</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>[[oc6::<div><ul style=\"margin-left: 20px; \"><li>Cyclosporine, azathioprine</li><li>Surgery (curative! proctocolectomy)</li></ul></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>Alternatives:&nbsp;infliximab, tacrolimus</div></blockquote>]]</li></ul></div>", 
                "Treatment of acute Ulcerative Colitis", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "5-ASAs ({{c1::5-Animosalicylic acid derivatives}}):<div><ul style=\"margin-left: 20px; \"><li></li><li>...</li><li>...</li><li>...</li></ul><b>Mild:</b> ...</div><div><br /></div><div><b>Moderate:</b> ...</div><div><br /></div><div><b>Severe:</b>&nbsp;...</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div>", 
                "5-ASAs (...):<div><ul style=\"margin-left: 20px; \"><li></li><li>{{c2::Mesalamine}}</li><li>{{c2::Sulfasalazine}}</li><li>{{c2::Olsalazine}}</li></ul><b>Mild:</b> ...</div><div><br /></div><div><b>Moderate:</b> ...</div><div><br /></div><div><b>Severe:</b>&nbsp;...</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div>", 
                "5-ASAs (...):<div><ul style=\"margin-left: 20px; \"><li></li><li>...</li><li>...</li><li>...</li></ul><b>Mild:</b> {{c3::5-ASA as suppository or enema, topical steroid (budesonide) if not tolerated}}</div><div><br /></div><div><b>Moderate:</b> ...</div><div><br /></div><div><b>Severe:</b>&nbsp;...</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div>", 
                "5-ASAs (...):<div><ul style=\"margin-left: 20px; \"><li></li><li>...</li><li>...</li><li>...</li></ul><b>Mild:</b> ...</div><div><br /></div><div><b>Moderate:</b> {{c4::Oral + topical 5-ASAs, can use in combination with topical budesonide}}</div><div><br /></div><div><b>Severe:</b>&nbsp;...</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div>", 
                "5-ASAs (...):<div><ul style=\"margin-left: 20px; \"><li></li><li>...</li><li>...</li><li>...</li></ul><b>Mild:</b> ...</div><div><br /></div><div><b>Moderate:</b> ...</div><div><br /></div><div><b>Severe:</b>&nbsp;{{c5::High dose oral + topical 5-ASA and Oral corticosteroids.</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>if insufficient: IV corticosteroids}}</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div>", 
                "5-ASAs (...):<div><ul style=\"margin-left: 20px; \"><li></li><li>...</li><li>...</li><li>...</li></ul><b>Mild:</b> ...</div><div><br /></div><div><b>Moderate:</b> ...</div><div><br /></div><div><b>Severe:</b>&nbsp;...</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>{{c6::<div><ul style=\"margin-left: 20px; \"><li>Cyclosporine</li><li>Surgery</li></ul></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>Alternatives: infliximab, tacrolimus, azathioprine</div></blockquote>}}</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "5-ASAs ({{c21::5-Animosalicylic acid derivatives}}):<div><ul style=\"margin-left: 20px; \"><li></li><li>{{c21::Mesalamine}}</li><li>{{c21::Sulfasalazine}}</li><li>{{c21::Olsalazine}}</li></ul><b>Mild:</b> {{c21::5-ASA as suppository or enema, topical steroid (budesonide) if not tolerated}}</div><div><br /></div><div><b>Moderate:</b> {{c21::Oral + topical 5-ASAs, can use in combination with topical budesonide}}</div><div><br /></div><div><b>Severe:</b>&nbsp;{{c21::High dose oral + topical 5-ASA and Oral corticosteroids.</div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>if insufficient: IV corticosteroids}}</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div><br /></div></blockquote><b>Steroid-refractory Disease:</b>&nbsp;<div><ul style=\"margin-left: 20px; \"><li>{{c21::<div><ul style=\"margin-left: 20px; \"><li>Cyclosporine</li><li>Surgery</li></ul></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>Alternatives: infliximab, tacrolimus, azathioprine</div></blockquote>}}</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "i7DP|TD%iE", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "1st line (dec. risk of colon cancer)<div><ul style=\"margin-left: 20px; \"><li>[[oc1::mild: oral/rectal 5-ASA]]</li><li>[[oc1::mod-severe: oral + rectal 5-ASA]]</li><li>[[oc1::5-ASA intolerance: probiotics (E Coli strain Nissle 1917)]]</li></ul><div>Alternatives:</div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc2::Azathioprine/6-mercaptopurine]]</li><li>[[oc2::Infliximab]]&nbsp;</li></ul><div>Surgery:[[oc3::</div><div><div></div></div><div><ul style=\"margin-left: 20px; \"><li>curative, reduces risk of colon cancer</li><li>indicated if acute complications, severe relapses, long term dependance on steroids</li><li>Proctocolectomy</li><li>can be cured surgically, unlike Crohn's&nbsp;</li></ul></div>]]</div>", 
                "Long-Term Therapy for Ulcerative Colitis", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "1st line (dec. risk of colon cancer)<div><ul style=\"margin-left: 20px; \"><li>{{c1::mild: oral/rectal 5-ASA}}</li><li>{{c1::mod-severe: oral + rectal 5-ASA}}</li><li>{{c1::5-ASA intolerance: probiotics (E Coli strain Nissle 1917)}}</li></ul><div>Alternatives:</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...&nbsp;</li></ul><div>Surgery:...</div></div>", 
                "1st line (dec. risk of colon cancer)<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li></ul><div>Alternatives:</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c2::Azathioprine or 6-mercaptopurine}}</li><li>{{c2::Infliximab}}&nbsp;</li></ul><div>Surgery:...</div>", 
                "1st line (dec. risk of colon cancer)<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li></ul><div>Alternatives:</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...&nbsp;</li></ul><div>Surgery:{{c3::</div><div><div></div></div><div><ul style=\"margin-left: 20px; \"><li>curative, reduces risk of colon cancer</li><li>indicated if acute complications, severe relapses, long term dependance on steroids</li><li>Proctocolectomy</li><li>can be cured surgically, unlike Crohn's&nbsp;</li></ul></div>}}</div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "1st line (dec. risk of colon cancer)<div><ul style=\"margin-left: 20px; \"><li>{{c21::mild: oral/rectal 5-ASA}}</li><li>{{c21::mod-severe: oral + rectal 5-ASA}}</li><li>{{c21::5-ASA intolerance: probiotics (E Coli strain Nissle 1917)}}</li></ul><div>Alternatives:</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Azathioprine or 6-mercaptopurine}}</li><li>{{c21::Infliximab}}&nbsp;</li></ul><div>Surgery:{{c21::</div><div><div></div></div><div><ul style=\"margin-left: 20px; \"><li>curative, reduces risk of colon cancer</li><li>indicated if acute complications, severe relapses, long term dependance on steroids</li><li>Proctocolectomy</li><li>can be cured surgically, unlike Crohn's&nbsp;</li></ul></div>}}</div>"
            ], 
            "flags": 0, 
            "guid": "GGT(4p9@fg", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>[[oc1::nicotine]] abstinence</li><li>lactose intolerance - [[oc2::lactose-free diet]]</li><li>appropriate [[oc3::nutrion]] supplementation</li><li>bile acid diarrhoea - [[oc4::give ion-exchange resins to bind bile acids (eg. cholestyramine) to reduce osmotic diarhhoea (risk of steatorrhoea)]]</li><li>During acute episodes: [[oc5::avoid dietary fibre, consider parenteral nutrition]]</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>[[oc6::step up or step down therapy (weak to strong, or strong to weak meds)]]</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc7::</li><li>if medical therapy fails, or complications (obstruction, fistula, stricture)</li><li>non-curative, last resort</li><li>resection of affected bowel</li>]]</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>[[oc8::</li><li>regular check ups</li><li>Smoking cessation</li><li>prophylactic Abx, 5-ASAs, etc</li>]]</ul></div>", 
                "General Structure of treatment of Crohn's disease", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>{{c1::nicotine}} abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - {{c2::lactose-free diet}}</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate {{c3::nutrion}} supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - {{c4::give ion-exchange resins to bind bile acids (eg. cholestyramine) to reduce osmotic diarhhoea (risk of steatorrhoea)}}</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: {{c5::avoid dietary fibre, consider parenteral nutrition}}</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>{{c6::step up or step down therapy (weak to strong, or strong to weak meds)}}</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c7::</li><li>if medical therapy fails, or complications (obstruction, fistula, stricture)</li><li>non-curative, last resort</li><li>resection of affected bowel</li>}}</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div>", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>... abstinence</li><li>lactose intolerance - ...</li><li>appropriate ... supplementation</li><li>bile acid diarrhoea - ...</li><li>During acute episodes: ...</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>...</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>...</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>{{c8::</li><li>regular check ups</li><li>Smoking cessation</li><li>prophylactic Abx, 5-ASAs, etc</li>}}</ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><div>General</div><div><ul style=\"margin-left: 20px; \"><li>{{c21::nicotine}} abstinence</li><li>lactose intolerance - {{c21::lactose-free diet}}</li><li>appropriate {{c21::nutrion}} supplementation</li><li>bile acid diarrhoea - {{c21::give ion-exchange resins to bind bile acids (eg. cholestyramine) to reduce osmotic diarhhoea (risk of steatorrhoea)}}</li><li>During acute episodes: {{c21::avoid dietary fibre, consider parenteral nutrition}}</li></ul></div><div><br /></div><div>Pharmacotherapy</div><div><ul style=\"margin-left: 20px; \"><li>{{c21::step up or step down therapy (weak to strong, or strong to weak meds)}}</li></ul></div><div>Surgery</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::</li><li>if medical therapy fails, or complications (obstruction, fistula, stricture)</li><li>non-curative, last resort</li><li>resection of affected bowel</li>}}</ul></div><div>Prevention</div><div><ul style=\"margin-left: 20px; \"><li>{{c21::</li><li>regular check ups</li><li>Smoking cessation</li><li>prophylactic Abx, 5-ASAs, etc</li>}}</ul></div>"
            ], 
            "flags": 0, 
            "guid": "Alf$SpK!5}", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-1", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-1-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-1-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ul6NbW.uGQ", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-2", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-2-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-2-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Phc/cFs$v7", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-3", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-3-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-3-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z(`Kgi185I", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-4", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-4-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-4-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ihXN1x(2HV", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-5", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-5-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-5-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qp6$B^v;!N", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-6", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-6-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-6-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JY;Za)2.g]", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3e07b655cf444b62ae7e0b5fa52e1ac8-oa-7", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8_tmpmh0emc.png\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-7-Q.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-7-A.svg\" />", 
                "<img src=\"3e07b655cf444b62ae7e0b5fa52e1ac8-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "O(ySKRrAVt", 
            "note_model_uuid": "35a38c47-16e6-11e8-b5f1-0050b6c6d7f0", 
            "tags": [
                "Management", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><ol type=\"1\" start=\"1\"><li>[[oc1::Enters cell, binds to cytoplasmic glucocorticoid receptors]]</li><li>[[oc2::Receptor complex enters nucleus → gene transcription]]</li><li>[[oc3::↑ Annexin-1 protein]]</li><li>[[oc4::↓ Phospholipase A2]]</li><li>[[oc5::↓ COX, lipoxygenase]]</li><li>[[oc6::↓&nbsp;<b>PG</b>&nbsp;(D<sub>2</sub>,&nbsp;E<sub>2</sub>,<sub>&nbsp;</sub>F<sub>2</sub>, I<sub>2</sub>,),&nbsp;<b>LT</b>&nbsp;(B4,&nbsp;C4,&nbsp;D4,&nbsp;E4),&nbsp;<b>PAF </b>(from phospholipase A2)]]</li></ol></div>", 
                "What is the MOA of prednisone? (glucocorticoid)", 
                "", 
                "", 
                "5,1,0 | n,n,n,n", 
                "<div><ol type=\"1\" start=\"1\"><li>{{c1::Enters cell, binds to cytoplasmic glucocorticoid receptors}}</li><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ol></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Enters cell, binds to cytoplasmic glucocorticoid receptors</li><li>{{c2::Receptor complex enters nucleus → gene transcription}}</li><li>...</li><li>...</li><li>...</li><li>...</li></ol></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Enters cell, binds to cytoplasmic glucocorticoid receptors</li><li>Receptor complex enters nucleus → gene transcription</li><li>{{c3::↑ Annexin-1 protein}}</li><li>...</li><li>...</li><li>...</li></ol></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Enters cell, binds to cytoplasmic glucocorticoid receptors</li><li>Receptor complex enters nucleus → gene transcription</li><li>↑ Annexin-1 protein</li><li>{{c4::↓ Phospholipase A2}}</li><li>...</li><li>...</li></ol></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Enters cell, binds to cytoplasmic glucocorticoid receptors</li><li>Receptor complex enters nucleus → gene transcription</li><li>↑ Annexin-1 protein</li><li>↓ Phospholipase A2</li><li>{{c5::↓ COX, lipoxygenase}}</li><li>...</li></ol></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Enters cell, binds to cytoplasmic glucocorticoid receptors</li><li>Receptor complex enters nucleus → gene transcription</li><li>↑ Annexin-1 protein</li><li>↓ Phospholipase A2</li><li>↓ COX, lipoxygenase</li><li>{{c6::↓&nbsp;<b>PG</b>&nbsp;(D<sub>2</sub>,&nbsp;E<sub>2</sub>,<sub>&nbsp;</sub>F<sub>2</sub>, I<sub>2</sub>,),&nbsp;<b>LT</b>&nbsp;(B4,&nbsp;C4,&nbsp;D4,&nbsp;E4),&nbsp;<b>PAF </b>(from phospholipase A2)}}</li></ol></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><ol type=\"1\" start=\"1\"><li>{{c21::Enters cell, binds to cytoplasmic glucocorticoid receptors}}</li><li>{{c21::Receptor complex enters nucleus → gene transcription}}</li><li>{{c21::↑ Annexin-1 protein}}</li><li>{{c21::↓ Phospholipase A2}}</li><li>{{c21::↓ COX, lipoxygenase}}</li><li>{{c21::↓&nbsp;<b>PG</b>&nbsp;(D<sub>2</sub>,&nbsp;E<sub>2</sub>,<sub>&nbsp;</sub>F<sub>2</sub>, I<sub>2</sub>,),&nbsp;<b>LT</b>&nbsp;(B4,&nbsp;C4,&nbsp;D4,&nbsp;E4),&nbsp;<b>PAF </b>(from phospholipase A2)}}</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "pG*|Vm?|NH", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Cells (immunosuppression):<div><ul style=\"margin-left: 20px; \"><li>[[oc1::↓ neutrophil egress]]</li><li>[[oc1::↓ IL (most importantly, IL-2 --&nbsp;↓ T helper cell function)]]</li></ul><div>Mediators (anti-inflammatory):</div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc2::↓ COX --&nbsp;↓ PG]]</li><li>[[oc2::↓ IL, TNF]]</li></ul></div>", 
                "What is the effect of Prednisone (glucocorticoid) on cells and mediators?", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Cells (immunosuppression):<div><ul style=\"margin-left: 20px; \"><li>{{c1::↓ neutrophil egress}}</li><li>{{c1::↓ IL (most importantly, IL-2 --&nbsp;↓ T helper cell function)}}</li></ul><div>Mediators (anti-inflammatory):</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li></ul></div>", 
                "Cells (immunosuppression):<div><ul style=\"margin-left: 20px; \"><li>↓ neutrophil egress</li><li>↓ IL (most importantly, IL-2 --&nbsp;↓ T helper cell function)</li></ul><div>Mediators (anti-inflammatory):</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c2::↓ COX --&nbsp;↓ PG}}</li><li>{{c2::↓ IL, TNF}}</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Cells (immunosuppression):<div><ul style=\"margin-left: 20px; \"><li>{{c21::↓ neutrophil egress}}</li><li>{{c21::↓ IL (most importantly, IL-2 --&nbsp;↓ T helper cell function)}}</li></ul><div>Mediators (anti-inflammatory):</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::↓ COX --&nbsp;↓ PG}}</li><li>{{c21::↓ IL, TNF}}</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "Ku`Yi_$N5z", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><b>Acute:</b>&nbsp;[[oc1::immunosuppression, Addisonian/adrenal crisis (withdrawal if not weaned)]]<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;[[oc2::steroid psychosis, anxiety, depression, sleep disturbance]]</li><li><b>Eyes:</b>&nbsp;[[oc3::cataracts, retinopathy, glaucoma]]</li><li><b>Cardio:&nbsp;</b>[[oc4::fluid retention, HTN]]</li><li><b>Endocrine:&nbsp;</b>[[oc5::Cushing's syndrome, hyperglycaemia, insulin resistance/DM, erectile dysfunction, hypogonadism, amenorrhoea, adrenal suppression, thinning skin/easy bruising]]</li><li><b>Skeletal:&nbsp;</b>[[oc6::osteoporosis, muscle wasting/myopathy, avascular necrosis of femoral/humeral head]]</li><li><b>Immune:</b>&nbsp;[[oc7::candidiasis + other opportunistic infections, delated wound healing]]</li></ul></div></div>", 
                "What are the side effects of prednisone? (glucocorticoids)", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div><b>Acute:</b>&nbsp;{{c1::immunosuppression, Addisonian/adrenal crisis (withdrawal if not weaned)}}<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;...</li><li><b>Eyes:</b>&nbsp;...</li><li><b>Cardio:&nbsp;</b>...</li><li><b>Endocrine:&nbsp;</b>...</li><li><b>Skeletal:&nbsp;</b>...</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;immunosuppression, Addisonian/adrenal crisis (withdrawal if not weaned)<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;{{c2::steroid psychosis, anxiety, depression, sleep disturbance}}</li><li><b>Eyes:</b>&nbsp;...</li><li><b>Cardio:&nbsp;</b>...</li><li><b>Endocrine:&nbsp;</b>...</li><li><b>Skeletal:&nbsp;</b>...</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;...<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;steroid psychosis, anxiety, depression, sleep disturbance</li><li><b>Eyes:</b>&nbsp;{{c3::cataracts, retinopathy, glaucoma}}</li><li><b>Cardio:&nbsp;</b>...</li><li><b>Endocrine:&nbsp;</b>...</li><li><b>Skeletal:&nbsp;</b>...</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;...<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;...</li><li><b>Eyes:</b>&nbsp;cataracts, retinopathy, glaucoma</li><li><b>Cardio:&nbsp;</b>{{c4::fluid retention, HTN}}</li><li><b>Endocrine:&nbsp;</b>...</li><li><b>Skeletal:&nbsp;</b>...</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;...<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;...</li><li><b>Eyes:</b>&nbsp;...</li><li><b>Cardio:&nbsp;</b>fluid retention, HTN</li><li><b>Endocrine:&nbsp;</b>{{c5::Cushing's syndrome, hyperglycaemia, insulin resistance/DM, erectile dysfunction, hypogonadism, amenorrhoea, adrenal suppression, thinning skin/easy bruising}}</li><li><b>Skeletal:&nbsp;</b>...</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;...<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;...</li><li><b>Eyes:</b>&nbsp;...</li><li><b>Cardio:&nbsp;</b>...</li><li><b>Endocrine:&nbsp;</b>Cushing's syndrome, hyperglycaemia, insulin resistance/DM, erectile dysfunction, hypogonadism, amenorrhoea, adrenal suppression, thinning skin/easy bruising</li><li><b>Skeletal:&nbsp;</b>{{c6::osteoporosis, muscle wasting/myopathy, avascular necrosis of femoral/humeral head}}</li><li><b>Immune:</b>&nbsp;...</li></ul></div></div>", 
                "<div><b>Acute:</b>&nbsp;...<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;...</li><li><b>Eyes:</b>&nbsp;...</li><li><b>Cardio:&nbsp;</b>...</li><li><b>Endocrine:&nbsp;</b>...</li><li><b>Skeletal:&nbsp;</b>osteoporosis, muscle wasting/myopathy, avascular necrosis of femoral/humeral head</li><li><b>Immune:</b>&nbsp;{{c7::candidiasis + other opportunistic infections, delated wound healing}}</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><b>Acute:</b>&nbsp;{{c21::immunosuppression, Addisonian/adrenal crisis (withdrawal if not weaned)}}<div><div><br /></div><div><b>Chronic:&nbsp;</b></div></div><div><ul style=\"margin-left: 20px; \"><li><b>Neuropsych:</b>&nbsp;{{c21::steroid psychosis, anxiety, depression, sleep disturbance}}</li><li><b>Eyes:</b>&nbsp;{{c21::cataracts, retinopathy, glaucoma}}</li><li><b>Cardio:&nbsp;</b>{{c21::fluid retention, HTN}}</li><li><b>Endocrine:&nbsp;</b>{{c21::Cushing's syndrome, hyperglycaemia, insulin resistance/DM, erectile dysfunction, hypogonadism, amenorrhoea, adrenal suppression, thinning skin/easy bruising}}</li><li><b>Skeletal:&nbsp;</b>{{c21::osteoporosis, muscle wasting/myopathy, avascular necrosis of femoral/humeral head}}</li><li><b>Immune:</b>&nbsp;{{c21::candidiasis + other opportunistic infections, delated wound healing}}</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "r@<8h!)UCD", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<ol type=\"1\" start=\"1\"><li>[[oc1::Scavenges free radicals, inhibits PGs and LTs&nbsp;→&nbsp;↓Chemotaxis]]</li><li>[[oc2::Toxic to lymphocytes -- ↓ T cell-mediated inflammation]]</li><li>[[oc3::Poorly absorbed -- inflammatory action localised to bowel wall]]</li></ol>", 
                "What is the MOA of Sulfalazine? (5-ASA)", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<ol type=\"1\" start=\"1\"><li>{{c1::Scavenges free radicals, inhibits PGs and LTs&nbsp;→&nbsp;↓Chemotaxis}}</li><li>...</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>Scavenges free radicals, inhibits PGs and LTs&nbsp;→&nbsp;↓Chemotaxis</li><li>{{c2::Toxic to lymphocytes -- ↓ T cell-mediated inflammation}}</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>...</li><li>Toxic to lymphocytes -- ↓ T cell-mediated inflammation</li><li>{{c3::Poorly absorbed -- inflammatory action localised to bowel wall}}</li></ol>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<ol type=\"1\" start=\"1\"><li>{{c21::Scavenges free radicals, inhibits PGs and LTs&nbsp;→&nbsp;↓Chemotaxis}}</li><li>{{c21::Toxic to lymphocytes -- ↓ T cell-mediated inflammation}}</li><li>{{c21::Poorly absorbed -- inflammatory action localised to bowel wall}}</li></ol>"
            ], 
            "flags": 0, 
            "guid": "gZC5SRSLgj", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are side effects of sulfalazine?", 
                "5-Aminosalicylic acid<div><br /></div><div>S/E: Vomiting, oligospermia, mild haemolysis</div>"
            ], 
            "flags": 0, 
            "guid": "MePYVC7Kv/", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<ol type=\"1\" start=\"1\"><li>[[oc1::metabolised to <b>6-mercaptopurine</b>]]</li><li><b>[[oc2::</b><b>inhibited purine synthesis</b>, DNA+RNA nucleotide synthesis affected]]</li><li>[[oc3::<ol type=\"1\" start=\"1\"><li>inhibits proliferation of lymphocytes</li></ol><div>immunosuppression, inhibited inflammatory response</div>]]</li></ol>", 
                "What is the MOA of Azathioprine?", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<ol type=\"1\" start=\"1\"><li>{{c1::metabolised to <b>6-mercaptopurine</b>}}</li><li><b>...</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>metabolised to <b>6-mercaptopurine</b></li><li><b>{{c2::</b><b>inhibited purine synthesis</b>, DNA+RNA nucleotide synthesis affected}}</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>...</li><li><b></b><b>inhibited purine synthesis</b>, DNA+RNA nucleotide synthesis affected</li><li>{{c3::<ol type=\"1\" start=\"1\"><li>inhibits proliferation of lymphocytes</li></ol><div>immunosuppression, inhibited inflammatory response</div>}}</li></ol>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<ol type=\"1\" start=\"1\"><li>{{c21::metabolised to <b>6-mercaptopurine</b>}}</li><li><b>{{c21::</b><b>inhibited purine synthesis</b>, DNA+RNA nucleotide synthesis affected}}</li><li>{{c21::<ol type=\"1\" start=\"1\"><li>inhibits proliferation of lymphocytes</li></ol><div>immunosuppression, inhibited inflammatory response</div>}}</li></ol>"
            ], 
            "flags": 0, 
            "guid": "f*-.-7qM4&", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<ol type=\"1\" start=\"1\"><li>[[oc1::DHF-reductase inhibitor]]</li><li>[[oc2::Inhibits folic acid conversion]]</li><li>[[oc3::↓ DNA synthesis + cell replication]]</li><li>[[oc4::Cytotoxic, immunosuppressive and anti-inflammatory action]]</li></ol>", 
                "What is the MOA of Methotrexate?", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<ol type=\"1\" start=\"1\"><li>{{c1::DHF-reductase inhibitor}}</li><li>...</li><li>...</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>DHF-reductase inhibitor</li><li>{{c2::Inhibits folic acid conversion}}</li><li>...</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>...</li><li>Inhibits folic acid conversion</li><li>{{c3::↓ DNA synthesis + cell replication}}</li><li>...</li></ol>", 
                "<ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>↓ DNA synthesis + cell replication</li><li>{{c4::Cytotoxic, immunosuppressive and anti-inflammatory action}}</li></ol>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<ol type=\"1\" start=\"1\"><li>{{c21::DHF-reductase inhibitor}}</li><li>{{c21::Inhibits folic acid conversion}}</li><li>{{c21::↓ DNA synthesis + cell replication}}</li><li>{{c21::Cytotoxic, immunosuppressive and anti-inflammatory action}}</li></ol>"
            ], 
            "flags": 0, 
            "guid": "nH6Siwa|i7", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are some side effects of Azathioprine?", 
                "<b>Diarrhoea</b><div><b>Mouth ulcers</b></div><div>Oesophagitis</div><div>Myelosuppression</div><div>Alopecia</div>"
            ], 
            "flags": 0, 
            "guid": "y%IH<V:vq{", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are some side effects of Methotrexate?", 
                "<b>Nausea</b><div><b>Mouth ulcers</b></div><div>↑ AST/ALT (esp w/ leflunomide)</div><div>Myelosuppression</div><div>Pneumonitis/fibrosis</div><div><br /></div><div>Note:&nbsp;↓S/E w/ folic acid supplementation</div>"
            ], 
            "flags": 0, 
            "guid": "JQ@/H94dWV", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> [[oc1::uveitis, scleritis, episcleritis]]</li><li><b>Skin: </b>[[oc2::erythema nodosum (inflammation of subcut fat)]]</li><li><b>Rheum:</b> [[oc3::enteric arthritis, scroilitis, ankylosing spondylitis]]</li><li><b>Haem:&nbsp;</b>[[oc4::</li><li>Folate/B12 anaemia, Fe deficiency&nbsp;(malabsorption)]]</li><li><b>Hepatobill:</b> [[oc5::Primary sclerosing cholangitis]]</li><li><b>Bone:</b>&nbsp;[[oc6::dec. Ca<sup>2+</sup>&nbsp;(fat malabsorption) &gt; osteomalacia, osteoporosis]]</li><li><b>Systemic:</b> [[oc7::dehydration]]</li><li><b>Nails:</b> [[oc8::clubbing]]</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "What are the peripheral stigmata of Ulcerative Colitis?", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> {{c1::uveitis, scleritis, episcleritis}}</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>{{c2::erythema nodosum (inflammation of subcut fat)}}</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> {{c3::enteric arthritis, scroilitis, ankylosing spondylitis}}</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>{{c4::</li><li>Folate/B12 anaemia, Fe deficiency&nbsp;(malabsorption)}}</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> {{c5::Primary sclerosing cholangitis}}</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;{{c6::dec. Ca<sup>2+</sup>&nbsp;(fat malabsorption) &gt; osteomalacia, osteoporosis}}</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> {{c7::dehydration}}</li><li><b>Nails:</b> ...</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> ...</li><li><b>Skin: </b>...</li><li><b>Rheum:</b> ...</li><li><b>Haem:&nbsp;</b>...</li><li><b>Hepatobill:</b> ...</li><li><b>Bone:</b>&nbsp;...</li><li><b>Systemic:</b> ...</li><li><b>Nails:</b> {{c8::clubbing}}</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<ul style=\"margin-left: 20px; \"><li><b>Eyes:</b> {{c21::uveitis, scleritis, episcleritis}}</li><li><b>Skin: </b>{{c21::erythema nodosum (inflammation of subcut fat)}}</li><li><b>Rheum:</b> {{c21::enteric arthritis, scroilitis, ankylosing spondylitis}}</li><li><b>Haem:&nbsp;</b>{{c21::</li><li>Folate/B12 anaemia, Fe deficiency&nbsp;(malabsorption)}}</li><li><b>Hepatobill:</b> {{c21::Primary sclerosing cholangitis}}</li><li><b>Bone:</b>&nbsp;{{c21::dec. Ca<sup>2+</sup>&nbsp;(fat malabsorption) &gt; osteomalacia, osteoporosis}}</li><li><b>Systemic:</b> {{c21::dehydration}}</li><li><b>Nails:</b> {{c21::clubbing}}</li></ul><div>More likely for UC to have peripheral stigmata than Crohn's</div>"
            ], 
            "flags": 0, 
            "guid": "J%OzZ);%/,", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><div><ul style=\"margin-left: 20px; \"><li>[[oc1::Gross,uniform (no skip lesions)]] inflammation extending from [[oc1::rectum]]</li><li>Pale irregular areas = [[oc2::coalitions of ulcers! islands of mucosa left. Mucosal ulcers down to submucosa &amp; pseudopolyps (regenerating mucosa b/w ulcerations).]]</li><li>Dark material = [[oc3::faeces stained mucin&nbsp;]]</li><li>[[oc4::Sharp cut-off]] between affected and normal bowel&nbsp;</li><li>Wall is [[oc5::NOT thickened (c.f. thick in CD)]]&nbsp;</li><li>NO [[oc6::fissures]] (c.f. CD)&nbsp;</li><li>Inflammation typically begins in [[oc7::rectum and spreads proximally]], may involve [[oc7::whole colon (c.f. skip lesions in CD)]]</li></ul></div></div><div><br /></div>", 
                "Discuss the pathology of this pot<div><img src=\"paste-3539053051907.jpg\" /></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>{{c1::Gross,uniform (no skip lesions)}} inflammation extending from {{c1::rectum}}</li><li>Pale irregular areas = ...</li><li>Dark material = ...</li><li>... between affected and normal bowel&nbsp;</li><li>Wall is ...&nbsp;</li><li>NO ... (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>Gross,uniform (no skip lesions) inflammation extending from rectum</li><li>Pale irregular areas = {{c2::coalitions of ulcers! islands of mucosa left. Mucosal ulcers down to submucosa &amp; pseudopolyps (regenerating mucosa b/w ulcerations).}}</li><li>Dark material = ...</li><li>... between affected and normal bowel&nbsp;</li><li>Wall is ...&nbsp;</li><li>NO ... (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>... inflammation extending from ...</li><li>Pale irregular areas = coalitions of ulcers! islands of mucosa left. Mucosal ulcers down to submucosa &amp; pseudopolyps (regenerating mucosa b/w ulcerations).</li><li>Dark material = {{c3::faeces stained mucin&nbsp;}}</li><li>... between affected and normal bowel&nbsp;</li><li>Wall is ...&nbsp;</li><li>NO ... (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>... inflammation extending from ...</li><li>Pale irregular areas = ...</li><li>Dark material = faeces stained mucin&nbsp;</li><li>{{c4::Sharp cut-off}} between affected and normal bowel&nbsp;</li><li>Wall is ...&nbsp;</li><li>NO ... (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>... inflammation extending from ...</li><li>Pale irregular areas = ...</li><li>Dark material = ...</li><li>Sharp cut-off between affected and normal bowel&nbsp;</li><li>Wall is {{c5::NOT thickened (c.f. thick in CD)}}&nbsp;</li><li>NO ... (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>... inflammation extending from ...</li><li>Pale irregular areas = ...</li><li>Dark material = ...</li><li>... between affected and normal bowel&nbsp;</li><li>Wall is NOT thickened (c.f. thick in CD)&nbsp;</li><li>NO {{c6::fissures}} (c.f. CD)&nbsp;</li><li>Inflammation typically begins in ..., may involve ...</li></ul></div></div><div><br /></div>", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>... inflammation extending from ...</li><li>Pale irregular areas = ...</li><li>Dark material = ...</li><li>... between affected and normal bowel&nbsp;</li><li>Wall is ...&nbsp;</li><li>NO fissures (c.f. CD)&nbsp;</li><li>Inflammation typically begins in {{c7::rectum and spreads proximally}}, may involve {{c7::whole colon (c.f. skip lesions in CD)}}</li></ul></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Gross,uniform (no skip lesions)}} inflammation extending from {{c21::rectum}}</li><li>Pale irregular areas = {{c21::coalitions of ulcers! islands of mucosa left. Mucosal ulcers down to submucosa &amp; pseudopolyps (regenerating mucosa b/w ulcerations).}}</li><li>Dark material = {{c21::faeces stained mucin&nbsp;}}</li><li>{{c21::Sharp cut-off}} between affected and normal bowel&nbsp;</li><li>Wall is {{c21::NOT thickened (c.f. thick in CD)}}&nbsp;</li><li>NO {{c21::fissures}} (c.f. CD)&nbsp;</li><li>Inflammation typically begins in {{c21::rectum and spreads proximally}}, may involve {{c21::whole colon (c.f. skip lesions in CD)}}</li></ul></div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "OZq.vfTwjO", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Pathology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Patient presents with flank pain and dysuria.<div>Temp: 39<sup>o</sup>C</div><div>HR: 120 bpm</div><div>BP: 90/60</div><div><hr /></div><div>What is your diagnosis?</div></div>", 
                "<b>PDx:</b> Septic shock, secondary to pyelonephritis<blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>given low BP, tachycardai, fever, dysuria</div></blockquote><div><div><br /></div><div><b>DDx:&nbsp;</b></div><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>Infectious: acute cystitis, PID</div></blockquote><blockquote class=\"webkit-indent-blockquote\" style=\"margin: 0 0 0 40px; border: none; padding: 0px;\"><div>Non-infectious: renal calculi</div></blockquote></div>"
            ], 
            "flags": 0, 
            "guid": "tgxAa}xJ,z", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "Diagnostic"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>[[oc1::E. Coli (80-95%) (urinary pathogenic E. coli that has pyelonephritis assoc. pili]]</li><li>[[oc1::Proteus mirabilis]]</li><li>Other GN: [[oc2::klebsiella, enterobacter, pseudomonas]]</li><li>Other GP: [[oc3::enterococcus, staph epididermis]]</li><li>[[oc4::staph saprophyticus]] (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>[[oc5::Klebsiella]]</li><li>[[oc6::Candida]]</li><li>[[oc7::Pseudomonas]]</li><li>[[oc8::E Coli]]</li><li>[[oc9::Enterococcus]]</li></ul></div>", 
                "What are the common causative organisms of pyelonephritis?", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>{{c1::E. Coli (80-95%) (urinary pathogenic E. coli that has pyelonephritis assoc. pili}}</li><li>{{c1::Proteus mirabilis}}</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: {{c2::klebsiella, enterobacter, pseudomonas}}</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: {{c3::enterococcus, staph epididermis}}</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>{{c4::staph saprophyticus}} (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c5::Klebsiella}}</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>{{c6::Candida}}</li><li>...</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>{{c7::Pseudomonas}}</li><li>...</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>{{c8::E Coli}}</li><li>...</li></ul></div>", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>Other GN: ...</li><li>Other GP: ...</li><li>... (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>{{c9::Enterococcus}}</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Community acquired:<div><ul style=\"margin-left: 20px; \"><li>{{c21::E. Coli (80-95%) (urinary pathogenic E. coli that has pyelonephritis assoc. pili}}</li><li>{{c21::Proteus mirabilis}}</li><li>Other GN: {{c21::klebsiella, enterobacter, pseudomonas}}</li><li>Other GP: {{c21::enterococcus, staph epididermis}}</li><li>{{c21::staph saprophyticus}} (not a major cause of pyelonephritis, more for UTI/cystitis)</li></ul><div>Catheter-associated (Kleb Can PEE):&nbsp;</div></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Klebsiella}}</li><li>{{c21::Candida}}</li><li>{{c21::Pseudomonas}}</li><li>{{c21::E Coli}}</li><li>{{c21::Enterococcus}}</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "w{h`]G?J/$", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Microbiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine [[oc1::dipstick (leukocytes + nitrates (G-ve) +ve = high sensitivity &amp; specificity for UTI]]</li><li>[[oc1::Mid-stream urine MCS: culture organism, sensitivity to Abx]]</li><li>Blood [[oc2::culture and sensitivity]]</li><li>[[oc2::FBC:&nbsp;↑ WCC, anaemia&nbsp;]]</li><li>[[oc2::EUC:&nbsp;↑ creatinine, urea, K<sup>+</sup>, ↓Na<sup>+</sup>]]</li><li>[[oc2::CRP:&nbsp;↑]]</li><li>[[oc2::ABG: metabolic acidosis (shock)]]</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;[[oc3::</li><li>US (US KUB)</li><ul><li>small, irregular, scarred kidneys w/ echogenic parenchyma/fat stranding = pyelonephritis</li><li>hydronephrosis &amp; renal calculi</li></ul>]]<li>[[oc4::MRI: most sensitive for diagnosing pyelonephritis]]</li><li>Consider [[oc5::Cystoscopy: if still no answers]]</li></ul></div>", 
                "Patient presents with flank pain and dysuria.<div>Temp: 39<sup>o</sup>C</div><div>HR: 120 bpm</div><div>BP: 90/60</div><div><hr /></div><div>What investigations would you order after primary survey?</div>", 
                "", 
                "", 
                "0,1,0 | n,n,n,n", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine {{c1::dipstick (leukocytes + nitrates (G-ve) +ve = high sensitivity &amp; specificity for UTI}}</li><li>{{c1::Mid-stream urine MCS: culture organism, sensitivity to Abx}}</li><li>Blood ...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;...<li>...</li><li>Consider ...</li></ul></div>", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine ...</li><li>...</li><li>Blood {{c2::culture and sensitivity}}</li><li>{{c2::FBC:&nbsp;↑ WCC, anaemia&nbsp;}}</li><li>{{c2::EUC:&nbsp;↑ creatinine, urea, K<sup>+</sup>, ↓Na<sup>+</sup>}}</li><li>{{c2::CRP:&nbsp;↑}}</li><li>{{c2::ABG: metabolic acidosis (shock)}}</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;...<li>...</li><li>Consider ...</li></ul></div>", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine ...</li><li>...</li><li>Blood ...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;{{c3::</li><li>US (US KUB)</li><ul><li>small, irregular, scarred kidneys w/ echogenic parenchyma/fat stranding = pyelonephritis</li><li>hydronephrosis &amp; renal calculi</li></ul>}}<li>...</li><li>Consider ...</li></ul></div>", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine ...</li><li>...</li><li>Blood ...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;...<li>{{c4::MRI: most sensitive for diagnosing pyelonephritis}}</li><li>Consider ...</li></ul></div>", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine ...</li><li>...</li><li>Blood ...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;...<li>...</li><li>Consider {{c5::Cystoscopy: if still no answers}}</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<b>Lab:</b><div><ul style=\"margin-left: 20px; \"><li>Urine {{c21::dipstick (leukocytes + nitrates (G-ve) +ve = high sensitivity &amp; specificity for UTI}}</li><li>{{c21::Mid-stream urine MCS: culture organism, sensitivity to Abx}}</li><li>Blood {{c21::culture and sensitivity}}</li><li>{{c21::FBC:&nbsp;↑ WCC, anaemia&nbsp;}}</li><li>{{c21::EUC:&nbsp;↑ creatinine, urea, K<sup>+</sup>, ↓Na<sup>+</sup>}}</li><li>{{c21::CRP:&nbsp;↑}}</li><li>{{c21::ABG: metabolic acidosis (shock)}}</li></ul><div><div><b>Imaging:</b></div></div></div><div><ul style=\"margin-left: 20px; \"><li>Renal&nbsp;{{c21::</li><li>US (US KUB)</li><ul><li>small, irregular, scarred kidneys w/ echogenic parenchyma/fat stranding = pyelonephritis</li><li>hydronephrosis &amp; renal calculi</li></ul>}}<li>{{c21::MRI: most sensitive for diagnosing pyelonephritis}}</li><li>Consider {{c21::Cystoscopy: if still no answers}}</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "l.dW1mqdF7", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Diagnostics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><div><ol type=\"1\" start=\"1\"><li>[[oc1::Acute Coronary Syndrome]]</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>[[oc2::Progression to unstable angina]]</li><li>[[oc2::Acute MI (chest pain, on exertion, nausea, CVD risk factors)&nbsp;]]</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>[[oc3::Oesophagitis/GORD (commonly mimics angina)&nbsp;]]</li><li>[[oc3::Intercostal Strain (common benign cause of chest pain especially in those exercising)&nbsp;]]</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>[[oc4::PE&nbsp;]]</li><li>[[oc4::Aortic Dissection&nbsp;]]</li><li>[[oc4::Tension pneumothorax&nbsp;]]</li><li>[[oc4::Cardiac Tamponade&nbsp;]]</li><li>[[oc4::Pericarditis&nbsp;]]</li></ul></div></div><div><br /></div>", 
                "55M with 2hr hx of central, retrosternal, crushing chest pain and 10 year &nbsp;background of HT<hr />Provisional and Diff Dx? &nbsp;", 
                "", 
                "", 
                "3,1,0 | n,n,n,n", 
                "<div><div><ol type=\"1\" start=\"1\"><li>{{c1::Acute Coronary Syndrome}}</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div></div><div><br /></div>", 
                "<div><div><ol type=\"1\" start=\"1\"><li>Acute Coronary Syndrome</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>{{c2::Progression to unstable angina}}</li><li>{{c2::Acute MI (chest pain, on exertion, nausea, CVD risk factors)&nbsp;}}</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div></div><div><br /></div>", 
                "<div><div><ol type=\"1\" start=\"1\"><li>Acute Coronary Syndrome</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>Progression to unstable angina</li><li>Acute MI (chest pain, on exertion, nausea, CVD risk factors)&nbsp;</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>{{c3::Oesophagitis/GORD (commonly mimics angina)&nbsp;}}</li><li>{{c3::Intercostal Strain (common benign cause of chest pain especially in those exercising)&nbsp;}}</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></div></div><div><br /></div>", 
                "<div><div><ol type=\"1\" start=\"1\"><li>Acute Coronary Syndrome</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>Progression to unstable angina</li><li>Acute MI (chest pain, on exertion, nausea, CVD risk factors)&nbsp;</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>Oesophagitis/GORD (commonly mimics angina)&nbsp;</li><li>Intercostal Strain (common benign cause of chest pain especially in those exercising)&nbsp;</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>{{c4::PE&nbsp;}}</li><li>{{c4::Aortic Dissection&nbsp;}}</li><li>{{c4::Tension pneumothorax&nbsp;}}</li><li>{{c4::Cardiac Tamponade&nbsp;}}</li><li>{{c4::Pericarditis&nbsp;}}</li></ul></div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><div><ol type=\"1\" start=\"1\"><li>{{c21::Acute Coronary Syndrome}}</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Progression to unstable angina}}</li><li>{{c21::Acute MI (chest pain, on exertion, nausea, CVD risk factors)&nbsp;}}</li></ul></div><div><ol type=\"1\" start=\"2\"><li>DDx&nbsp;</li></ol></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Oesophagitis/GORD (commonly mimics angina)&nbsp;}}</li><li>{{c21::Intercostal Strain (common benign cause of chest pain especially in those exercising)&nbsp;}}</li></ul><ol type=\"1\" start=\"3\"><li>Differentials that may be life threatening that I would like to exclude:&nbsp;</li></ol><ul style=\"margin-left: 20px; \"><li>{{c21::PE&nbsp;}}</li><li>{{c21::Aortic Dissection&nbsp;}}</li><li>{{c21::Tension pneumothorax&nbsp;}}</li><li>{{c21::Cardiac Tamponade&nbsp;}}</li><li>{{c21::Pericarditis&nbsp;}}</li></ul></div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "x5ZF^Po}xY", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Anatomy", 
                "Cardiac,", 
                "DDx,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>[[oc1::ECG (repeated)&nbsp;]]</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>[[oc2::Peaked T waves,&nbsp;]]</li><li>[[oc2::ST elevation&nbsp;]]</li><li>[[oc2::T wave inversion (24h)&nbsp;]]</li><li>[[oc2::q waves (3d),&nbsp;]]</li><li>[[oc2::PE]]</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>[[oc3::Peaked 12-24hr (elevated for 1 wk). Increases in 2 hr, CK increases in 6hr&nbsp;]]</li></ul><li>What is Troponin&nbsp;</li><ul><li>[[oc4::Protein that regulated calcium mediated contraction of cardiac muscle&nbsp;]]</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>[[oc5::FBC – Exacerbating Anaemia or Infection (reduces O2 delivery)&nbsp;]]</div><div>[[oc5::EUC – Potassium levels (risk of arrhythmia), Baseline (to detect progress towards shock)&nbsp;]]</div><div>[[oc5::BGL – Diabetes if &gt;11.1mmol/L (risk factor)]]</div><div>[[oc5::HbA1C – &gt;7% (indicative of diabetes)&nbsp;]]</div><div>[[oc5::Lipids – LDL ↑, HDL ↓, Total Chol ↑, TG↑ (risk factor → statin)]]</div><div><br /></div><div>3. Imaging&nbsp;</div><div>[[oc6::CXR – LVF]]</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>[[oc7::Alveolar oedema]]</li><li>[[oc7::Kerly B lines]]</li><li>[[oc7::Effusion]]</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>[[oc8::Cardiomegaly,]]&nbsp;</li><li>[[oc8::Dilated upper vessels]]</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>[[oc10::TOE - LVF]]</div><div>[[oc11::Coronary angiogram – Narrowed segment of a coronary artery (likely LAD) with reduced flow distal to this]]</div><div><br /></div>", 
                "Primary investigations for ACS (Acute Coronary Syndrome)&nbsp;", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>{{c1::ECG (repeated)&nbsp;}}</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>ECG (repeated)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>{{c2::Peaked T waves,&nbsp;}}</li><li>{{c2::ST elevation&nbsp;}}</li><li>{{c2::T wave inversion (24h)&nbsp;}}</li><li>{{c2::q waves (3d),&nbsp;}}</li><li>{{c2::PE}}</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>Peaked T waves,&nbsp;</li><li>ST elevation&nbsp;</li><li>T wave inversion (24h)&nbsp;</li><li>q waves (3d),&nbsp;</li><li>PE</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>{{c3::Peaked 12-24hr (elevated for 1 wk). Increases in 2 hr, CK increases in 6hr&nbsp;}}</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>Peaked 12-24hr (elevated for 1 wk). Increases in 2 hr, CK increases in 6hr&nbsp;</li></ul><li>What is Troponin&nbsp;</li><ul><li>{{c4::Protein that regulated calcium mediated contraction of cardiac muscle&nbsp;}}</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>Protein that regulated calcium mediated contraction of cardiac muscle&nbsp;</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>{{c5::FBC – Exacerbating Anaemia or Infection (reduces O2 delivery)&nbsp;}}</div><div>{{c5::EUC – Potassium levels (risk of arrhythmia), Baseline (to detect progress towards shock)&nbsp;}}</div><div>{{c5::BGL – Diabetes if &gt;11.1mmol/L (risk factor)}}</div><div>{{c5::HbA1C – &gt;7% (indicative of diabetes)&nbsp;}}</div><div>{{c5::Lipids – LDL ↑, HDL ↓, Total Chol ↑, TG↑ (risk factor → statin)}}</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>FBC – Exacerbating Anaemia or Infection (reduces O2 delivery)&nbsp;</div><div>EUC – Potassium levels (risk of arrhythmia), Baseline (to detect progress towards shock)&nbsp;</div><div>BGL – Diabetes if &gt;11.1mmol/L (risk factor)</div><div>HbA1C – &gt;7% (indicative of diabetes)&nbsp;</div><div>Lipids – LDL ↑, HDL ↓, Total Chol ↑, TG↑ (risk factor → statin)</div><div><br /></div><div>3. Imaging&nbsp;</div><div>{{c6::CXR – LVF}}</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>CXR – LVF</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>{{c7::Alveolar oedema}}</li><li>{{c7::Kerly B lines}}</li><li>{{c7::Effusion}}</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>Alveolar oedema</li><li>Kerly B lines</li><li>Effusion</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>{{c8::Cardiomegaly,}}&nbsp;</li><li>{{c8::Dilated upper vessels}}</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>...</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>Cardiomegaly,&nbsp;</li><li>Dilated upper vessels</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>{{c9::TOE - LVF}}</div><div>...</div><div><br /></div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li><li>...</li><li>...</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>...</li></ul><li>What is Troponin&nbsp;</li><ul><li>...</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>...</div><div>...</div><div>...</div><div>...</div><div>...</div><div><br /></div><div>3. Imaging&nbsp;</div><div>...</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>...</li><li>...</li><li>...</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>...&nbsp;</li><li>...</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>TOE - LVF</div><div>{{c10::Coronary angiogram – Narrowed segment of a coronary artery (likely LAD) with reduced flow distal to this}}</div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div><ol type=\"1\" start=\"1\"><li>Primary Investigations&nbsp;</li></ol></div><div>{{c21::ECG (repeated)&nbsp;}}</div><div><ul style=\"margin-left: 20px; \"><li>Possible findings on ECG:&nbsp;</li><ul><li>{{c21::Peaked T waves,&nbsp;}}</li><li>{{c21::ST elevation&nbsp;}}</li><li>{{c21::T wave inversion (24h)&nbsp;}}</li><li>{{c21::q waves (3d),&nbsp;}}</li><li>{{c21::PE}}</li></ul></ul></div><div>Troponin T &amp; I&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>When is the peak elevation for Troponin, and how fast does it increase?&nbsp;</li><ul><li>{{c21::Peaked 12-24hr (elevated for 1 wk). Increases in 2 hr, CK increases in 6hr&nbsp;}}</li></ul><li>What is Troponin&nbsp;</li><ul><li>{{c21::Protein that regulated calcium mediated contraction of cardiac muscle&nbsp;}}</li></ul></ul></div><div><ol type=\"1\" start=\"2\"><li>Secondary Investigations (Bloods)&nbsp;</li></ol></div><div>{{c21::FBC – Exacerbating Anaemia or Infection (reduces O2 delivery)&nbsp;}}</div><div>{{c21::EUC – Potassium levels (risk of arrhythmia), Baseline (to detect progress towards shock)&nbsp;}}</div><div>{{c21::BGL – Diabetes if &gt;11.1mmol/L (risk factor)}}</div><div>{{c21::HbA1C – &gt;7% (indicative of diabetes)&nbsp;}}</div><div>{{c21::Lipids – LDL ↑, HDL ↓, Total Chol ↑, TG↑ (risk factor → statin)}}</div><div><br /></div><div>3. Imaging&nbsp;</div><div>{{c21::CXR – LVF}}</div><div><ul style=\"margin-left: 20px; \"><li>Signs of acute heart failure:&nbsp;</li><ul><li>{{c21::Alveolar oedema}}</li><li>{{c21::Kerly B lines}}</li><li>{{c21::Effusion}}</li></ul><li>Signs of chronic heart failure:&nbsp;</li><ul><li>{{c21::Cardiomegaly,}}&nbsp;</li><li>{{c21::Dilated upper vessels}}</li></ul></ul></div><div>Signs of DDx&nbsp;</div><div>{{c21::TOE - LVF}}</div><div>{{c21::Coronary angiogram – Narrowed segment of a coronary artery (likely LAD) with reduced flow distal to this}}</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "tSOSr)K&XI", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-1", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-1-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J>4QW]KrRP", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-2", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-2-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I]YykMzX[&", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-3", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-3-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "oy=^ewM1RC", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-4", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-4-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ch3UH@AzZ$", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-5", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-5-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vZ(Y~_OQIA", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-6", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-6-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q#l@}+^gvl", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-7", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-7-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AA?uobf0le", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-8", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-8-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g0t^(.llW*", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-9", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-9-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AZ[vc$;csr", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-10", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-10-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dUs=`_Xa^t", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-11", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-11-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kmG^_ELNgU", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-12", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-12-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FHkldMsg=Y", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a98e7f6f69d546e88ea027530f7358c1-ao-13", 
                "", 
                "<img src=\"tmprblswa.png\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-13-A.svg\" />", 
                "<img src=\"a98e7f6f69d546e88ea027530f7358c1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r$,aYc{k97", 
            "note_model_uuid": "5f872740-5d06-11e8-8d49-30e37ab3e4ac", 
            "tags": [
                "Cardiac", 
                "Ix,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What is your provisional dx?</div>", 
                "UTI"
            ], 
            "flags": 0, 
            "guid": "ABoR}GzK6k", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – [[oc1::urethritis]] or [[oc2::PID]] (chlamydia, gonorrhea)</div><div>- [[oc3::Vaginitis]] (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- [[oc4::Non-infectious urethritis]] (from mechanical irritation)&nbsp;</div><div>- [[oc5::Over-active bladder]] (urgency, frequency, nil UTI)&nbsp;</div><div>- [[oc6::Urothelial carcinoma]]&nbsp;</div><div>- [[oc7::Urolithiasis]]</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – {{c1::urethritis}} or ... (chlamydia, gonorrhea)</div><div>- ... (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- ... (from mechanical irritation)&nbsp;</div><div>- ... (urgency, frequency, nil UTI)&nbsp;</div><div>- ...&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – urethritis or {{c2::PID}} (chlamydia, gonorrhea)</div><div>- ... (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- ... (from mechanical irritation)&nbsp;</div><div>- ... (urgency, frequency, nil UTI)&nbsp;</div><div>- ...&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – ... or PID (chlamydia, gonorrhea)</div><div>- {{c3::Vaginitis}} (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- ... (from mechanical irritation)&nbsp;</div><div>- ... (urgency, frequency, nil UTI)&nbsp;</div><div>- ...&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – ... or ... (chlamydia, gonorrhea)</div><div>- Vaginitis (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- {{c4::Non-infectious urethritis}} (from mechanical irritation)&nbsp;</div><div>- ... (urgency, frequency, nil UTI)&nbsp;</div><div>- ...&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – ... or ... (chlamydia, gonorrhea)</div><div>- ... (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- Non-infectious urethritis (from mechanical irritation)&nbsp;</div><div>- {{c5::Over-active bladder}} (urgency, frequency, nil UTI)&nbsp;</div><div>- ...&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – ... or ... (chlamydia, gonorrhea)</div><div>- ... (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- ... (from mechanical irritation)&nbsp;</div><div>- Over-active bladder (urgency, frequency, nil UTI)&nbsp;</div><div>- {{c6::Urothelial carcinoma}}&nbsp;</div><div>- ...</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – ... or ... (chlamydia, gonorrhea)</div><div>- ... (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- ... (from mechanical irritation)&nbsp;</div><div>- ... (urgency, frequency, nil UTI)&nbsp;</div><div>- Urothelial carcinoma&nbsp;</div><div>- {{c7::Urolithiasis}}</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What are your differentials?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Infection</li></ul></div><div>- STI – {{c21::urethritis}} or {{c21::PID}} (chlamydia, gonorrhea)</div><div>- {{c21::Vaginitis}} (vaginal discharge, itch, burning)&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Non-infectious</li></ul></div><div>- {{c21::Non-infectious urethritis}} (from mechanical irritation)&nbsp;</div><div>- {{c21::Over-active bladder}} (urgency, frequency, nil UTI)&nbsp;</div><div>- {{c21::Urothelial carcinoma}}&nbsp;</div><div>- {{c21::Urolithiasis}}</div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "CWb(Ool18*", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>[[oc1::MIDSTREAM Urine dipstick]]: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- [[oc2::Microscopy and gram staining]] --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- [[oc3::Culture &amp; Sensitivity]]: diagnosed at [[oc4::&gt; 10^8 CFU/L]]&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- [[oc5::Vaginal swab]] ?STI</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c1::MIDSTREAM Urine dipstick}}: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- ... --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- ...: diagnosed at ...&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- ... ?STI</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>MIDSTREAM Urine dipstick: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- {{c2::Microscopy and gram staining}} --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- ...: diagnosed at ...&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- ... ?STI</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>...: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- Microscopy and gram staining --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- {{c3::Culture &amp; Sensitivity}}: diagnosed at ...&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- ... ?STI</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>...: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- ... --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- Culture &amp; Sensitivity: diagnosed at {{c4::&gt; 10^8 CFU/L}}&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- ... ?STI</div></div><div><br /></div>", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>...: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- ... --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- ...: diagnosed at &gt; 10^8 CFU/L&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- {{c5::Vaginal swab}} ?STI</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What laboratory tests would you like to do?</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c21::MIDSTREAM Urine dipstick}}: nitrites ++, leukocytes ++ &nbsp;(will also tell you glucose, ketones, protein, etc.)</li></ul></div><div>If +ve for nitrites and leukocytes then treat empirically. If –ve then consider these:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>URINE MCS&nbsp;</li></ul></div><div>- {{c21::Microscopy and gram staining}} --&gt; leukocytes and or bacteria (93% sensitive and 95% specific when positive)</div><div>- {{c21::Culture &amp; Sensitivity}}: diagnosed at {{c21::&gt; 10^8 CFU/L}}&nbsp;</div><div>- EUC: check renal function&nbsp;</div><div>- FBC, CRP, Blood cultures: if systemically unwell&nbsp;</div><div>- {{c21::Vaginal swab}} ?STI</div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "nziqWdDZ[H", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>28yo sexually active female presents with burning, frequency of urination and discharge</div><div><br /></div><div>What imaging would you like to do? (only in men, children, UTI, non-responsive, pyelonephritis/haematuria)</div>", 
                "<div><ul style=\"margin-left: 20px; \"><li>Bladder Ultrasound: stone, tumour.&nbsp;</li><li>Renal US &amp; KUB X-ray&nbsp;</li><li>Cystoscopy: if no answers still&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "K!z77T!;X/", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What contaminants could you find in an MSU?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Normal skin or vaginal flora&nbsp;</li><li>E. Coli</li><li>Squamous epithelial cells&nbsp;</li><li>Staph saprophyticus</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "zd{%ZTJ=+}", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you do a MSU?<div><br /></div><div><div>1. Wash hands &amp; urethra + surrounding skin [[oc1::in normal SALINE]]</div><div>2. Begin urination (do not collect [[oc2::first urine passed 20-30mL]])&nbsp;</div><div>3. Collect urine midway through which is less likely to be contaminated&nbsp;</div><div>4. Tightly cap container&nbsp;</div><div>5. Wash hands&nbsp;</div><div>6. Label container&nbsp;</div><div>7. [[oc3::Take to lab as quickly as possible]] (reduce time allowed for further growth of organisms or alternatively, store at 4 degrees)</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "How would you do a MSU?<div><br /></div><div><div>1. Wash hands &amp; urethra + surrounding skin {{c1::in normal SALINE}}</div><div>2. Begin urination (do not collect ...)&nbsp;</div><div>3. Collect urine midway through which is less likely to be contaminated&nbsp;</div><div>4. Tightly cap container&nbsp;</div><div>5. Wash hands&nbsp;</div><div>6. Label container&nbsp;</div><div>7. ... (reduce time allowed for further growth of organisms or alternatively, store at 4 degrees)</div></div><div><br /></div>", 
                "How would you do a MSU?<div><br /></div><div><div>1. Wash hands &amp; urethra + surrounding skin in normal SALINE</div><div>2. Begin urination (do not collect {{c2::first urine passed 20-30mL}})&nbsp;</div><div>3. Collect urine midway through which is less likely to be contaminated&nbsp;</div><div>4. Tightly cap container&nbsp;</div><div>5. Wash hands&nbsp;</div><div>6. Label container&nbsp;</div><div>7. ... (reduce time allowed for further growth of organisms or alternatively, store at 4 degrees)</div></div><div><br /></div>", 
                "How would you do a MSU?<div><br /></div><div><div>1. Wash hands &amp; urethra + surrounding skin ...</div><div>2. Begin urination (do not collect first urine passed 20-30mL)&nbsp;</div><div>3. Collect urine midway through which is less likely to be contaminated&nbsp;</div><div>4. Tightly cap container&nbsp;</div><div>5. Wash hands&nbsp;</div><div>6. Label container&nbsp;</div><div>7. {{c3::Take to lab as quickly as possible}} (reduce time allowed for further growth of organisms or alternatively, store at 4 degrees)</div></div><div><br /></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "How would you do a MSU?<div><br /></div><div><div>1. Wash hands &amp; urethra + surrounding skin {{c21::in normal SALINE}}</div><div>2. Begin urination (do not collect {{c21::first urine passed 20-30mL}})&nbsp;</div><div>3. Collect urine midway through which is less likely to be contaminated&nbsp;</div><div>4. Tightly cap container&nbsp;</div><div>5. Wash hands&nbsp;</div><div>6. Label container&nbsp;</div><div>7. {{c21::Take to lab as quickly as possible}} (reduce time allowed for further growth of organisms or alternatively, store at 4 degrees)</div></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "I^7}YtJkAf", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What can you find on a MSU dipstick?", 
                "<div>protein,&nbsp;blood, albumin, glucose, ketones, leucocytes, nitrites, bilirubin, spec gravity, pH&nbsp;</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "y7~LUQg.,^", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What can you find on a MSU microscopy?", 
                "<div>leucocytes, epithelial cells, red cells, bacteria, casts and crystals&nbsp;</div>"
            ], 
            "flags": 0, 
            "guid": "K@5SWi5>l{", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What would you find on urinalysis if there is a UTI?", 
                "<div><ul style=\"margin-left: 20px; \"><li>nitrites ++</li><li>leukocytes ++&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "yO-Gao3ShO", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which would you most likely see on urine microscopy if there is a UTI?", 
                "<div>leukocytes and/or bacteria&nbsp;<br /><br /></div>"
            ], 
            "flags": 0, 
            "guid": "NB7D9!yo?x", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What organisms would you likely find on a gram stain if there is a UTI?", 
                "<ul style=\"margin-left: 20px; \"><li>gram –ve rods = e. coli, klebsiella, enterobacteria, pseudomonas</li><li>gram +ve cocci = staphylococcus saphrophyticus, enterococcus</li></ul>"
            ], 
            "flags": 0, 
            "guid": "k1j;O[.-jW", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the most common organisms for UTI?", 
                "<b>1. E. Coli 70-95% (Gram -ve bacillus aerobic and facultative anaerobe)</b><div><b>2. Staph saprophytics 5-20% (gram +ve cocci facultative anaerobe)</b></div><div><b>3. Proteus mirabilis ~1% (gram -ve facultative anaerobe)</b></div><div>4. Other G-ve: klebsiella, pseudonomas aeruginosa, enterobacter</div><div>5. Other G+ve: eneterococcus, staph epidermidis</div>"
            ], 
            "flags": 0, 
            "guid": "deDIR[T#@6", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>[[oc1::Trimethoprim 300mg PO 3/7]]</li><li>[[oc2::Cephalexin 500mg PO BD 5/7]]</li><li>[[oc3::(Augmentin) Amoxycillin + clavulanate 500mg+125mg PO BD 5/7]]</li><li>[[oc4::Nitrofurantoin 100mg PO BD 5.7]]</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>{{c1::Trimethoprim 300mg PO 3/7}}</li><li>...</li><li>...</li><li>...</li></ol></div></div>", 
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>Trimethoprim 300mg PO 3/7</li><li>{{c2::Cephalexin 500mg PO BD 5/7}}</li><li>...</li><li>...</li></ol></div></div>", 
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>...</li><li>Cephalexin 500mg PO BD 5/7</li><li>{{c3::(Augmentin) Amoxycillin + clavulanate 500mg+125mg PO BD 5/7}}</li><li>...</li></ol></div></div>", 
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>(Augmentin) Amoxycillin + clavulanate 500mg+125mg PO BD 5/7</li><li>{{c4::Nitrofurantoin 100mg PO BD 5.7}}</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What is the acute pharmacological treatment for UTI in a hospital setting in non-pregnant women?<div><br /></div><div>TCA/N<div><ol type=\"1\" start=\"1\"><li>{{c21::Trimethoprim 300mg PO 3/7}}</li><li>{{c21::Cephalexin 500mg PO BD 5/7}}</li><li>{{c21::(Augmentin) Amoxycillin + clavulanate 500mg+125mg PO BD 5/7}}</li><li>{{c21::Nitrofurantoin 100mg PO BD 5.7}}</li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "PCY1gn:SEx", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the acute pharmacological treatment for UTI in a hospital setting in pregnant women?", 
                "Same as non-pregnant except trimethoprim&nbsp;"
            ], 
            "flags": 0, 
            "guid": "k9{}XQX%eT", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "If you left the urine out for 4 hrs in room temperature, what would happen?&nbsp;", 
                "<div>Organisms collected would grow by itself leading to falsely elevated bacterial counts</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "Q(_lh`|ISu", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "If you left the urine out for 4 hrs in room temp, what organisms can grow?&nbsp;", 
                "<div><ul style=\"margin-left: 20px; \"><li>Causative pathogen&nbsp;</li><li>Commensals/natural flora (staph epidermidis, staph aureus, strep pyogenes)</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "r{+~34y&3|", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "If you left the urine out for 4 hrs in room temp, how would \u000bthis affect the results?&nbsp;", 
                "<div><ul style=\"margin-left: 20px; \"><li>May give a false +ve if a large increase in a pathogenic organisms level was found&nbsp;</li><li>May deem result useless as contaminated if commensals overgrow&nbsp;</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "D}{a$iJ%5z", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "If you left the urine out for 4 hrs in room temperature and&nbsp;the patient has been in hospital for 2 weeks catheterised, what organisms would grow?", 
                "<div><ul style=\"margin-left: 20px; \"><li>E. Coli (40%)</li><li>Enterococcus (15%)</li><li>Candida (13%)</li><li>Pseudomonas aeruginosa (11%)</li><li>Klebsiella (11%)&nbsp;</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "FRZRs)u|iG", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = [[oc1::Calibration-Dichotomous-Susceptibility]]&nbsp;</li><li>Organism is cultured on agar plates containing discs [[oc2::impregnated with different antibiotics]].&nbsp;</li><li>A [[oc3::zone of inhibition]] is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. [[oc4::≥6mm annulus radius for most antibiotics, ≥2mm if vancomycin]]&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = {{c1::Calibration-Dichotomous-Susceptibility}}&nbsp;</li><li>Organism is cultured on agar plates containing discs ....&nbsp;</li><li>A ... is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. ...&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>", 
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = Calibration-Dichotomous-Susceptibility&nbsp;</li><li>Organism is cultured on agar plates containing discs {{c2::impregnated with different antibiotics}}.&nbsp;</li><li>A ... is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. ...&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>", 
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = ...&nbsp;</li><li>Organism is cultured on agar plates containing discs impregnated with different antibiotics.&nbsp;</li><li>A {{c3::zone of inhibition}} is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. ...&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>", 
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = ...&nbsp;</li><li>Organism is cultured on agar plates containing discs ....&nbsp;</li><li>A zone of inhibition is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. {{c4::≥6mm annulus radius for most antibiotics, ≥2mm if vancomycin}}&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "How do we test for sensitivity of abx<div><div><ul style=\"margin-left: 20px; \"><li>CDS system = {{c21::Calibration-Dichotomous-Susceptibility}}&nbsp;</li><li>Organism is cultured on agar plates containing discs {{c21::impregnated with different antibiotics}}.&nbsp;</li><li>A {{c21::zone of inhibition}} is seen around those antibiotics the micro-organism is sensitive to&nbsp;</li><li>Zone of inhibition = area where no colonies are seen around the antibiotic impregnated disc. {{c21::≥6mm annulus radius for most antibiotics, ≥2mm if vancomycin}}&nbsp;</li><li>The disc itself is 6mm too, so basically a zone with an 18mm diameter must be found to say the micro-organism is susceptible.&nbsp;&nbsp;</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "N+2l{#%5CC", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "DiagnosticQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Patient presents with a bee sting. Had been stung before but had only a mild response.&nbsp;</div><div>Now presents with tachycardia, tachypnoea, pale, drowsy, angioedema and insp and exp stridor</div><div><br /></div><div>What is your clinical dx?</div>", 
                "<div>Anaphylactic Shock (hypotensive, tachycardic, swollen tongue and urticaria) – a type of ‘distributive’ shock</div>"
            ], 
            "flags": 0, 
            "guid": "QQ&{K:2P&E", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Patient presents with a bee sting. Had been stung before but had only a mild response.&nbsp;</div><div>Now presents with tachycardia, tachypnoea, pale, drowsy, angioedema and insp and exp stridor</div><div><br /></div><div>What are your differentials?</div>", 
                "<div><u>Life Threatening</u></div><div><ul style=\"margin-left: 20px; \"><li>Status asthmaticus (atopic, stridor, tachypnoea)&nbsp;</li><li>Other forms of shock (Cardiogenic, Obstructive, Hypovolaemic, Distributive)&nbsp;</li></ul></div><div><u>Non-life threatening (consider if patient not in shock):&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Urticaria/angio-oedema – medications&nbsp;</li><li>Asthma&nbsp;</li><li>Hyperventilation/panic attack</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "CO)i}]DMz", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for [[oc1::foreign body]]</li><li>[[oc2::Intubate]] if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>[[oc3::High flow O2 (&gt;10L/min)]], elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>[[oc4::Raise legs above heart]]</li><li>[[oc5::2 large bore cannula IV access]]</li><li>[[oc6::Bolus]]&nbsp;</li><li>[[oc7::Give adrenaline IM 0.5mg]] (0.5mL of 1:1000) OR if no pulse [[oc8::IV 1mL of 1:10,000]]</li></ol></div></div>", 
                "<div><br /></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for {{c1::foreign body}}</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for foreign body</li><li>{{c2::Intubate}} if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>Intubate if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>{{c3::High flow O2 (&gt;10L/min)}}, elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>High flow O2 (&gt;10L/min), elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>{{c4::Raise legs above heart}}</li><li>...</li><li>...&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Raise legs above heart</li><li>{{c5::2 large bore cannula IV access}}</li><li>...&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>2 large bore cannula IV access</li><li>{{c6::Bolus}}&nbsp;</li><li>... (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>Bolus&nbsp;</li><li>{{c7::Give adrenaline IM 0.5mg}} (0.5mL of 1:1000) OR if no pulse ...</li></ol></div></div>", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for ...</li><li>... if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>..., elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li><li>Give adrenaline IM 0.5mg (0.5mL of 1:1000) OR if no pulse {{c8::IV 1mL of 1:10,000}}</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What would the emergency management for anaphylactic shock be?<div><br /></div><div><div><u>Secure <b>Airway</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>Check for {{c21::foreign body}}</li><li>{{c21::Intubate}} if necessary (airway oedema, trauma, altered respiration)</li></ol></div><div><u>Check <b>Breathing</b>:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>{{c21::High flow O2 (&gt;10L/min)}}, elevate head of bed&nbsp;</li></ol></div><div><u>Provide <b>Circulation</b> support:</u>&nbsp;</div><div><ol type=\"1\" start=\"1\"><li>{{c21::Raise legs above heart}}</li><li>{{c21::2 large bore cannula IV access}}</li><li>{{c21::Bolus}}&nbsp;</li><li>{{c21::Give adrenaline IM 0.5mg}} (0.5mL of 1:1000) OR if no pulse {{c21::IV 1mL of 1:10,000}}</li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "o2mj!:E0/0", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What difference in function is there between giving adrenaline vs noradrenaline?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Adrenaline (more affinity for β receptors --&gt; bronchodilation) vs.</li><li>Noradrenaline (more affinity for α receptors --&gt; vasoconstriction - use NorAd in septic shock)&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "B&O]>{>wUD", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you manage persistent hypotension in the context of anaphylactic shock?", 
                "<ol type=\"1\" start=\"1\"><li>Normal saline (max 50mL/kg)</li><li>If cardiogenic cause- IV glucagon bolus 1-2mg</li></ol>"
            ], 
            "flags": 0, 
            "guid": "e|m^0l4r8n", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you manage upper airway obstruction in the context of anaphylactic shock?", 
                "<ol type=\"1\" start=\"1\"><li>Nebulised adrenaline 5mL of 1:1000</li><li>Consider intubation</li></ol>"
            ], 
            "flags": 0, 
            "guid": "z8G[zLVCyc", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you manage persistent wheeze in the context of anaphylactic shock?", 
                "<div><ol type=\"1\" start=\"1\"><li>Bronchodilators (salbutamol 8-12 puffs using spacer 100mcg, or 5mg salbutamol nebuliser)</li><li>Oral prednisolone (1mg/kg, max 50mg)</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "thbpF^vVs^", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>[[oc1::ECG]] – must do before adrenaline, AMI&nbsp;</li><li>[[oc2::Pulse oximetry]]&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>[[oc3::ABG]] – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>[[oc4::FBC]] – eosinophilia&nbsp;</li><li>[[oc5::EUC]] – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>[[oc6::Serum tryptase (from mast cells)]] – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>[[oc7::RAST – radioallergosorbent test]] (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>[[oc8::Skin test:]] &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>[[oc9::Challenge test]]</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c1::ECG}} – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>ECG – must do before adrenaline, AMI&nbsp;</li><li>{{c2::Pulse oximetry}}&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>Pulse oximetry&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c3::ABG}} – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>ABG – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>{{c4::FBC}} – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>FBC – eosinophilia&nbsp;</li><li>{{c5::EUC}} – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>EUC – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c6::Serum tryptase (from mast cells)}} – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>Serum tryptase (from mast cells) – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>{{c7::RAST – radioallergosorbent test}} (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>... &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>RAST – radioallergosorbent test (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>{{c8::Skin test:}} &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>...</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – must do before adrenaline, AMI&nbsp;</li><li>...&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>... – eosinophilia&nbsp;</li><li>... – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>... – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>... (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>Skin test: &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>{{c9::Challenge test}}</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What investigations would you do for anaphylactic shock?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Clinical dx</li></ul><u>Bedside</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c21::ECG}} – must do before adrenaline, AMI&nbsp;</li><li>{{c21::Pulse oximetry}}&nbsp;</li></ul></div></div><div><u>Basics</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c21::ABG}} – mixed respiratory &amp; metabolic acidosis&nbsp;</li><li>{{c21::FBC}} – eosinophilia&nbsp;</li><li>{{c21::EUC}} – renal impairment from shock &amp; K levels in case of arrhythmia</li></ul></div></div><div><u>Allergy-Specific</u></div><div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Serum tryptase (from mast cells)}} – elevated 1-3 hrs post anaphylaxis&nbsp;</li><li>{{c21::RAST – radioallergosorbent test}} (measures allergen specific IgE in serum): &gt;0.35 IU/L to inciting antigens&nbsp;</li><li>{{c21::Skin test:}} &gt;3mm diameter wheal (good to exclude food allergy)&nbsp;</li><li>{{c21::Challenge test}}</li></ul></div></div><div><u>Imaging</u></div><div><div><ul style=\"margin-left: 20px; \"><li>CXR: exclude CHF, radio-opaque foreign body, pneumonia</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "o`g/cvs;*T", 
            "note_model_uuid": "5f874e54-5d06-11e8-8b3a-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = [[oc1::pharyngeal &amp; laryngeal oedema]] --&gt; airway obstruction --&gt; [[oc2::inability to blow off CO2]]. This CO2 + H2O --&gt; [[oc3::H2CO3]] --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= [[oc4::bronchiolar constriction]] impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = [[oc5::anaerobic metabolism]]--&gt; [[oc6::lactic acidosis]] (anion gap should be [[oc7::↑]]) which uses up [[oc8::HCO3]] --&gt; [[oc9::↓ HCO3&nbsp;]]</li></ul></div></div>", 
                "<div><div><br /></div></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = {{c1::pharyngeal &amp; laryngeal oedema}} --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = pharyngeal &amp; laryngeal oedema --&gt; airway obstruction --&gt; {{c2::inability to blow off CO2}}. This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; inability to blow off CO2. This CO2 + H2O --&gt; {{c3::H2CO3}} --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; H2CO3 --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= {{c4::bronchiolar constriction}} impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= bronchiolar constriction impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = {{c5::anaerobic metabolism}}--&gt; ... (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = anaerobic metabolism--&gt; {{c6::lactic acidosis}} (anion gap should be ...) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; lactic acidosis (anion gap should be {{c7::↑}}) which uses up ... --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ↑) which uses up {{c8::HCO3}} --&gt; ...</li></ul></div></div>", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = ... --&gt; airway obstruction --&gt; .... This CO2 + H2O --&gt; ... --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= ... impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = ...--&gt; ... (anion gap should be ...) which uses up HCO3 --&gt; {{c9::↓ HCO3&nbsp;}}</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Interpret this ABG:<div>pH 7.24 (lo)</div><div>PaO2 52 (lo)</div><div>PaCO2 (hi)</div><div>Bicarb 18 (lo)</div><div>Base excess -6 (lo)</div><div>O2 sat (lo)</div><div><br /></div><div><div><ul style=\"margin-left: 20px; \"><li>Shows mixed metabolic and respiratory acidosis (low pH)&nbsp;</li><li>High PaCO2 = {{c21::pharyngeal &amp; laryngeal oedema}} --&gt; airway obstruction --&gt; {{c21::inability to blow off CO2}}. This CO2 + H2O --&gt; {{c21::H2CO3}} --&gt; acidosis.&nbsp;</li><li>PaO2 and O2 Sat ↓= {{c21::bronchiolar constriction}} impairs O2 exchange &amp; low lung perfusion causes reduced gas exchange&nbsp;</li><li>Low O2 = {{c21::anaerobic metabolism}}--&gt; {{c21::lactic acidosis}} (anion gap should be {{c21::↑}}) which uses up {{c21::HCO3}} --&gt; {{c21::↓ HCO3&nbsp;}}</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "n!l#8i[sGj", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- [[oc1::IgE-sensitized mast cells]] from prev. exposure causes degranulation and release of [[oc2::histamine]], [[oc3::tryptase]], [[oc4::PGD2]] and [[oc5::LTD4]] as well as chemotactic factors which all contribute to eventual [[oc6::leukocyte recruitment]]&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – [[oc7::SMC contraction and laryngeal oedema]]<br />- Wheeze and rhonchi – [[oc8::bronchospasm and mucous secretion]]</li><li>Urticaria and angioedema<br />- [[oc9::Vasodilation and increased vascular permeability]]</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- [[oc10::Vasodilation and extravasation of fluid]]</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- {{c1::IgE-sensitized mast cells}} from prev. exposure causes degranulation and release of ..., ..., ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- IgE-sensitized mast cells from prev. exposure causes degranulation and release of {{c2::histamine}}, ..., ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of histamine, {{c3::tryptase}}, ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., tryptase, {{c4::PGD2}} and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., PGD2 and {{c5::LTD4}} as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., ... and LTD4 as well as chemotactic factors which all contribute to eventual {{c6::leukocyte recruitment}}&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., ... and ... as well as chemotactic factors which all contribute to eventual leukocyte recruitment&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – {{c7::SMC contraction and laryngeal oedema}}<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – SMC contraction and laryngeal oedema<br />- Wheeze and rhonchi – {{c8::bronchospasm and mucous secretion}}</li><li>Urticaria and angioedema<br />- ...</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – bronchospasm and mucous secretion</li><li>Urticaria and angioedema<br />- {{c9::Vasodilation and increased vascular permeability}}</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- ...</li></ul></div></div>", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- ... from prev. exposure causes degranulation and release of ..., ..., ... and ... as well as chemotactic factors which all contribute to eventual ...&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – ...<br />- Wheeze and rhonchi – ...</li><li>Urticaria and angioedema<br />- Vasodilation and increased vascular permeability</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- {{c10::Vasodilation and extravasation of fluid}}</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Provide pathophysiology behind clinical manifestations of anaphylactic shock<div><div><ul style=\"margin-left: 20px; \"><li>Inflammation<br />- {{c21::IgE-sensitized mast cells}} from prev. exposure causes degranulation and release of {{c21::histamine}}, {{c21::tryptase}}, {{c21::PGD2}} and {{c21::LTD4}} as well as chemotactic factors which all contribute to eventual {{c21::leukocyte recruitment}}&nbsp;</li><li>Bronchoconstriction<br />- Tachypnoea and stridor – {{c21::SMC contraction and laryngeal oedema}}<br />- Wheeze and rhonchi – {{c21::bronchospasm and mucous secretion}}</li><li>Urticaria and angioedema<br />- {{c21::Vasodilation and increased vascular permeability}}</li><li>Hypotension with associated poor end organ perfusion (pale, drowsy, incoherent + tachycardia)<br />- {{c21::Vasodilation and extravasation of fluid}}</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "DNmLcnv->Z", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by [[oc1::IgE]] antibodies formed in response to a particular allergen/antigen. Bound to [[oc2::mast cells and basophils]]. In sensitised individuals, they respond by [[oc3::synthesising large amounts of IgE to an allergen]].</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>[[oc4::Dendritic cells]] take up allergen --&gt; present to [[oc5::T cells]] --&gt; differentiate into [[oc6::TH2 cells]] --&gt; TH2 cells stimulate [[oc7::B cells into plasma cells]] --&gt; [[oc8::making IgE]] --&gt; IgE binds to [[oc9::FC component on mast cells]] (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; [[oc10::crosslinks IgE]] --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- [[oc11::Histamine+ LTD4]] &nbsp;--&gt; [[oc12::↑ Vascular permeability, Vasodilation, Bronchoconstriction, Mucus]]&nbsp;<br />- Adenosine --&gt; [[oc14::bronchoconstriction]]&nbsp;<br />- [[oc15::Tryptase]] --&gt; [[oc16::inflammation and chemotactic factors]] for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>[[oc17::Phospholipase A2]] --&gt; AA --&gt; [[oc18::PG (bronchospasm)]] &amp; [[oc19::LT (↑vascular permeability &amp; bronchoconstriction)]]&nbsp;</li><li>[[oc20::PAF]] --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines [[oc21::(TNF, IL-1, 4 ,5 ,6)]] --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by {{c1::IgE}} antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by IgE antibodies formed in response to a particular allergen/antigen. Bound to {{c2::mast cells and basophils}}. In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to mast cells and basophils. In sensitised individuals, they respond by {{c3::synthesising large amounts of IgE to an allergen}}.</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by synthesising large amounts of IgE to an allergen.</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>{{c4::Dendritic cells}} take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Dendritic cells take up allergen --&gt; present to {{c5::T cells}} --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to T cells --&gt; differentiate into {{c6::TH2 cells}} --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into TH2 cells --&gt; TH2 cells stimulate {{c7::B cells into plasma cells}} --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate B cells into plasma cells --&gt; {{c8::making IgE}} --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; making IgE --&gt; IgE binds to {{c9::FC component on mast cells}} (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to FC component on mast cells (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; {{c10::crosslinks IgE}} --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; crosslinks IgE --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- {{c11::Histamine+ LTD4}} &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- Histamine+ LTD4 &nbsp;--&gt; {{c12::↑ Vascular permeability, Vasodilation, Bronchoconstriction, Mucus}}&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ↑ Vascular permeability, Vasodilation, Bronchoconstriction, Mucus&nbsp;<br />- Adenosine --&gt; {{c13::bronchoconstriction}}&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; bronchoconstriction&nbsp;<br />- {{c14::Tryptase}} --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- Tryptase --&gt; {{c15::inflammation and chemotactic factors}} for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; inflammation and chemotactic factors for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>{{c16::Phospholipase A2}} --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Phospholipase A2 --&gt; AA --&gt; {{c17::PG (bronchospasm)}} &amp; ...&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; PG (bronchospasm) &amp; {{c18::LT (↑vascular permeability &amp; bronchoconstriction)}}&nbsp;</li><li>... --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; LT (↑vascular permeability &amp; bronchoconstriction)&nbsp;</li><li>{{c19::PAF}} --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines ... --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by ... antibodies formed in response to a particular allergen/antigen. Bound to .... In sensitised individuals, they respond by ....</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>... take up allergen --&gt; present to ... --&gt; differentiate into ... --&gt; TH2 cells stimulate ... --&gt; ... --&gt; IgE binds to ... (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; ... --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- ... &nbsp;--&gt; ...&nbsp;<br />- Adenosine --&gt; ...&nbsp;<br />- ... --&gt; ... for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>... --&gt; AA --&gt; ... &amp; ...&nbsp;</li><li>PAF --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines {{c20::(TNF, IL-1, 4 ,5 ,6)}} --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>", 
                "Explain why patient has reacted with anaphylaxis only now and not previously<div><br /></div><div><div><u>Allergic hypersensitivity (type 1)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Mediated by {{c21::IgE}} antibodies formed in response to a particular allergen/antigen. Bound to {{c21::mast cells and basophils}}. In sensitised individuals, they respond by {{c21::synthesising large amounts of IgE to an allergen}}.</li></ul></div><div><u>First exposure to allergen&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Dendritic cells}} take up allergen --&gt; present to {{c21::T cells}} --&gt; differentiate into {{c21::TH2 cells}} --&gt; TH2 cells stimulate {{c21::B cells into plasma cells}} --&gt; {{c21::making IgE}} --&gt; IgE binds to {{c21::FC component on mast cells}} (arming them)&nbsp;</li></ul></div><div>(only happens in susceptible people)</div><div><br /></div><div><u>Later exposure to allergen (Anaphylaxis)&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Binds to IgE on mast cells --&gt; {{c21::crosslinks IgE}} --&gt; mast cell degranulation&nbsp;</li><li>1° Mediator release (Initial – maximal at 15mins post exposure)<br />- {{c21::Histamine+ LTD4}} &nbsp;--&gt; {{c21::↑ Vascular permeability, Vasodilation, Bronchoconstriction, Mucus}}&nbsp;<br />- Adenosine --&gt; {{c21::bronchoconstriction}}&nbsp;<br />- {{c21::Tryptase}} --&gt; {{c21::inflammation and chemotactic factors}} for neutrophils &amp; eosinophils</li></ul></div><div><br /></div><div><u>2° Mediator release (Late-phase – appears at 6hours persists for&lt;72hrs)</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>{{c21::Phospholipase A2}} --&gt; AA --&gt; {{c21::PG (bronchospasm)}} &amp; {{c21::LT (↑vascular permeability &amp; bronchoconstriction)}}&nbsp;</li><li>{{c21::PAF}} --&gt; platelet aggregation, histamine release &amp; bronchospasm&nbsp;</li><li>Mast-cell cytokines {{c21::(TNF, IL-1, 4 ,5 ,6)}} --&gt; recruit other inflammatory cells&nbsp;</li></ul></div></div>"
            ], 
            "flags": 0, 
            "guid": "J#;|d:vGAm", 
            "note_model_uuid": "5f874e54-5d06-11e8-8b3a-30e37ab3e4ac", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-1", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-1-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y391)29Y%b", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-2", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-2-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EW1R/J8[@0", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-3", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-3-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "NM72uz^Uh>", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-4", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-4-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DGn2MCaNFv", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-5", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-5-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b=U%3@OyzZ", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "169747a37db545b38cd40d8c86d4b008-oa-6", 
                "", 
                "<img src=\"tmpk6Dfx1.png\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-6-A.svg\" />", 
                "<img src=\"169747a37db545b38cd40d8c86d4b008-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lucls_bg;v", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-1", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-1-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b~Uw-*F?G", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-2", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-2-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y-t*{`R3?`", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-3", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-3-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u+jl%mBWXr", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-4", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-4-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "NO3bAN9nIF", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-5", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-5-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q!WiUOjK_:", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-6", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-6-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PHy^^zGzI(", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "97e3949ec6864d339848a7028ed74ead-oa-7", 
                "", 
                "<img src=\"tmpvvPiYo.png\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-7-A.svg\" />", 
                "<img src=\"97e3949ec6864d339848a7028ed74ead-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M&n{ep<r4h", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates [[oc1::inflammatory mediator release]] from mast cells (i.e. histamine, tryptase) --&gt; reduces [[oc2::urticaria, angioedema]]&nbsp;</li><li><b>α1/α2 agonist</b> – [[oc3::vascular smooth m contraction]] --&gt; [[oc4::↑peripheral vasoconstriction]] --&gt; [[oc5::↑peripheral vascular resistance]] &amp; [[oc6::↓oedema leakage]] --&gt; [[oc7::↑BP]] + [[oc8::↓mucosal oedema]]&nbsp;</li><li><b>[[oc9::β2 agonist]]</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – [[oc10::+ve chronotropic (↑HR)]] and [[oc11::+ve inotropic (↑force of contraction)]] --&gt; [[oc12::↑BP]]&nbsp;</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates {{c1::inflammatory mediator release}} from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates inflammatory mediator release from mast cells (i.e. histamine, tryptase) --&gt; reduces {{c2::urticaria, angioedema}}&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces urticaria, angioedema&nbsp;</li><li><b>α1/α2 agonist</b> – {{c3::vascular smooth m contraction}} --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – vascular smooth m contraction --&gt; {{c4::↑peripheral vasoconstriction}} --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ↑peripheral vasoconstriction --&gt; {{c5::↑peripheral vascular resistance}} &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ↑peripheral vascular resistance &amp; {{c6::↓oedema leakage}} --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ↓oedema leakage --&gt; {{c7::↑BP}} + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ↑BP + {{c8::↓mucosal oedema}}&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ↓mucosal oedema&nbsp;</li><li><b>{{c9::β2 agonist}}</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>β2 agonist</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – {{c10::+ve chronotropic (↑HR)}} and ... --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – +ve chronotropic (↑HR) and {{c11::+ve inotropic (↑force of contraction)}} --&gt; ...&nbsp;</li></ol></div></div>", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates ... from mast cells (i.e. histamine, tryptase) --&gt; reduces ...&nbsp;</li><li><b>α1/α2 agonist</b> – ... --&gt; ... --&gt; ... &amp; ... --&gt; ... + ...&nbsp;</li><li><b>...</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – ... and +ve inotropic (↑force of contraction) --&gt; {{c12::↑BP}}&nbsp;</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Explain the mechanism of adrenaline<div><div><ol type=\"1\" start=\"1\"><li>Downregulates {{c21::inflammatory mediator release}} from mast cells (i.e. histamine, tryptase) --&gt; reduces {{c21::urticaria, angioedema}}&nbsp;</li><li><b>α1/α2 agonist</b> – {{c21::vascular smooth m contraction}} --&gt; {{c21::↑peripheral vasoconstriction}} --&gt; {{c21::↑peripheral vascular resistance}} &amp; {{c21::↓oedema leakage}} --&gt; {{c21::↑BP}} + {{c21::↓mucosal oedema}}&nbsp;</li><li><b>{{c21::β2 agonist}}</b> – bronchodilation&nbsp;</li><li><b>β1 agonist</b> – {{c21::+ve chronotropic (↑HR)}} and {{c21::+ve inotropic (↑force of contraction)}} --&gt; {{c21::↑BP}}&nbsp;</li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "s_d3g@A-[*", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PharmQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>46F presents for a routine Pap smear. She has been experiencing intermenstrual and post-coital bleeding.&nbsp;</div><div>On speculum exam she has an ulcerated lesion on the cervix. Rest of the vaginal exam appears normal</div><div><br /></div><div>What is your provisional dx?</div>", 
                "Cervical cancer- likely SCC (69%), &gt; adeno"
            ], 
            "flags": 0, 
            "guid": "h[=nAGGMVc", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>46F presents for a routine Pap smear. She has been experiencing intermenstrual and post-coital bleeding.&nbsp;</div><div>On speculum exam she has an ulcerated lesion on the cervix. Rest of the vaginal exam appears normal</div><div><br /></div><div>What are your differential diagnoses?</div>", 
                "<div><u>Other neoplastic</u></div><div><ul style=\"margin-left: 20px; \"><li>Endometrial/vaginal ca</li><li>Cervical fibroids (leiomyoma)</li><li>Cervical endometrial polyp</li></ul><div><div><u>Pre-malignant</u></div><div><ul style=\"margin-left: 20px; \"><li>CIN (cervical intra-epithelial neoplasia)</li><li>Cervical adenocarcinoma-in-situ</li></ul></div><div><u>Infection</u></div><div><ul style=\"margin-left: 20px; \"><li>Cervicitis – infectious (HPV)&nbsp;</li><li>PID (chlamydia – obligate intracellular, gonorrhoea – GN cocci)</li></ul></div></div></div><div><u>Benign</u></div><div><ul style=\"margin-left: 20px; \"><li>Nabothian cyst – may be ruptured (cyst on cervix)</li><li>Endometriosis&nbsp;</li><li>Cervical Ectropion – usually in pregnancy or younger women (endocervical protrusion)</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "qEhRDtX&Ie", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What primary investigations would you do for cervical ca?", 
                "<div><ol type=\"1\" start=\"1\"><li>Speculum exam with Papanicolau test: cytobrush with endocervical and endometrial sampling &nbsp;</li><li>Colposcopy: for more definitive diagnosis &nbsp;<br />- Acetic acid staining of dyskaryotic cells --&gt; Cone Biopsy</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "g,w~o>hJA+", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What laboratory investigations would you perform for cervical ca?", 
                "<div><ol type=\"1\" start=\"1\"><li>FBC: WCC (cervicitis), Hb low if excess bleeding from endometriosis&nbsp;</li><li>EUC &amp; LFT: metastatic disease if suspicious of cervical cancer&nbsp;</li><li>Coagulation studies</li><li>[HPV testing]</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "Fm@t}_8Xj;", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What imaging would you do for cervical ca?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Transvaginal Ultrasound: allows good visualisation of cervix, uterus, ovaries and fallopian tubes to evaluate for tumours and cysts&nbsp;<br />- Pelvic U/S can be performed if TVUS did not visualise structures sufficiently&nbsp;</li><li>CXR – screen for metastasis</li><li>Staging imaging – full body CT, PET, bone scan</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "B!kVn@][bC", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the pathogenesis of cervical ca?", 
                "<div><ul style=\"margin-left: 20px; \"><li>HPV detected in 85-90% of precancerous lesions and invasive neoplasms</li><li>High-risk types = 16 [SCC] and 18 [adenoca]</li><li>Integrate DNA into genome of epithelial cells --&gt; blocks TSGs P53 --&gt; uncontrolled cellular proliferation</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "igLp+X?)x:", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What types of pre-cancerous development can you get prior to cervical ca?", 
                "<div><ul style=\"margin-left: 20px; \"><li>CIN I, II and III (carcinoma in situ)<br />- II and III = high grade requiring further colposcopy and diagnostic biospy</li><li>SIL (Squamous intra-epithelial lesion)</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "L[H(@Pg#LB", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>[[oc1::HPV transmission via microabrasions]]</li><li>[[oc2::Acute HPV infection (anogenital warts?)]]</li><li>[[oc3::Viral persistence + precancerous lesion]]</li><li>[[oc4::Basement membrane invasion]]</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c1::HPV transmission via microabrasions}}</li><li>...</li><li>...</li><li>...</li></ol></div></div>", 
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>HPV transmission via microabrasions</li><li>{{c2::Acute HPV infection (anogenital warts?)}}</li><li>...</li><li>...</li></ol></div></div>", 
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>Acute HPV infection (anogenital warts?)</li><li>{{c3::Viral persistence + precancerous lesion}}</li><li>...</li></ol></div></div>", 
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>Viral persistence + precancerous lesion</li><li>{{c4::Basement membrane invasion}}</li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "4 stages of HPV transmission?<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>{{c21::HPV transmission via microabrasions}}</li><li>{{c21::Acute HPV infection (anogenital warts?)}}</li><li>{{c21::Viral persistence + precancerous lesion}}</li><li>{{c21::Basement membrane invasion}}</li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "Nhpl$4I1(q", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What prevention measure is there for cervical ca?", 
                "<div><ul style=\"margin-left: 20px; \"><li>HPV vaccine covering types 6,11,16 and 18</li><li>Given to women aged between 9-26 as a 3 part course<br />- 0,2 and 6 months</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "L3d]}kqD]b", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What screening measures are in place for cervical ca and consider pros/cons?", 
                "<ul style=\"margin-left: 20px; \"><li>HPV screening for sexually active women 25-74YO every 5 years if low risk &amp; first time 2 years after last normal pap&nbsp;</li></ul><u>Pros</u><br /><ul style=\"margin-left: 20px; \"><li></li><li>Slow progression from CIN to invasive so therefore effective as a form of prevention (may even be 10-20 years)</li><li>Cervical cancer drop by 70-90% since intro</li></ul><u>Cons</u><div><ul style=\"margin-left: 20px; \"><li>Cytology does not give clear structure of tissue</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "cW(w!&CTY&", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "OtherQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>42 year old woman who discovered a hard non-tender breast lump 15mm in diameter, cousin had breast cancer</div><div><br /></div><div>What is your provisional dx?</div>", 
                "Fibroadenoma (benign)"
            ], 
            "flags": 0, 
            "guid": "MHy-7(V<{c", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>42 year old woman who discovered a hard non-tender breast lump 15mm in diameter, cousin had breast cancer</div><div><br /></div><div>What are your differential diagnoses?</div>", 
                "<div><u>Non-malignant</u></div><div><ol type=\"1\" start=\"1\"><li>Cystic/fibrocystic change (pain during luteal phase)</li><li>Fat necrosis (hx of trauma)</li><li>Breast Abscess or mastitis</li><li>Lipoma</li></ol></div><div><u>Malignant – non-invasive</u></div><div><ol type=\"1\" start=\"1\"><li>DCIS</li><li>Paget’s disease (extension of DCIS into lactiferous ducts and areola)</li><li>LCIS</li></ol></div><div><u>Malignant &nbsp;- Invasive</u></div><div><ol type=\"1\" start=\"1\"><li>Invasive ductal cell carcinoma</li><li>Invasive lobular cell carcinoma</li><li>Medullary carcinoma</li><li>Colloid/mucoid carcinoma</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "B?`mBY1}nT", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What further hx would arouse suspicion of breast ca?", 
                "<div><ol type=\"1\" start=\"1\"><li>Size change: gradual increase = cancer, fluctuating = fibrocystic change&nbsp;</li><li>Axillary Lymphadenopathy&nbsp;</li><li>Systemic features (weight loss, night sweats, setc.) and signs of metastases (lung, bone, liver)</li><li>Prev hx&nbsp;</li><li>Family hx – 1°, genetic (BRCA ½)</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "vt4(R{N:0H", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What exam findings would arouse further suspicion of breast ca?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Systemic signs --&gt; cachexia</li><li>Mets screen- peripheries (lymphadenopathy), bony tenderness, hepatomegaly, resp (cough/pneumonia)</li></ul><u>Breast</u>&nbsp;<br /><ol type=\"1\" start=\"1\"><li>Overlying skin changes (erythema, peau d’orange – skin dimpling)</li><li>Nipple inversion, discharge and signs of pargets</li><li>Palpation (fixed/mobile, hardness, tenderness, irregularity)</li><li>Hard, irregular, non-tender = malignant</li><li>Well-circumscribed, mobile, rubbery = fibroadenoma</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "c[J!:SNyK6", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Significance of family hx and breast ca?", 
                "<div><ol type=\"1\" start=\"1\"><li>A&nbsp;1<sup>o</sup>&nbsp;Relative with unilateral Breast Ca = <i>2.0x</i> RR increase&nbsp;</li><li>A 1<sup>o</sup> Relative with bilateral Breast Ca = <i>5.0x</i> RR increase&nbsp;</li><li>Family hx of ovarian ca = <i>5.0x</i> RR increase</li></ol></div>"
            ], 
            "flags": 0, 
            "guid": "=,_(%&MO_", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- [[oc1::LCIS or DCIS]] =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of [[oc2::ovarian cancer]] = <i>5.0x RR</i>&nbsp;</li><li>Age [[oc3::&gt;50]] = <i>4.0x RR</i>&nbsp;</li><li>[[oc4::BRCA1/2 (AD - tumour suppressor genes) +ve]] = <i>4.0x RR&nbsp;</i></li><li>[[oc5::High oestrogen exposure]]&nbsp;</li><li>[[oc6::Smoking]] = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "<div><div><br /></div></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- {{c1::LCIS or DCIS}} =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of ... = <i>5.0x RR</i>&nbsp;</li><li>Age ... = <i>4.0x RR</i>&nbsp;</li><li>... = <i>4.0x RR&nbsp;</i></li><li>...&nbsp;</li><li>... = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- LCIS or DCIS =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of {{c2::ovarian cancer}} = <i>5.0x RR</i>&nbsp;</li><li>Age ... = <i>4.0x RR</i>&nbsp;</li><li>... = <i>4.0x RR&nbsp;</i></li><li>...&nbsp;</li><li>... = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- ... =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of ovarian cancer = <i>5.0x RR</i>&nbsp;</li><li>Age {{c3::&gt;50}} = <i>4.0x RR</i>&nbsp;</li><li>... = <i>4.0x RR&nbsp;</i></li><li>...&nbsp;</li><li>... = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- ... =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of ... = <i>5.0x RR</i>&nbsp;</li><li>Age &gt;50 = <i>4.0x RR</i>&nbsp;</li><li>{{c4::BRCA1/2 (AD - tumour suppressor genes) +ve}} = <i>4.0x RR&nbsp;</i></li><li>...&nbsp;</li><li>... = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- ... =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of ... = <i>5.0x RR</i>&nbsp;</li><li>Age ... = <i>4.0x RR</i>&nbsp;</li><li>BRCA1/2 (AD - tumour suppressor genes) +ve = <i>4.0x RR&nbsp;</i></li><li>{{c5::High oestrogen exposure}}&nbsp;</li><li>... = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- ... =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of ... = <i>5.0x RR</i>&nbsp;</li><li>Age ... = <i>4.0x RR</i>&nbsp;</li><li>... = <i>4.0x RR&nbsp;</i></li><li>High oestrogen exposure&nbsp;</li><li>{{c6::Smoking}} = <i>1.5x RR</i>&nbsp;</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "List other risk factors for breast ca<div><ul style=\"margin-left: 20px; \"><li>Related pathology<br />- {{c21::LCIS or DCIS}} =&nbsp;<i>7-12x</i>&nbsp;RR&nbsp;<br />Past history = <i>5.0x RR</i>&nbsp;</li><li>Family hx of {{c21::ovarian cancer}} = <i>5.0x RR</i>&nbsp;</li><li>Age {{c21::&gt;50}} = <i>4.0x RR</i>&nbsp;</li><li>{{c21::BRCA1/2 (AD - tumour suppressor genes) +ve}} = <i>4.0x RR&nbsp;</i></li><li>{{c21::High oestrogen exposure}}&nbsp;</li><li>{{c21::Smoking}} = <i>1.5x RR</i>&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "g<msg5vdW", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are some causes of increased estrogen exposure?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Nulliparous = <i>3.0x</i> RR&nbsp;</li><li>First live birth &gt;35 = <i>1.9x</i> RR&nbsp;</li><li>Overweight/obese = <i>1.5x </i>RR&nbsp;</li><li>Late menopause = <i>1.5x</i> RR&nbsp;</li><li>OCP = <i>1.2x RR</i> increase&nbsp;</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "hh5=/2.G6r", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the triple assessment?", 
                "<div>Dx for breast ca requires Triple Assessment</div><div><ol type=\"1\" start=\"1\"><li>Clinical examination – Lump and nodes&nbsp;</li><li>Imaging (U/S &lt;35, mammography+ US &gt;35)&nbsp;</li><li>Biopsy for Cytology/histology</li></ol></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "j;p$DyuB=W", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When do you use U/S vs mammogram?", 
                "<div><ul style=\"margin-left: 20px; \"><li>&lt;35y = US only, mammogram useless as breast tissue too dense&nbsp;</li><li>&gt;50y = mammogram +/- US as breast is less dense (more adipose, less ligaments &amp; ducts by %)&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "k4U:.U]r[B", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-1", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-1-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yU6oD+;ufo", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-2", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-2-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s!%v=[g((E", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-3", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-3-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n/W:]1yHJ/", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-4", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-4-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "SZ]yLj:WR", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-5", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-5-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DY~>d|+~[?", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-6", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-6-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J&J*$V|~cr", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-7", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-7-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GcfYgGm(Wy", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52ff00f3d70e41368901ccf194969601-oa-8", 
                "", 
                "<img src=\"tmpiorSOQ.png\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-8-A.svg\" />", 
                "<img src=\"52ff00f3d70e41368901ccf194969601-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ba8C!)GAR:", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. [[oc1::breast micro/macro cyst]], [[oc2::stromal fibrosis]]<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>[[oc3::Confers negligible increased risk]]</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. [[oc4::Epithelial hyperplasia]], [[oc5::sclerosing adenosis]] (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>[[oc6::1.5-2.5x]]</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. {{c1::breast micro/macro cyst}}, ...<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>...</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. ..., ... (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>...</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. breast micro/macro cyst, {{c2::stromal fibrosis}}<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>...</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. ..., ... (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>...</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. ..., stromal fibrosis<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>{{c3::Confers negligible increased risk}}</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. ..., ... (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>...</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. ..., ...<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>Confers negligible increased risk</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. {{c4::Epithelial hyperplasia}}, ... (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>...</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. ..., ...<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>...</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. Epithelial hyperplasia, {{c5::sclerosing adenosis}} (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>...</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. ..., ...<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>...</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. ..., sclerosing adenosis (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>{{c6::1.5-2.5x}}</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Does fibrocystic change predispose to carcinoma?<div><br /></div><div><div>Benign breast lesions can be classified histologically into three categories:&nbsp;</div><div><ol type=\"1\" start=\"1\"><li><u>Non-proliferative</u> e.g. {{c21::breast micro/macro cyst}}, {{c21::stromal fibrosis}}<br />- Exaggerated response of normal breast changes that occurs in menstrual &nbsp;cycle<br />- <i>{{c21::Confers negligible increased risk}}</i> of carcinoma&nbsp;</li><li><u>Proliferative</u> e.g. {{c21::Epithelial hyperplasia}}, {{c21::sclerosing adenosis}} (glandular aggregation and fibrous overgrowth)<br />- Small increased risk of developing breast cancer =&nbsp;<i>{{c21::1.5-2.5x}}</i></li><li><u>Atypical lobular hyperplasia</u> = <i>x5 risk</i></li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "F!l2!S.&Jg", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What cancer factors determine bresat ca prognosis?", 
                "<div><u>Grade</u>&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>Degree of differentiation</li><li>Mitoses/tubule formation</li></ul></div><div><u>Stage</u></div><div><ul style=\"margin-left: 20px; \"><li>Tumor (size, lobular/ductal, invasive/in situ)</li><li>Nodes</li><li>Mets</li></ul><ul style=\"margin-left: 20px; \"><li>HER-2 Receptor&nbsp;</li><li>Estrogen/progesterone receptor&nbsp;</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "cd<bBXu<g$", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What patient factors determine breast ca prognosis?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Age</li><li>Comorbidities</li><li>Treatments selected/suitable</li><li>Surgical margins</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "E*Xnn}4w-~", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Discuss features of breast cancer pot<div><br /></div><div><img src=\"paste-43349104918912.jpg\" /></div><div><img src=\"paste-43383464657282.jpg\" /></div>", 
                "<div><u>Macroscopic</u></div><div><ul style=\"margin-left: 20px; \"><li>White/pale lesion centrally</li><li>Hard on palpation</li><li>Some degree of retraction</li></ul></div><div><u>Microscopic</u></div><div><ul style=\"margin-left: 20px; \"><li>Heterogenous tubule formation&nbsp;</li><li>Invasion into adipose tissue</li><li>Peri-tumour fibrosis</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "o@Cy!]Bx,g", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "PathQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A 65 year old man presented to the Emergency Department with a six-hour history of interscapular pain, urinary retention and mild bilateral leg weakness. On further questioning, he revealed that he had felt unwell for six weeks and had lost 3 kg in the past month.&nbsp;</div><div><br /></div><div>On examination he had a distended bladder, signs of motor dysfunction in both legs, decreased sensation to the level of his rib cage and reduction in vibration sense below his iliac crest.&nbsp;</div><div><br /></div><div>What is your provisional dx?</div>", 
                "<div><ul style=\"margin-left: 20px; \"><li>Spinal Metastases --&gt; spinal cord compression</li><li>Note: Cancers metastasising to bone = lung, prostate, breast, colon, myeloma, kidney&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "D/^ys:%Cd_", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A 65 year old man presented to the Emergency Department with a six-hour history of interscapular pain, urinary retention and mild bilateral leg weakness. On further questioning, he revealed that he had felt unwell for six weeks and had lost 3 kg in the past month.&nbsp;</div><div><br /></div><div>On examination he had a distended bladder, signs of motor dysfunction in both legs, decreased sensation to the level of his rib cage and reduction in vibration sense below his iliac crest.&nbsp;</div><div><br /></div><div>What are your differential diagnoses?</div>", 
                "<div><ol type=\"1\" start=\"1\"><li>Vertebral # (OP --&gt; crush # --&gt; retro-pulsion of fragment impinges spinal cord)&nbsp;</li><li>Vertebral Disk Herniation&nbsp;</li><li>Osteomyelitis/Abscess (UTI or other infection source spreading to spine )&nbsp;</li></ol>Pott’s Disease (TB --&gt; vertebral osteomyelitis)&nbsp;<br />Paget’s Disease&nbsp;<br />Spondylolisthesis (zygapophyseal joint dislocation – would likely need to be bilateral)&nbsp;<br />Multiple myeloma (myeloma --&gt; lytic lesion --&gt; pathological fracture)&nbsp;</div>"
            ], 
            "flags": 0, 
            "guid": "x&rHm5~a9M", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A 65 year old man presented to the Emergency Department with a six-hour history of interscapular pain, urinary retention and mild bilateral leg weakness. On further questioning, he revealed that he had felt unwell for six weeks and had lost 3 kg in the past month.&nbsp;</div><div><br /></div><div>On examination he had a distended bladder, signs of motor dysfunction in both legs, decreased sensation to the level of his rib cage and reduction in vibration sense below his iliac crest.&nbsp;</div><div><br /></div><div>What investigations are appropriate?</div>", 
                "<div><u>Bedside</u>&nbsp;</div><div>Urinalysis</div><div><br /></div><div><div><u>Bloods</u></div><div>FBC:&nbsp;</div><div><ul style=\"margin-left: 20px; \"><li>normochromic, normocytic anaemia and thrombocytopenia (bone marrow involvement)</li><li>Raised WCC (osteomyelitis)</li><li>CMP (↑Ca2+, paraneoplastic effect)&nbsp;</li><li>ALP (↑in bony mets)&nbsp;</li><li>EUC (↑ in urinary retention 2<sup>o</sup>&nbsp;to&nbsp;prostate cancer causing obstruction)&nbsp;</li><li>LFT (mets)&nbsp;</li><li>PSA &amp; DRE (↑ suggests prostate cancer, &gt;20ng/mL --&gt; bone scan)&nbsp;</li></ul></div></div><div><u>Imaging&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>MRI/CT spine (osteoblastic lesions in prostate ca)&nbsp;</li><li>CXR (TB, malignancy)&nbsp;</li><li>Transrectal U/S &amp; biopsy</li><li>Bone scan (mets-later)&nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "m5iK6>+{7&", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>[[oc1::Detect prostate cancer early (usually is asymptomatic)&nbsp;]]</li><li>[[oc2::Men diagnosed with early PCa live longer c.f. more advanced ca&nbsp;]]</li><li>[[oc3::PCa which has spread outside of prostate is generally incurable]]&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>[[oc4::5% of men &gt; 80years have prostate cancer but only &lt;4% will die for it]]</li><li>[[oc5::A/E of unnecessary treatment = erectile dysfunction, urinary incontinence]]</li><li>[[oc6::By itself, PSA has too low PPV-&nbsp;false +ves:&nbsp;BPH, Prostatitis, 24 hours post ejaculation, &lt;7d post urinary catheterisation, TURP]]</li></ol></div></div></div>", 
                "<u><br /></u>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>{{c1::Detect prostate cancer early (usually is asymptomatic)&nbsp;}}</li><li>...</li><li>...&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...</li></ol></div></div></div>", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>Detect prostate cancer early (usually is asymptomatic)&nbsp;</li><li>{{c2::Men diagnosed with early PCa live longer c.f. more advanced ca&nbsp;}}</li><li>...&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...</li></ol></div></div></div>", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>...</li><li>Men diagnosed with early PCa live longer c.f. more advanced ca&nbsp;</li><li>{{c3::PCa which has spread outside of prostate is generally incurable}}&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...</li></ol></div></div></div>", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>PCa which has spread outside of prostate is generally incurable&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>{{c4::5% of men &gt; 80years have prostate cancer but only &lt;4% will die for it}}</li><li>...</li><li>...</li></ol></div></div></div>", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>5% of men &gt; 80years have prostate cancer but only &lt;4% will die for it</li><li>{{c5::A/E of unnecessary treatment = erectile dysfunction, urinary incontinence}}</li><li>...</li></ol></div></div></div>", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>...</li><li>...</li><li>...&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>...</li><li>A/E of unnecessary treatment = erectile dysfunction, urinary incontinence</li><li>{{c6::By itself, PSA has too low PPV-&nbsp;false +ves:&nbsp;BPH, Prostatitis, 24 hours post ejaculation, &lt;7d post urinary catheterisation, TURP}}</li></ol></div></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Discuss public health perspectives of PSA screening<div><br /></div><div><u>Pros</u><div><ol type=\"1\" start=\"1\"><li>{{c21::Detect prostate cancer early (usually is asymptomatic)&nbsp;}}</li><li>{{c21::Men diagnosed with early PCa live longer c.f. more advanced ca&nbsp;}}</li><li>{{c21::PCa which has spread outside of prostate is generally incurable}}&nbsp;</li></ol></div><div><div><u>Cons</u></div></div><div><div><ol type=\"1\" start=\"1\"><li>{{c21::5% of men &gt; 80years have prostate cancer but only &lt;4% will die for it}}</li><li>{{c21::A/E of unnecessary treatment = erectile dysfunction, urinary incontinence}}</li><li>{{c21::By itself, PSA has too low PPV-&nbsp;false +ves:&nbsp;BPH, Prostatitis, 24 hours post ejaculation, &lt;7d post urinary catheterisation, TURP}}</li></ol></div></div></div>"
            ], 
            "flags": 0, 
            "guid": "sa.X^C.ku&", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts [[oc1::bladder]]</li><li>Apex <i>inferiorly</i> abuts [[oc2::fascia of external sphincter urethrae]]</li><li>Hugged <i>inferolaterally</i> by [[oc3::levator ani]]</li><li>[[oc4::Rectum]] lies <i>posteriorly</i></li></ol></div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts {{c1::bladder}}</li><li>Apex <i>inferiorly</i> abuts ...</li><li>Hugged <i>inferolaterally</i> by ...</li><li>... lies <i>posteriorly</i></li></ol></div></div>", 
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts bladder</li><li>Apex <i>inferiorly</i> abuts {{c2::fascia of external sphincter urethrae}}</li><li>Hugged <i>inferolaterally</i> by ...</li><li>... lies <i>posteriorly</i></li></ol></div></div>", 
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts ...</li><li>Apex <i>inferiorly</i> abuts fascia of external sphincter urethrae</li><li>Hugged <i>inferolaterally</i> by {{c3::levator ani}}</li><li>... lies <i>posteriorly</i></li></ol></div></div>", 
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts ...</li><li>Apex <i>inferiorly</i> abuts ...</li><li>Hugged <i>inferolaterally</i> by levator ani</li><li>{{c4::Rectum}} lies <i>posteriorly</i></li></ol></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Relations of prostate<div><br /></div><div><div><ol type=\"1\" start=\"1\"><li>Base <i>superiorly</i> abuts {{c21::bladder}}</li><li>Apex <i>inferiorly</i> abuts {{c21::fascia of external sphincter urethrae}}</li><li>Hugged <i>inferolaterally</i> by {{c21::levator ani}}</li><li>{{c21::Rectum}} lies <i>posteriorly</i></li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "e+fmo!N,Xk", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the prostate<div><br /></div><div><div>A [[oc1::glandular]] organ with a [[oc2::fibromuscular]] capsule shaped like an [[oc3::inverted pyramid]] which surrounds the [[oc4::neck of the urinary bladder]]. It contains the [[oc5::two ejaculatory ducts]] which both join with the [[oc6::proximal urethra]] to form the [[oc7::prostatic urethra]].</div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Describe the prostate<div><br /></div><div><div>A {{c1::glandular}} organ with a ... capsule shaped like an ... which surrounds the .... It contains the ... which both join with the ... to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A glandular organ with a {{c2::fibromuscular}} capsule shaped like an ... which surrounds the .... It contains the ... which both join with the ... to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A ... organ with a fibromuscular capsule shaped like an {{c3::inverted pyramid}} which surrounds the .... It contains the ... which both join with the ... to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A ... organ with a ... capsule shaped like an inverted pyramid which surrounds the {{c4::neck of the urinary bladder}}. It contains the ... which both join with the ... to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A ... organ with a ... capsule shaped like an ... which surrounds the neck of the urinary bladder. It contains the {{c5::two ejaculatory ducts}} which both join with the ... to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A ... organ with a ... capsule shaped like an ... which surrounds the .... It contains the two ejaculatory ducts which both join with the {{c6::proximal urethra}} to form the ....</div></div>", 
                "Describe the prostate<div><br /></div><div><div>A ... organ with a ... capsule shaped like an ... which surrounds the .... It contains the ... which both join with the proximal urethra to form the {{c7::prostatic urethra}}.</div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Describe the prostate<div><br /></div><div><div>A {{c21::glandular}} organ with a {{c21::fibromuscular}} capsule shaped like an {{c21::inverted pyramid}} which surrounds the {{c21::neck of the urinary bladder}}. It contains the {{c21::two ejaculatory ducts}} which both join with the {{c21::proximal urethra}} to form the {{c21::prostatic urethra}}.</div></div>"
            ], 
            "flags": 0, 
            "guid": "yiIPD^N#2E", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-1", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-1-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g^BE+ml#`#", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-2", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-2-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K6y*D:N&iU", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-3", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-3-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "LY:`@hZP&F", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-4", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-4-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P~:#W-9,AW", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-5", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-5-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "KJvRW-wI[F", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7a5c00eb50a54ed5b6538d3ad2f97923-oa-6", 
                "", 
                "<img src=\"tmpqQN7cL.png\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-6-A.svg\" />", 
                "<img src=\"7a5c00eb50a54ed5b6538d3ad2f97923-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v!!Xm)2<T9", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad09d0d34d2d464dbf64527c53e0058b-oa-1", 
                "", 
                "<img src=\"tmpLS5C_u.png\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-1-A.svg\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ug}kOs.u&R", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad09d0d34d2d464dbf64527c53e0058b-oa-2", 
                "", 
                "<img src=\"tmpLS5C_u.png\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-2-A.svg\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OpxRtKlsy+", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad09d0d34d2d464dbf64527c53e0058b-oa-3", 
                "", 
                "<img src=\"tmpLS5C_u.png\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-3-A.svg\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g.VUJX.i:M", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad09d0d34d2d464dbf64527c53e0058b-oa-4", 
                "", 
                "<img src=\"tmpLS5C_u.png\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-4-A.svg\" />", 
                "<img src=\"ad09d0d34d2d464dbf64527c53e0058b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "f15!/A&J:t", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "02ec0421dd3c4d5c963b8f320b19967a-oa-1", 
                "", 
                "<img src=\"tmpYAdUX8.png\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-1-A.svg\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tpT<3m.U7R", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "02ec0421dd3c4d5c963b8f320b19967a-oa-2", 
                "", 
                "<img src=\"tmpYAdUX8.png\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-2-A.svg\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ix)ecE.r&R", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "02ec0421dd3c4d5c963b8f320b19967a-oa-3", 
                "", 
                "<img src=\"tmpYAdUX8.png\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-3-A.svg\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "uOMC!2%)I5", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "02ec0421dd3c4d5c963b8f320b19967a-oa-4", 
                "", 
                "<img src=\"tmpYAdUX8.png\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-4-A.svg\" />", 
                "<img src=\"02ec0421dd3c4d5c963b8f320b19967a-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b$_.hF(wB&", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Blood supply of prostate?", 
                "inferior vesical a. (branch of internal iliac)"
            ], 
            "flags": 0, 
            "guid": "c*}Q5^s|l>", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Nerve supply to prostate?", 
                "<ul style=\"margin-left: 20px; \"><li>Parasympathetic = pelvic splanchnic (S2-S4)</li><li>Sympathetic = inferior hypogastric plexus</li></ul>"
            ], 
            "flags": 0, 
            "guid": "w||vV5dTxB", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "DRE clinical exam of prostate findings if Ca vs BPH?", 
                "<ul style=\"margin-left: 20px; \"><li>Ca = rock/stony hard</li><li>BPH = enlarged</li></ul>"
            ], 
            "flags": 0, 
            "guid": "gXxfux+Oi7", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Surgical treatment of PCa?", 
                "<ol type=\"1\" start=\"1\"><li>TURP</li><li>Radical prostatectomy</li></ol>"
            ], 
            "flags": 0, 
            "guid": "lNA<9;2nPW", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-1", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-1-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": ",1S5W#8T{", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-2", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-2-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mEGCWz$h?l", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-3", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-3-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "iPvJn6Fz::", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-4", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-4-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cw#~pI{e<!", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-5", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-5-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "LPw9y-c^v%", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-6", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-6-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q%U[Eq6:0V", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-7", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-7-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jf$P&Ke[*v", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-8", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-8-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qe8.zM0,tN", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-9", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-9-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d_P7%O4|$j", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-10", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-10-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "*<f${~/n4", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-11", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-11-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EMsnEjNW#R", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c83fc304c11f412abfb7a595aa3f498e-oa-12", 
                "", 
                "<img src=\"tmpnDFoAn.png\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-12-A.svg\" />", 
                "<img src=\"c83fc304c11f412abfb7a595aa3f498e-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mx4ZZ->e?F", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is BPH?", 
                "Prostate&nbsp;gland enlargement by nodules arising from the transitional zone"
            ], 
            "flags": 0, 
            "guid": "AH)fFI~($q", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where do most cases of PCa arise from?", 
                "<b>Peripheral part of the prostate</b> (70% of the prostate), particularly in the <b>posterior region</b>, facilitating palpation during rectal examination"
            ], 
            "flags": 0, 
            "guid": "kVbgyY$ZE4", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the [[oc1::urethral sphincter]], and above it is the [[oc2::vesical sphincter]]. When the [[oc3::vesical sphincter]] is encroached upon, leads to leakage of urine into the [[oc4::prostatic urethra]] and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged [[oc5::median lobe]] can also compress the [[oc6::urethral orifice]] in the bladder and act like a [[oc7::flap valve]] every time the pressure (to pee) rises, leading to [[oc8::difficulty starting a stream]]</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the [[oc9::prostatic urethra]] is elongated, compressed and distorted &nbsp;by the [[oc10::expanding medial and lateral lobes]]</div></div></div>", 
                "<div><br /></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the {{c1::urethral sphincter}}, and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the urethral sphincter, and above it is the {{c2::vesical sphincter}}. When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the vesical sphincter. When the {{c3::vesical sphincter}} is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the vesical sphincter is encroached upon, leads to leakage of urine into the {{c4::prostatic urethra}} and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the prostatic urethra and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged {{c5::median lobe}} can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged median lobe can also compress the {{c6::urethral orifice}} in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the urethral orifice in the bladder and act like a {{c7::flap valve}} every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a flap valve every time the pressure (to pee) rises, leading to {{c8::difficulty starting a stream}}</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the ... is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to difficulty starting a stream</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the {{c9::prostatic urethra}} is elongated, compressed and distorted &nbsp;by the ...</div></div></div>", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the ..., and above it is the .... When the ... is encroached upon, leads to leakage of urine into the ... and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged ... can also compress the ... in the bladder and act like a ... every time the pressure (to pee) rises, leading to ...</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the prostatic urethra is elongated, compressed and distorted &nbsp;by the {{c10::expanding medial and lateral lobes}}</div></div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Signs and symptoms of BPH?<div><br /></div><div>(mostly from obstruction)<div><div><u>Urgency</u></div><div>Below the prostate is the {{c21::urethral sphincter}}, and above it is the {{c21::vesical sphincter}}. When the {{c21::vesical sphincter}} is encroached upon, leads to leakage of urine into the {{c21::prostatic urethra}} and an intense desire to micturate</div><div><br /></div><div><u>Hesitancy</u></div><div>Enlarged {{c21::median lobe}} can also compress the {{c21::urethral orifice}} in the bladder and act like a {{c21::flap valve}} every time the pressure (to pee) rises, leading to {{c21::difficulty starting a stream}}</div><div><br /></div><div><u>Poor stream</u></div><div>Once stream starts, poor stream &nbsp;because the {{c21::prostatic urethra}} is elongated, compressed and distorted &nbsp;by the {{c21::expanding medial and lateral lobes}}</div></div></div>"
            ], 
            "flags": 0, 
            "guid": "uD`.jM,`Ou", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>[[oc1::Median lobe]] &nbsp;which expanded upwards can create a bump/elevation in the [[oc2::bladder trigone]] and this is called the [[oc3::prostatic uvula]]- can cause stagnant urine [[oc4::posterior]] to this leading to [[oc5::recurrent cystitis]]</div></div>", 
                "<div><u><br /></u></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>{{c1::Median lobe}} &nbsp;which expanded upwards can create a bump/elevation in the ... and this is called the ...- can cause stagnant urine ... to this leading to ...</div></div>", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>Median lobe &nbsp;which expanded upwards can create a bump/elevation in the {{c2::bladder trigone}} and this is called the ...- can cause stagnant urine ... to this leading to ...</div></div>", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>... &nbsp;which expanded upwards can create a bump/elevation in the bladder trigone and this is called the {{c3::prostatic uvula}}- can cause stagnant urine ... to this leading to ...</div></div>", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>... &nbsp;which expanded upwards can create a bump/elevation in the ... and this is called the prostatic uvula- can cause stagnant urine {{c4::posterior}} to this leading to ...</div></div>", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>... &nbsp;which expanded upwards can create a bump/elevation in the ... and this is called the ...- can cause stagnant urine posterior to this leading to {{c5::recurrent cystitis}}</div></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "Complications of BPH?<div><br /></div><div><div><u>Recurrent cystitis</u></div><div>{{c21::Median lobe}} &nbsp;which expanded upwards can create a bump/elevation in the {{c21::bladder trigone}} and this is called the {{c21::prostatic uvula}}- can cause stagnant urine {{c21::posterior}} to this leading to {{c21::recurrent cystitis}}</div></div>"
            ], 
            "flags": 0, 
            "guid": "P7!U6DAK}z", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does PCa spread directly?", 
                "Local invasion into:<div><div><ol type=\"1\" start=\"1\"><li>Seminal Vesicles (nearly always)&nbsp;</li><li>Bladder&nbsp;</li><li>Rectum (unusual)</li></ol></div></div>"
            ], 
            "flags": 0, 
            "guid": "Cugg>&7hL[", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does PCa spread haematogenously?<div><br /></div><div><div>[[oc1::Prostatic venous plexus]] ([[oc2::Batson's plexus]]) is a venous plexus that is [[oc3::THIN walled]] and [[oc4::VALVELESS]] and communicates with the [[oc5::vesical veins]] and, importantly, the [[oc6::spinal venous plexus]].&nbsp;</div><div><br /></div><div>It is supposed to drain into the [[oc7::internal iliacs]] ultimately. However, because it is valveless, during &nbsp;[[oc8::coughing or straining]], there can be [[oc9::RETROGRADE flow]] from the [[oc10::Batson's plexus]] to the [[oc11::spinal venous plexus]], and cancer cells can float up this &nbsp;[[oc12::valveless venous system]] all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the [[oc13::lower veterbral column]] and &nbsp;[[oc14::pelvic bones]] in prostate cancer</div><div><br /></div><div>No cough means [[oc15::IVC]] drains to [[oc16::lung]] (lung mets, liver mets)&nbsp;</div></div>", 
                "", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>{{c1::Prostatic venous plexus}} (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>Prostatic venous plexus ({{c2::Batson's plexus}}) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (Batson's plexus) is a venous plexus that is {{c3::THIN walled}} and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is THIN walled and {{c4::VALVELESS}} and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and VALVELESS and communicates with the {{c5::vesical veins}} and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the vesical veins and, importantly, the {{c6::spinal venous plexus}}.&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the spinal venous plexus.&nbsp;</div><div><br /></div><div>It is supposed to drain into the {{c7::internal iliacs}} ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the internal iliacs ultimately. However, because it is valveless, during &nbsp;{{c8::coughing or straining}}, there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;coughing or straining, there can be {{c9::RETROGRADE flow}} from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be RETROGRADE flow from the {{c10::Batson's plexus}} to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the Batson's plexus to the {{c11::spinal venous plexus}}, and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the spinal venous plexus, and cancer cells can float up this &nbsp;{{c12::valveless venous system}} all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;valveless venous system all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the {{c13::lower veterbral column}} and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the lower veterbral column and &nbsp;{{c14::pelvic bones}} in prostate cancer</div><div><br /></div><div>No cough means ... drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;pelvic bones in prostate cancer</div><div><br /></div><div>No cough means {{c15::IVC}} drains to ... (lung mets, liver mets)&nbsp;</div></div>", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>... (...) is a venous plexus that is ... and ... and communicates with the ... and, importantly, the ....&nbsp;</div><div><br /></div><div>It is supposed to drain into the ... ultimately. However, because it is valveless, during &nbsp;..., there can be ... from the ... to the ..., and cancer cells can float up this &nbsp;... all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the ... and &nbsp;... in prostate cancer</div><div><br /></div><div>No cough means IVC drains to {{c16::lung}} (lung mets, liver mets)&nbsp;</div></div>", 
                "", 
                "", 
                "", 
                "", 
                "How does PCa spread haematogenously?<div><br /></div><div><div>{{c21::Prostatic venous plexus}} ({{c21::Batson's plexus}}) is a venous plexus that is {{c21::THIN walled}} and {{c21::VALVELESS}} and communicates with the {{c21::vesical veins}} and, importantly, the {{c21::spinal venous plexus}}.&nbsp;</div><div><br /></div><div>It is supposed to drain into the {{c21::internal iliacs}} ultimately. However, because it is valveless, during &nbsp;{{c21::coughing or straining}}, there can be {{c21::RETROGRADE flow}} from the {{c21::Batson's plexus}} to the {{c21::spinal venous plexus}}, and cancer cells can float up this &nbsp;{{c21::valveless venous system}} all the way up to the skull.&nbsp;</div><div><br /></div><div>This explains the &nbsp;frequent occurrence of skeletal mets in the {{c21::lower veterbral column}} and &nbsp;{{c21::pelvic bones}} in prostate cancer</div><div><br /></div><div>No cough means {{c21::IVC}} drains to {{c21::lung}} (lung mets, liver mets)&nbsp;</div></div>"
            ], 
            "flags": 0, 
            "guid": "Mj/AEjlk5:", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does PCa spread lymphatically?", 
                "<div>Internal iliac --&gt; common iliac --&gt; para-aortic lumbar nodes&nbsp;</div>"
            ], 
            "flags": 0, 
            "guid": "mT4?l:>g^b", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-1", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-1-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s1+#AcnX`A", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-2", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-2-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N2(Wm33:*P", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-3", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-3-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M)UFRZ!$=b", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-4", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-4-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IFej(`f+$!", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-5", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-5-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q5;Sb5p4Q4", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-6", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-6-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "klozOxS-3+", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-7", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-7-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Jh!M/?o2#y", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-8", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-8-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "f.[vDSGtm?", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-9", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-9-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JB*?#nck_]", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-10", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-10-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BY7XU]yj70", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-11", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-11-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GkTk[1Fv?l", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9bb412689a134f32933ea71a789c39cf-oa-12", 
                "", 
                "<img src=\"tmp2ytuxP.png\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-12-A.svg\" />", 
                "<img src=\"9bb412689a134f32933ea71a789c39cf-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Js#),)(=c~", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the [[oc1::aggressiveness]] of PCa&nbsp;</li><li>Ranges from [[oc2::1-5]] and describes how much the cancer from a biopsy looks like healthy ([[oc3::lower score]])/abnormal ([[oc4::higher score]]) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different [[oc5::grades]], two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the [[oc6::largest area of the tumor]] and a secondary grade is given to describe the cells of [[oc7::the next largest area]]. &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "<div><div><br /></div></div>", 
                "", 
                "", 
                "1,1,0 | n,n,n,n", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the {{c1::aggressiveness}} of PCa&nbsp;</li><li>Ranges from ... and describes how much the cancer from a biopsy looks like healthy (...)/abnormal (...) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different ..., two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the ... and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the aggressiveness of PCa&nbsp;</li><li>Ranges from {{c2::1-5}} and describes how much the cancer from a biopsy looks like healthy (...)/abnormal (...) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different ..., two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the ... and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the ... of PCa&nbsp;</li><li>Ranges from 1-5 and describes how much the cancer from a biopsy looks like healthy ({{c3::lower score}})/abnormal (...) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different ..., two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the ... and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the ... of PCa&nbsp;</li><li>Ranges from ... and describes how much the cancer from a biopsy looks like healthy (lower score)/abnormal ({{c4::higher score}}) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different ..., two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the ... and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the ... of PCa&nbsp;</li><li>Ranges from ... and describes how much the cancer from a biopsy looks like healthy (...)/abnormal (higher score) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different {{c5::grades}}, two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the ... and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the ... of PCa&nbsp;</li><li>Ranges from ... and describes how much the cancer from a biopsy looks like healthy (...)/abnormal (...) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different grades, two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the {{c6::largest area of the tumor}} and a secondary grade is given to describe the cells of .... &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the ... of PCa&nbsp;</li><li>Ranges from ... and describes how much the cancer from a biopsy looks like healthy (...)/abnormal (...) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different ..., two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the largest area of the tumor and a secondary grade is given to describe the cells of {{c7::the next largest area}}. &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "What is the Gleason Score?<div><br /></div><div><ul style=\"margin-left: 20px; \"><li>Grading system used to determine the {{c21::aggressiveness}} of PCa&nbsp;</li><li>Ranges from {{c21::1-5}} and describes how much the cancer from a biopsy looks like healthy ({{c21::lower score}})/abnormal ({{c21::higher score}}) tissue</li><li>Since prostate tumors are often made up of cancerous cells that have different {{c21::grades}}, two grades are assigned for each patient. &nbsp;</li><li>A primary grade is given to describe the cells that make up the {{c21::largest area of the tumor}} and a secondary grade is given to describe the cells of {{c21::the next largest area}}. &nbsp;</li><li>For instance, if the Gleason Score is written as 3+4=7, it means most of the tumor is grade 3 and the next largest section of the tumor is grade 4, together they make up the total Gleason Score. &nbsp;</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "O|OIrTF%G!", 
            "note_model_uuid": "416fc301-5c2c-11e8-9ae9-5ce0c5bacc04", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4740d913cfa140c3a4207d3c151f2a7b-oa-1", 
                "", 
                "<img src=\"tmpZHmUBT.png\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-1-A.svg\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e3]xBdrS.@", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4740d913cfa140c3a4207d3c151f2a7b-oa-2", 
                "", 
                "<img src=\"tmpZHmUBT.png\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-2-A.svg\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yf?(3vVkzZ", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4740d913cfa140c3a4207d3c151f2a7b-oa-3", 
                "", 
                "<img src=\"tmpZHmUBT.png\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-3-A.svg\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "C5xLuCfMyt", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4740d913cfa140c3a4207d3c151f2a7b-oa-4", 
                "", 
                "<img src=\"tmpZHmUBT.png\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-4-A.svg\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "o,F~2jD|UG", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4740d913cfa140c3a4207d3c151f2a7b-oa-5", 
                "", 
                "<img src=\"tmpZHmUBT.png\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-5-A.svg\" />", 
                "<img src=\"4740d913cfa140c3a4207d3c151f2a7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y%kn_-]px=", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4ca0f2879c1741d4907301a746fdcaa6-oa-1", 
                "", 
                "<img src=\"tmpkwNqOz.png\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-1-A.svg\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "faK(tE0p,%", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4ca0f2879c1741d4907301a746fdcaa6-oa-2", 
                "", 
                "<img src=\"tmpkwNqOz.png\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-2-A.svg\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N:3vv:i6Yo", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4ca0f2879c1741d4907301a746fdcaa6-oa-3", 
                "", 
                "<img src=\"tmpkwNqOz.png\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-3-A.svg\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HY8*b}^F:2", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4ca0f2879c1741d4907301a746fdcaa6-oa-4", 
                "", 
                "<img src=\"tmpkwNqOz.png\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-4-A.svg\" />", 
                "<img src=\"4ca0f2879c1741d4907301a746fdcaa6-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Nc2GD&*O[F", 
            "note_model_uuid": "046d1c78-618b-11e8-835e-784f43a01554", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you treat Stage I &amp; II PCa?", 
                "<div><ul style=\"margin-left: 20px; \"><li>If Gleason score 2-5 (out of 10) = watch and wait<br />- Monitor with PSA levels</li><li>If gleason score greater --&gt; radical prostactectomy</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "HcI^s-KOAV", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you treat Stage III PCa?", 
                "<div>EBRT (external beam) + androgen deprivation therapy or radical prostatectomy</div>"
            ], 
            "flags": 0, 
            "guid": "PUA`BmY309", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you treat Stage IV PCa?", 
                "<div><ul style=\"margin-left: 20px; \"><li>Androgen deprivation therapy</li><li>Palliative care</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "A~u:n;aLeT", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ6"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the risk factors for ischaemic stroke? (CVD factors + AS)", 
                "<div><u>Non-modifiable</u></div><div><ul style=\"margin-left: 20px; \"><li>Age&nbsp;</li><li>Feale gender&nbsp;</li><li>FH</li><li>Past TIA or MI</li><li>Thrombophilia (Anti-thrombin 3 deficiency)&nbsp;</li><li>Pregnancy, cancer and other hypercoagulable states&nbsp;</li></ul></div><div><br /></div><div><u>Modifiable&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>AF&nbsp;</li><li>Smoking&nbsp;</li><li>DM&nbsp;</li><li>CKD</li><li>Obesity&nbsp;</li><li>Hypercholesterolaemia&nbsp;</li></ul></div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "c<],<?8!W$", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the risk factors for haemorrhagic stroke? (HTN + AS)", 
                "<div><u>Non-modifiable&nbsp;</u></div><div><ul style=\"margin-left: 20px; \"><li>Age</li><li>Male gender</li><li>FH</li><li>CT disease e.g. Ehler Danlos, vasculitis&nbsp;</li></ul></div><div><br /></div><div><u>Modifiable</u></div><div><ul style=\"margin-left: 20px; \"><li>HTN&nbsp;</li><li>Anticoagulant Rx</li></ul></div><div>+ risk factors for ischaemic stroke, as it can contribute to AS</div>"
            ], 
            "flags": 0, 
            "guid": "faUg]6p)jj", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": [
                "AnatQ3"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are some physical examination findings you may find with people with cardiovascular risk factors?", 
                "<div><ul style=\"margin-left: 20px; \"><li>General inspection: obesity, male, age, marfan’s</li><li>Hands: nicotine staining, clubbing (cyanotic heart disease), xanthomma</li><li>Pulse: irregularly irregular</li><li>BP: hypertensive</li><li>Face: xanthelesma, diabetic retinopathy</li><li>Chest: sternotomy scar, lateral displaced apex, thrills, murmurs</li><li>Carotids: bruits&nbsp;</li><li>Abdomen: AAA&nbsp;</li><li>Legs: skin changes, ulcers, pulses absent, PVD</li></ul></div>"
            ], 
            "flags": 0, 
            "guid": "tBN,s7sDWy", 
            "note_model_uuid": "1b65a503-5770-11e8-bbfe-30e37ab3e4ac", 
            "tags": []
        }
    ]
}